Reference ranges 2013 PAGE 1 NAME REFERENCE LOW REFERENCE HIGH UNITS ------(Log copies/mL) ANTIADRENAL AB SCREEN W/REFLEX (8292) BARBITURATES BY GCMS(D'CD 12/20/10) DRVVT FISH t(9;22)(BCR/ABL)(14861) FREE LIGHT CH 138832 PLT AB:GP IIb/IIIa "Negative" S. HYPOGLYCEMICS (DC'D 05/20/2010) # OF CELLS # OF CELLS # OF CELLS % FREE TESTOSTERONE % % CDT "<2.5" % % FREE PSA % % FREE TESTOSTERONE % % NEUTRALIZED % % RANK (B-LD CH) % % RANK (CHOL) % % RANK (TRIG) % % of Reference (LUA) RATIO ratio *MID (NE-GA) 24 %M 0.00% NACL OD OD 0.30% NACL % % 0.30% NACL OD OD 0.35% NACL % % 0.35% NACL OD OD 0.40% NACL % % 0.40% NACL OD OD 0.45% NACL % % 0.45% NACL OD OD 0.50% NACL % % 0.50% NACL OD OD 0.55% NACL % % 0.55% NACL OD OD 0.60% NACL % % 0.60% NACL OD OD 0.65% NACL % % 0.65% NACL OD OD 0.85% NACL % % 0.85% NACL OD OD 1,25-DIHYDROXYVIT D3 (DC'D 10/22/09) pg/mL 1/2HR LTT 1/2Hr.GTT MG/DL 1/2Hr.GTT (URINE) mg/dL 11-DEOXYCORTISOL (673) ug/mL 17-HYDROXYPROGESTERONE(17180) ng/dL 17-KETOGENIC STEROIDS (280) mg/24 hr 17-KETOSTEROIDS,TOTAL (277) mg/24 hr 17-OH (279) mg/24 hr 17OH PREGNENOL.34972 ng/mL 18-HYDROXYCORTICOSTERONE 900453 ng/dL 18-HYDROXYDEOXYCORTICOSTERONE 1HR INCUB. MIX sec. 1HR LTT 1HRTEST RESEARCH 1Hr.GTT mg/dL 1Hr.GTT (URINE) mg/dL 1TEST RESEARCH 2-METHYLCITRIC ACID Page 1 Reference ranges 2013 21-HYDROXYLASE (37916) 21-HYDROXYLASE AB, S "<1 U/ml" U/ml 24 HR URINE CORTISOL ug/24 h 24 HR URINE CORTISOL (135286) 24 HR. FECES TOTAL WEIGHT grams 24HR URINE VOL VMA 24hr. Urine Volume mL/24hrs. 2HR LTT 2Hr.GTT MG/DL 2Hr.GTT (URINE) mg/dL 3HR LTT 3Hr.GTT mg/dL 3Hr.GTT (URINE) mg/dL 3TC MUTATIONS 3TC 4Hr.GTT MG/DL 4Hr.GTT (URINE) mg/dL 5' NUCLEOTIDASE (14624*) U/L 5-1-1 (d'cd 8/30/07) 5-FLUOROCYTOSINE MIC 5-SITE REARRANGEMENT PANEL 5Hr.GTT MG/DL 5Hr.GTT (URINE) mg/dL 6 ACETYLMORPHINE ng/mL 6-MONOACETMORP 16097 "NONE DETECTED" 6-MONOACETYLMORPHINE "None detected" ng/mL 6Hr.GTT MG/DL MG/DL 6Hr.GTT (URINE) mg/dL 6MMP METABOLITE 6MP METABOLITES (PROMETHEUS) 6TG METABOLITE 72 HR. FECES TOTAL WEIGHT grams 8-OH AMOXAPINE MCG/L 8-OH LOXAPINE A A LOCUS A&N (2106) A-1-CONVERT. ENZYME A-1-CONVERT. ENZYME (SERUM) (5632) U/L A. FLAVUS A. FLAVUS AB "Negative" A. FUMIGATUS A. FUMIGATUS #1 A. FUMIGATUS #2 A. FUMIGATUS #3 A. FUMIGATUS #6 A. FUMIGATUS AB "Negative" A. NIGER A. NIGER AB "Negative" A. PULLULANS A.IGM AB PL,SER14532 A2 ANTIPLASMIN 48493 85 156 % A2 HEMOGLOBIN BY COLUMN 1.8 3.4 % % 4.41 7.41 % 1.86 3.36 % ABACAVIR MUTATIONS ABC ABG (CORRECTED FOR PT.TEMP.) ABL KINASE DOMAIN MUTATION ABL T3151 MUT.19782 "NEGATIVE" ABNORMAL FORMS 0 39 % ABNORMAL PROTEIN BAND 1 "NONE DETECTED" ABNORMAL PROTEIN BAND 1 (R) mg/dL ABNORMAL PROTEIN BAND 1 (U) mg/24 h ABNORMAL PROTEIN BAND 2 "NONE DETECTED" ABNORMAL PROTEIN BAND 2 (R) mg/dL Page 2 Reference ranges 2013 ABNORMAL PROTEIN BAND 2 (U) mg/24 h ABNORMAL PROTEIN BAND 3 ABNORMAL PROTEIN BAND 3 (R) mg/dL ABNORMAL PROTEIN BAND 3 (U) mg/24 h ABO TITER ABO/RH - LAB ABO/RH CONFIRMATION ABO/RH TYPING ABSOLUTE RETICULOCYE COUNT /cmm ACA CONTROLS ACANTHAMOEBA CULTURE ACANTHAMOEBA STAIN ACANTHOCYTES ACETALDEHYDE mg/dL ACETAMINOPHEN 10 30 ug/mL 10 30 ug/mL 19 35 UG/ML 65 88 UG/ML 110 164 UG/ML 20 41 UG/ML 67 97 UG/ML 113 170 UG/ML 7.5 22.3 mg/mL 99 187 mg/mL 6.90 20.60 106.00 198.00 94.0 122.0 ug/mL 4.08 6.52 ug/mL 26.7 34.7 ug/mL ACETAMINOPHEN (2106)
ACETAMINOPHEN (BLD) "None detected" ACETAZOLAMIDE ACETOHEXAMIDE ACETONE "NEG" "NEG" mg/dL "NEG" "NEG" mg/dL mg/dL ACETONE (2106) "NONE DETECTED"
ACETONE (BLD) "None detected" ACETONE, SERUM 205 "NEGATIVE" ACETYCHOLINESTERASE (1853) ACETYLCHOLINE RECEPTOR 206 nmol/L ACID FAST STAIN ACREMONIUM ACT-K, ANCILLARY 90 170 SEC ACTH (211) pg/mL pg/mL ACTHSTM 3 SPEC 149308 ACTIVATED PROTEIN C RESISTANCE (5865*) ratio ACTIVE METABOLITE ACUTE VIRAL HEPATITIS PROFILE ACYCLOVIR SENSITIVITY
ACh REC. BIND. AB nmol/L ACh REC. MOD. AB % ADAMTS13 (BC of SW Wisconsin) ADAMTS13 ACTIVITY % ADAMTS13 INHIBITOR Inh. Units ADDIS COUNT Page 3 Reference ranges 2013 ADDITIONAL CD MARKER1 ADDITIONAL CD MARKER10 ADDITIONAL CD MARKER11 ADDITIONAL CD MARKER12 ADDITIONAL CD MARKER13 ADDITIONAL CD MARKER14 ADDITIONAL CD MARKER15 ADDITIONAL CD MARKER16 ADDITIONAL CD MARKER17 ADDITIONAL CD MARKER18 ADDITIONAL CD MARKER19 ADDITIONAL CD MARKER2 ADDITIONAL CD MARKER20 ADDITIONAL CD MARKER21 ADDITIONAL CD MARKER22 ADDITIONAL CD MARKER23 ADDITIONAL CD MARKER24 ADDITIONAL CD MARKER25 ADDITIONAL CD MARKER26 ADDITIONAL CD MARKER27 ADDITIONAL CD MARKER28 ADDITIONAL CD MARKER29 ADDITIONAL CD MARKER3 ADDITIONAL CD MARKER30 ADDITIONAL CD MARKER4 ADDITIONAL CD MARKER5 ADDITIONAL CD MARKER6 ADDITIONAL CD MARKER7 ADDITIONAL CD MARKER8 ADDITIONAL CD MARKER9 ADDITIONAL DRUGS ADDITIONAL SCANS ADDITIONAL TESTING ADEFOVIR MUTATIONS ADENOSINE DEAMINASE, FLUID (17696) U/L U/L "<9.2" U/L U/L ADENOVIRUS DILS ADENOVIRUS (GPHL) ADENOVIRUS AB titer ADENOVIRUS AB, CF ADENOVIRUS TITER ADP (PLT AGG) ADV AFB CULTURE AFB CULTURE ASPIRATE AFB CULTURE BLOOD AFB CULTURE BRONCHIAL BRUSH AFB CULTURE BRONCHIAL WASH AFB CULTURE BRONCHOALVEOLAR LAVAGE AFB CULTURE CATHETER URINE AFB CULTURE CLEAN CATCH URINE AFB CULTURE CSF AFB CULTURE EXUDATE AFB CULTURE FOLEY URINE AFB CULTURE LEFT NEPHROSTOMY AFB CULTURE PERICARDIAL AFB CULTURE PERITONEAL AFB CULTURE PLEURAL FLUID AFB CULTURE RIGHT NEPHROSTOMY AFB CULTURE SKIN AFB CULTURE SPUTUM AFB CULTURE SUPRAPUBIC URINE AFB CULTURE SYNOVIAL AFB CULTURE TISSUE AFB CULTURE TRACHEAL ASPIRATE Page 4 Reference ranges 2013 AFB CULTURE TRANSTRACHEAL AFB ID, SEQ. 16714 AFB SMEAR AFB SMEAR ASPIRATE AFB SMEAR BRONCHIAL WASH AFB SMEAR BRONCHOALVEOLAR LAVAGE AFB SMEAR EXUDATE AFB SMEAR PERICARDIAL AFB SMEAR PERITONEAL AFB SMEAR PLEURAL FLUID AFB SMEAR SPUTUM AFB SMEAR STOOL AFB SMEAR SYNOVIAL AFB SMEAR TISSUE AFB SMEAR TRACHEAL ASPIRATE AFB SMEAR TRANSTRACHEAL AHT (2106) ALA,ETN ALB/GLOB .95 1.59 RATIO .95 1.59 RATIO 1.0 1.6 Ratio ALBUMIN 3 5 g/dL 3.0 5.0 g/dL 3.4 4.8 g/dL mg/dL g/dL g/dL g/dL g/dL 1980 2678 5146 6962 2.4 3.0 g/dL 4.6 5.2 g/dL 2.00 2.80 g/dL 3.80 5.40 g/dL 2.30 2.90 g/dL 4.40 5.20 g/dL g/dL 2.86 3.66 g/dL 2.64 3.36 g/dL ALBUMIN (2106) mg/dL ALBUMIN (NE-GA) 3.4 5.0 g/dl ALBUMIN (Q) 3.5 4.7 g/dL ALBUMIN - PE 3.50 4.70 g/dl 3.0 5 g/dL 14.60 20.60 mg/dL 40.5 52.5 mg/dL 3.7 4.9 1631 2447 mg/dL 4261 6391 mg/dL 3.05 4.15 g/dL 2.40 4.20 g/dL 3.85 4.0 2.5 2.71 ALBUMIN 24HR % ALBUMIN, CSF 8.0 42.0 mg/dL ALBUMIN, RANDOM URINE % ALBUMIN, SERUM 3.5 4.9 g/dL ALBUMIN-BOUND T4 ug T4/dL ALBUMIN-BOUND T4/ALBUMIN ug/G ALCIAN BLUE STAIN ALCOHOL, ISOPROPANOL (782) ALDOLASE (0212) IU/L ALDOSTERONE ug/24 hr ng/dL ALDOSTERONE ng/mL ALDOSTERONE (24HR URINE) (13856) Page 5 Reference ranges 2013 ALDOSTERONE (53532) ng/dL ALDOSTERONE(SERUM)(53532*)(D'CD12/10/10) ALDOSTERONE, 24 HR. ug/24 hr ALDRIN ALK PHOS (BONE) ALK PHOS (BONE) (2106) ALK PHOS (INTESTINAL) ALK PHOS (LIVER) ALK PHOS (NE-GA) 50 136 U/L ALK PHOS (TOTAL) 30 115 U/L 30 115 IU/L 32 103 IU/L 64 82 IU/L 340 400 IU/L 64 84 IU/L 358 418 IU/L 67 87 IU/L 369 409 IU/L 65.4 83.4 IU/L 183 231 IU/L ALK PHOS BONE 900859 U/L ALK PHOS ISOENZYMES (6432) ALK PHOS, HEAT LABILE (2106) ALK PHOS, HEAT STABLE (2106) ALK. PHOS. FRACTIONATION 1422 ALL ALLELE 1 (dc'd 09/10/07) ALLELE 2 (dc'd 09/10/07) ALLOPURINOL ALLOPURINOL PANEL (2106) ALPHA 1 GLOBULIN 0.1 0.3 g/dL ALPHA 1 GLOBULIN 24HR % ALPHA 2 GLOBULIN 0.5 1.0 g/dL ALPHA 2 GLOBULIN 24HR % ALPHA PITUITARY G HORMONE (PRE-7/18/01) ng/mL ALPHA SUBUNIT (2106) ALPHA-1 FRACTION ALPHA-1 GLOBULIN 0.10 0.30 g/dL .1 .3 g/dL .08 .32 0.1 0.3 g/dL 0.10 0.30 g/dL 0.14 0.17 0.08 0.12 ALPHA-1-ANTITRYPSIN mg/dL ALPHA-1-ANTITRYPSIN (ATT) 83 199 mg/dL 69 103 mg/dL 166 250 mg/dL 62 94 mg/dL 141 211 mg/dL ALPHA-1-ANTITRYPSIN PHENOTYPE ALPHA-1-ANTITRYPSIN PHENOTYPING (1819*) ALPHA-1-ANTITRYPSIN, FECES (5351) mg/dL ALPHA-2 FRACTION ALPHA-2 GLOBULIN 0.50 1.00 g/dL .6 1 g/dL .4 1.0 g/dL 0.3 0.7 g/dL 0.3 0.7 g/dL 0.55 0.59 0.33 0.40 ALPHA-FETO PROTEIN - TUMOR MARKER 0 9.0 ng/mL 0 8.4 ng/mL 18.5 28.5 ng/mL 110.8 156.2 ng/mL 11.3 16.9 ng/mL 108 164 ng/mL Page 6 Reference ranges 2013 6.60 19.70 97.00 180.00
ALPHA-FETOPROTEIN (Prior to 11/17/99) ng/mL ALPHA-FETOPROTEIN NEURAL TUBE DEFECT ALPHA-GL COMMON11175 ALPHA-GLOBIN MUT(11533)(DC'D12/6/12) ALPHA-HIGH DENSITY ALPHA-HIGH DENSITY CHOLESTEROL ALPHA-HIGH DENSITY TRIGLYCERIDE ALPHA-SUBUNIT, PITUITARY GLY ng/mL ALPHA-SUBUNIT, PITUITARY GLY (7823*)) ALPHA-THAL.GEN900619(DC'D 12/6/12) ALPHA-TOCOPHEROL 5.7 19.9 mg/L ALPHA-TOCOPHEROL (prior to 5/13/03) ug/mL ALPHA1 GLOBULIN RANDOM URINE % ALPHA2 GLOBULIN RANDOM URINE % ALPRAZOLAM ALT (SGPT) ALT (SGPT) 3 36 IU/L $S(SEX="M":0,1:0) $S(SEX="M":44,1:33) IU/L 19.0 25.0 IU/L 151 183 IU/L 17 29 IU/L 168 188 IU/L 21.0 27.0 IU/L 174 194 IU/L 31.0 39.4 IU/L 104 132 IU/L ALTERNARIA TENUIS ALUMINUM (2958) "<7 mcg/L" ug/L ug/L AM PHOSPHATE CRYSTALS AM URATE CRYSTALS AMANTADINE (2106) AMIKACIN (prior to 11/25/03) ug/mL uG/ML 4.3 6.50 UG/ML 18.5 26.5 UG/ML 4.3 6.5 UG/ML 14.7 16.7 UG/ML 18.5 26.5 UG/ML 3.0 9.0 ug/mL 17.2 32.0 ug/mL 3.20 9.70 18.3 34.0 AMIKACIN-PEAK (236) mcg/mL AMIKACIN-RANDOM (236) mcg/mL AMIKACIN-TROUGH (236) mcg/mL AMINO ACID, QUALITATIVE, URINE (14191) AMINOLEVULINIC ACID (114) mg/dL AMIODARONE ug/mL AMIODARONE (1990*) AMITRIPTYLINE ng/mL AMITRIPTYLINE (890*) AMM BIUR CRYSTALS AMMONIA 11 35 umol/L 9 35 umol/L 21 61 umol/L 595 685 umol/L AMOBARBITAL ng/mL ng/mL Page 7 Reference ranges 2013 ng/mL AMOBARBITAL (PM) AMOBARBITAL, URINE "Negative" ng/mL AMOEBA CULTURE (EMORY) AMOEBIASIS AMOEBIC CF ANTIBODY AMOEBIC IHA ANTIBODY AMOR PHOS CRYSTALS AMOR URATE CRYSTALS AMORBARBITAL AMORPHOUS SEDIMENT "NONE" u/L AMORPHOUS SEDIMENT (NE-GA) AMOXAPINE AMP AMPHETAMINE (PM) AMPHETAMINE CONFIRMATION BY GCMS AMPHETAMINE GCMS ng/ml AMPHETAMINES
AMPHETAMINES (2106)
AMPHETAMINES (BLD) "None detected" AMPHETAMINES (PM) AMPHETAMINES (on or before 5/29/03) 395 mA 240 280 mA 385 485 mA 340 400 mA 375 455 mA AMPHOTERICIN B AMPHOTERICIN B MIC AMPHOTERICIN MIC AMPICILLIN AMPRENAVIR MUTATIONS AMPRENAVIR (TDM) ug/mL AMYLASE 0 455 U/24hr 2 19 U/hr $S(SEX="M":16,1:21) $S(SEX="M":491,1:447 U/L 28 100 U/L 28 100 U/L U/L U/L U/L U/L 32 44 U/L 207 247 U/L 22 42 U/L 42 72 U/L 35 45 U/L 203 243 U/L 123.0 185.0 238.0 358.0 34.0 44.0 U/L 220 240 U/L 68 102 U/L 290 410 U/L U/L 65.2 83.2 IU/L 160 204 IU/L
AMYLASE (NE-GA) 25 115 U/L Page 8 Reference ranges 2013 AMYLASE ISOENZYMES (8142) AMYLASE TOTAL U/L AMYLASE, 24HR URINE AMYLOID STAIN AMYLOIDOSIS (4713) ANA ANA (PLEURAL FL.) (2106) ANAEROBE IDENTIFICATION ANAEROBIC CULTURE ANAFRANIL (2040) ANCA IgG ELISA EU/mL ANCA VASCULITIDES AB (36733) ANCILLARY BASE EXCESS -2 3 ANCILLARY BICARBONATE 18 23 Meq/L ANCILLARY BILIRUBIN "NEGATIVE" ANCILLARY BLOOD "NEGATIVE" ANCILLARY CARBOXYHEMOGLOBIN % ANCILLARY CHLORIDE mmol/L 122.20 131.20 mmol/L 91.50 100.50 mmol/L ANCILLARY FIO2 % ANCILLARY GLU. (dc'd 9/18/07) "NORMAL" ANCILLARY GLUCOSE 70 110 MG/DL MG/DL ANCILLARY GLUCOSE (BG) 70 110 MG/DL 76.00 90.00 MG/DL 183.00 213.00 MG/DL 284.00 334.00 MG/DL 0.56 0.74 mg/dL 263.00 313.00 mg/dL ANCILLARY HCT 42 52 % 30.3 34.3 % 49.2 54.2 % 33.00 38.00 % 45.00 51.00 % ANCILLARY HGB g/dL 9.70 12.70 g/dL 14.60 17.60 g/dL ANCILLARY HGB A1C % 4.5 6.7 % 8.2 12.4 % ANCILLARY INR 0.83 1.38 1.10 1.90 2.50 4.50 ANCILLARY IONIZED CALCIUM 1.13 1.33 MMOL/L 1.38 1.58 MMOL/L 0.99 1.15 MMOL/L 0.45 0.57 MMOL/L 1.03 1.19 mmol/L 1.50 1.74 mmol/L ANCILLARY IONIZED MAGNESIUM 0.42 0.62 mmol/L 0.84 1.14 MMOL/L 0.46 0.60 MMOL/L 0.29 0.41 MMOL/L ANCILLARY KETONES "NEGATIVE" ANCILLARY LACTATE 0.5 2.2 MMOL/L .50 1.00 MMOL/L 2.4 3.0 MMOL/L 6.8 8.2 MMOL/L ANCILLARY LEU. EST. "NEGATIVE" ANCILLARY METHEMOGLOBIN 0.4 1.2 % ANCILLARY NITRITE "NEGATIVE" ANCILLARY O2 SATURATION 94 100 % 49.1 55.1 % 92.3 98.3 % 36.8 42.8 % 94.4 100.4 % 54.70 63.70 % Page 9 Reference ranges 2013 88.90 96.90 % ANCILLARY OXYHEMOGLOBIN 94 100 % ANCILLARY PCO2 35 45 MMHG 50.90 60.90 MMHG 38.40 44.40 MMHG 19.0 24.00 MMHG 52.10 62.60 MMHG 37.60 44.60 MMHG 22.40 27.90 MMHG ANCILLARY PH 7.35 7.45 7.167 7.217 7.432 7.482 7.646 7.696 7.20 7.25 7.41 7.46 7.54 7.59 ANCILLARY PH (UA) 5 7 ANCILLARY PO2 80 90 MMHG 51.30 63.30 MMHG 93.40 105.40 MMHG 123.00 143.0 MMHG 52.00 68.00 MMHG 100.00 116.00 MMHG 129.00 153.00 MMHG ANCILLARY POTASSIUM 3.5 5.3 MMOL/L 5.67 6.17 MMOL/L 4.15 4.65 MMOL/ 1.69 2.29 MMOL/L 3.80 4.30 mmol/L 6.28 6.88 mmol/L ANCILLARY PROTEIN "NEGATIVE" ANCILLARY SODIUM 138 148 MMOL/L 157.70 162.70 MMOL/L 128.90 136.90 MMOL/L 120.90 128.90 MMOL/L 139.20 147.20 mmol/L 112.80 120.80 mmol/L ANCILLARY SPECIFIC GRAVITY 1.010 1.025 ANCILLARY TOTAL CO2 25 32 Meq/L ANCILLARY TOTAL HB (HGB) $S(SEX="M":14,1:12) $S(SEX="M":18,1:16) G/DL ANCILLARY TROPONIN-I ORDER ANCILLARY UREASE TEST "NEGATIVE" ANCILLARY URINALYSIS ANCILLARY UROBIL. "NORMAL" EU/dL ANDROSTENEDIONE (17182*) ng/dL ANIDULAFUNGIN ANION GAP mmol/L mmol/L ANISO (NE-GA) ANISOCYTOSIS ANNA-1 (anti-Hu) ratio ANNA-2 (anti-Ri) ANTHRAQUINONES (2106) ANTI EARLY ANTIGEN ANTIBODY "<1:20 (NEGATIVE)" ANTI HU (2106) ANTI MITOCHONDRIAL (693*)(DC'D03/31/11) Units ANTI NEUTRO CYTO AB ANTI NUCLEAR ANTIGEN ANTIBODY "<1:5 (NEGATIVE)" ANTI SMOOTH MUSCLE "<1:20 (NEGATIVE)" ANTI VIRAL CAPSID ANTIGEN ANTIBODY "<1:80 (NEGATIVE)" ANTI-ADRENAL AB (829) ANTI-CHIMERIC ANTIBODY mcg/mL Page 10 Reference ranges 2013 ANTI-CRYPTOCOCCAL LATEX ANTI-CYTOKERATIN % % 0 5 % 0 100 % % ANTI-CYTOKERATIN CELLS/CMM CELLS/CMM 0 75 CELLS/CMM 0 15000 CELLS/CMM 0 1 CELLS/CMM ANTI-CYTOKERATIN MARKERS ANTI-DNA ANTIBODY ANTI-EPIDERMAL AB ANTI-GLOM BASEMENT MEM (2873*) units ANTI-HBc, TOTAL ANTI-HBc, TOTAL (813) ANTI-HBs ANTI-HBs (2106) ANTI-HBs RATIO UNITS ANTI-HCV, 2nd Generation ANTI-HCV, 2nd Generation (2106) ANTI-HDV (1459) ANTI-IGE IGG 18877 "<168" ng/mL ANTI-LKM AB (71902) Units ANTI-MICROSOMAL ANTIBODY ANTI-MITOCHONDRIAL ANTIBODIES ANTI-MYOCARDIAL (4268) titer ANTI-OmpC IgA ELISA EU/mL ANTI-PARIETAL CELL AB (Prior to 1/1/03) titer ANTI-PLT AB 16288 (DC'D 08/18/10) ANTI-RETICULIN AB ANTI-SKELETAL MUSCLE (28*) titer ANTI-STREPTOLYSIN-O AB (031*) IU/mL ANTI-STRIATED MUSCLE ANTI-THROMBIN III ACT 80 120 % ANTI-THROMBIN III ACTIVITY 80 125 % ANTI-THROMBIN III ACTIVITY (F) % ANTI-THROMBIN III AG mg/dL ANTI-THROMBIN III PANEL (2106) ANTI-THYROGLOBULIN AB IU/mL ANTI-THYROGLOBULIN AB (700*) ANTI-THYROGLOBULIN ANTIBODY ANTI-THYROID AB PANEL 9042 ANTI-THYROID ANTIBODIES GROUP ANTI-THYROID PEROXIDASE (TPO) AB 5292 ANTI-TPO AB IU/mL ANTIBIOTIC LEVEL ANTIBODY SCREEN - LAB ANTIBODY SCREEN, PLATELET ANTIBODY SCREEN, PLATELET (Red Cross) ANTICARDIOLIPIN AB PANEL 19152 ANTICARDIOLIPIN IGG "<10" GPL U/mL ANTICARDIOLIPIN IGM "<10" MPL U/mL ANTICENTROMERE (2106) ANTICOAGULANTS ANTICONVULSANTS (2106)
ANTIDEPRESSANT (2106)
ANTIDEPRESSANT (BLD) "None detected" ANTIDIURETIC HOR (824*) pg/mL pg/mL ANTIEPILEPTICS ANTIFUNGAL DRUG LEVEL (2106) Page 11 Reference ranges 2013 ANTIFUNGAL MIC - AMPHOTERICIN (14169) ANTIFUNGAL MIC - FLUCONAZOLE (14170) ANTIFUNGAL MIC - ITRACONAZOLE (14171) ANTIFUNGAL MIC - KETOCONAZOLE (14173) ANTIFUNGAL MIC - VORICONAZOLE (14882) ANTIFUNGAL MIC 5-FLUOROCYTOSINE (14172) ANTIHISTAMINE (2106) ANTIMONY (2106) ANTINEUTROPHIL AB (RED CROSS) ANTISTREPTOLYSIN SC (2106) ANTISTREPTOLYSIN-O ANTITHROMBIN (216) AOH ALPRASOLAM (PM) AOH TRIAZOLAM (PM) APOLIPOPROTEIN A-1 (22252) mg/dL APOLIPOPROTEIN B-100 (22262) mg/dL APOLIPOPROTEIN-E GENOTYPE APPEARANCE "CLEAR"
APTT sec. 22 34 sec. APTT (2106) sec. sec. APTT MIX (2106) sec. sec. APTT MIXING STUDIES (2106) APTT SUB TEST (Prior to 3/31/99) APTT SUBSTITUTION TEST ARACHIDONIC ACID (PLT AGG) 83 % ARBOVIRUS ARBOVIRUS CALIF TITER ARBOVIRUS EEE TITER titer ARBOVIRUS IGM AB PANEL, CSF (18344*) ARBOVIRUS SLE TITER titer ARBOVIRUS TITER ARBOVIRUS WEE TITER titer ARG,LYS,ASA,SER,TAU ARGENTAFFIN STAIN ARGYROPHIL STAIN ARSENIC ug/L "<23" mcg/L mcg/L ARSENIC (269) ARSENIC, 24HR URINE "<=80" mcg/mL ARSENIC, RANDOM UR mcg/g cr ARTIFACT "NONE" ARYLSULFATASE A ARYLSULFATASE A (34694X) U/mL ASCA IgA ELISA EU/mL ASCA IgG ELISA EU/mL ASCARIS ASPERGILLUS AB BY CF titer ASPERGILLUS AB SCREEN, SERUM (1445*) ASPERGILLUS AB SERUM ASPERGILLUS AG, S (DC'D 11/6/12) "<0.5" INDEX ASPERGILLUS ANTIGEN (14950) ASPERGILLUS COMPLEMENT TITER 0 "1:8" ASPERGILLUS FUMIGATUS (CF) ASPERGILLUS FUMIGATUS (ID) ASPERGILLUS INDEX "<5" Page 12 Reference ranges 2013 ASPERGILLUS INTERP. ASPERGILLUS MIXED (ID) ASPERGILLUS MIXED (ID) ASPIRATION, BONE MARROW AST (SGOT) 8 40 IU/L 8 40 IU/L 8 40 IU/L 24 32 IU/L 155 195 IU/L 27.8 39.8 IU/L 175 203 IU/L 26 36 IU/L 175 207 IU/L 31.9 40.7 IU/L 104 132 IU/L ATAXIA PROFILE (2106)(dc'd 9/7/07) ATAXIA PROFILE-COMPLETE (dc'd 9/7/07) ATM ATV ATYPICAL LYMPHOCYTES % % % % % % % AUER RODS AUTOLOGOUS CYTAPH NOT 1ST AUTOLOGOUS CYTAPHERESIS 1ST AUTOLOGOUS PLASMAPH NOT 1ST AUTOLOGOUS PLASMAPHERESIS 1ST AUTOLOGOUS WHOLE BLOOD 1ST AUTOLOGOUS WHOLE BLOOD NOT 1ST AUTOPSY AUTOPSY H & E AUTOPSY LOG-IN AUTOPSY SECTION COMPLETE AUTOPSY UNSTAINED SLIDE AZT MUTATIONS AZT/ddI/ddC MUTATIONS Anti-HCV ApoE allele 1 ApoE allele 2 B B 12 200 800 pG/ML 200 800 pG/ML 180 914 pG/ML 125 245 pg/ml 455 595 pg/ml 871.077 1171.077 pg/ml 148 304 pg/mL 527.0 921.0 pg/mL 127.00 259.00 524.00 819.00 796 1194 pg/mL 368.6 627.4 pg/mL B LOCUS B LYMPHOCYTES B-CELL GENE REARRANGEMENT, PCR (14868)
B-LD CHOLESTEROL B-LD TRIGLYCERIDE B. HENSELAE AB PANEL B. HENSELAE IGG titer B. HENSELAE IGG SCR "NEGATIVE" B. HENSELAE IGG TIT. "<1:64" B. HENSELAE IGM titer Page 13 Reference ranges 2013 B. HENSELAE IGM SCR "NEGATIVE" B. HENSELAE IGM TIT. "<1:20" B. PARAPERTUSSIS DNA "Not detected" B. PERTUSSIS 17136 B. PERTUSSIS DNA "Not detected" B. QUINTANA AB PANEL B. QUINTANA IGG titer B. QUINTANA IGG SCR "NEGATIVE" B. QUINTANA IGG TIT. "<1.64" B. QUINTANA IGM titer B. QUINTANA IGM SCR "NEGATIVE" B. QUINTANA IGM TIT. "<1:20" B. dermatitidis, CF titer BACTERIAL IDENTIFICATION BACTERIAL MENINGITIS ANTIGENS (34084) BAND (NE-GA) % BAND RESOLUTION BANDING TECHNIQUE BARBITURATES
BARBITURATES (2106)
BARBITURATES (408) BARBITURATES (BLD) "None detected" BARBITURATES (PM) BARBITURATES (on or before 5/29/03) mA 330 410 mA 521 561 mA 392 472 mA 447 527 mA BARBITURATES BY GC/MS UR (4087) BARTONELLA DNA, PCR (6639) BARTONELLA HENSELAE DNA "NOT DETECTED" "NOT DETECTED" BARTONELLA QUINTANA DNA "NOT DETECTED" BARTONELLA RFL144002 BASE EXCESS -2.0 +3.0 mmol/L -2.0 +2.0 mmol/L BASIC METABOLIC PANEL BASIC METABOLIC PANEL (NE-GA) BASO # 0.01 0.08 K/cmm BASO % 0.0 2.5 % BASO (NE-GA) % BASO STIP (NE-GA) BASO.MYELO/METAS 0 1 % BASOPHIL-BANDS 0 1 % BASOPHILIC STIPPLING BASOPHILS 0 3 % 0 1 % BATH SALTS, UR 90979 BB (Isoenzyme) % BCL 6 BCL-2 GR (EMORY) BCR-ABL, SOUTHERN BLOT BCR-ABL, SOUTHERN BLOT (11334) BCR-ABL1 GENE REARR QNT PCR 91065 BCR-ABL1/ABL1 % % % BCR-ABL1/ABL1 %(IS) % % BCR/ABL BCR/ABL (EMORY) BCR/ABL GENE REAR15052(DC'D08/12) BENCE JONES PROTEIN BENZENE Page 14 Reference ranges 2013 BENZODIAZEPINE CONF.BY GCMS(19137) BENZODIAZEPINES
BENZODIAZEPINES (2106)
BENZODIAZEPINES (PM) BENZODIAZEPINES (on or before 5/29/03) mA 281 361 mA 436 516 mA 410 490 mA 455 535 mA BENZOYLECGONINE ng/mL BENZOYLECGONINE (PM) BERYLLIUM BETA 2 MICROGLOBULIN (852) "<=2.51" mg/L BETA FRACTION BETA GLOBULIN 0.80 1.40 g/dL .6 1.3 g/dL 0.60 1.20 0.5 0.9 g/dL 0.5 0.9 g/dL 0.66 0.72 0.45 0.52 BETA GLOBULIN (Q) 0.8 1.4 g/dL BETA GLOBULIN 24HR % BETA GLOBULIN RANDOM URINE % BETA HCG - QUANT. (prior to 7/29/03) 0 9.9 mIU/mL 22.5 32.10 mIU/mL 533 733 mIU/mL 22.5 32.1 mIU/mL 533 733 mIU/mL 14.00 21.00 533 733 5.85 8.77 mIU/mL 18.56 27.84 mIU/mL BETA HCG - QUANTITATIVE 0 3 mIU/mL 0 3 mIU/mL
BETA HYDROXYBUTYRATE 0.0 0.3 mM 0.0 0.3 mM 0.41 0.61 mM 1.15 1.55 mM BETA LACTOGLOBULIN BETA&GAMMA-TOCOPHEROL (prior to 5/13/03) ug/mL BETA-2 GLYCOPROTEIN 1 AB (IGG) "LESS THAN 20 U/ml" U/ml BETA-GAMMA TOCOPHEROL "<=4.3" mg/L BETA-GLOBIN COMPLETE (14974) BETA-VLD BETA-VLD CHOL BETA-VLD TRIG BETA2 TRANSF. 10640 BETHESDA ASY BETHESDA UNITS BI-LOBED NEUTROPHILS BICARBONATE (HCO3) 18.0 23.0 mmol/L 22.0 29.0 mmol/L BIELSCHOWSKY STAIN BILE, STEIN, OR GMELIN STAIN BILIRUBIN,TOTAL & DIRECT BIOCEPT G (2106) BIOCHEMICAL RISK FACTOR BIOPSY Page 15 Reference ranges 2013 BISCODYL (2106) BISMUTH, SERUM (513) MCG/L BK AND JC VIRUS DNA(DC'D 03/23/11) BK VIRUS DNA QNT PCR "<500" copies/mL BK VIRUS DNA, QL PCR "Not detected" "Not detected" BK VIRUS QNT 112748 BK VIRUS, PCR (EMORY) copies/ml BK/JC VIRUS (110688) BLAST (NE-GA) % BLASTOMYCES AB BLASTOMYCES AB, ID "Negative" BLASTOMYCES COMPLEMENT(PRIOR TO 3/20/96) 0 "1:8" BLASTOMYCES DERMATITIDIS (CF) BLASTOMYCES DERMATITIDIS (ID) BLASTS % % % % % % % % BLASTS 1 3 % BLASTS # # BLEEDING TIME 2.4 9.5 mins. BLOCK/SPECIMEN ID BLOOD COMPONENT LOG-IN BLOOD CULTURE BLOOD CULTURE BLOOD GAS PROFILE (CONTROLS) BLOOD GAS PROFILE (NOVA M) BLOOD GAS PROFILE - HCT/O2 SAT (NOVA M) BLOOD GAS, ANCILLARY BLOOD GASES BLOOD SMEAR INTERPRETATION BNP (IN-HOUSE) 0 99 pg/mL BNP(SEND OUT)(13121*) pg/mL pg/mL BONE MARROW ASPIRATION BONE MARROW DIFFERENTIAL BONE SP. ALK. PHOS 7.6 14.9 mcg/L BONE SP. ALK. PHOS.(29498) BORDETELLA PERTUSSIS BORDETELLA PERTUSSIS SMEAR BOVINE BRACANALYSIS BRAF MUTATION BRAF MUTATION 16767 BRAF V600 MUTATION BRCA1 SEQUENCING BRCA2 SEQUENCING BROAD CASTS "NONE" /LPF BROMIDE (063) ug/mL BRONCHIAL BRUSHING CYTOLOGY BRONCHIAL WASHING CYTOLOGY BRONCHOALVEOLAR LAVAGE BRUC. IGG,IGM 142032 BRUCELLA (IgG, IgM) EIA (DC'D 09/27/11) BRUCELLA AB IgG Units BRUCELLA AB IgM Units BRUCELLA ABORTUS AB (018) titer BRUCELLA BLOCKING ANTIBODIES BRUSHITE RS 2 2 BUDDING YEAST "NONE" Page 16 Reference ranges 2013 BUFFERED LATEX (NAL)* U/ml BULLOUS PEMPH. 16034 U/mL BUN (NE-GA) 3 23 mg/dl BUPRENORPHINE (16310) "None detected" BURR CELLS 0 1 BUTABARBITAL ng/mL ng/mL ng/mL BUTABARBITAL (2106) BUTABARBITAL, URINE "Negative" ng/mL BUTALBITAL ng/mL ng/mL ng/mL BUTALBITAL (2106) BUTALBITAL (PM) BUTALBITAL, URINE "Negative" ng/mL BW (dc'd 9/25/07) Bw C DIFF TOX B GENE PCR "" "Negative" C DIFFICILE TOXIN (PRIOR TO 7/14/97) C LOCUS C&S (ANAEROBE) AQUEOUS FLUID C&S (ANAEROBE) CSF C&S (ANAEROBE) PERICARDIAL C&S (ANAEROBE) PERITONEAL C&S (ANAEROBE) PLEURAL FLUID C&S (ANAEROBE) SYNOVIAL C&S (ANAEROBE) TRANSTRACHEAL C&S (ANAEROBE) VITREOUS FLUID C&S (ANAEROBES) ASPIRATE C&S (ANAEROBES) EXUDATE C&S (ANAEROBES) LEFT NEPHROSTOMY C&S (ANAEROBES) RIGHT NEPHROSTOMY C&S (ANAEROBES) SUPRAPUBIC URINE C&S (ANAEROBES) TISSUE C&S BONE C&S BRONCHIAL BRUSH C&S BRONCHIAL WASH C&S BRONCHOALVEOLAR LAVAGE C&S CATHETER URINE C&S CATHETER, NOS C&S CENTRAL IV CATHETER C&S CERVICAL SWAB C&S CLEAN CATCH URINE C&S CORNEA C&S CORNEA DONOR C&S CORNEA RECIPIENT C&S CORNEAL SCRAPINGS C&S EYE C&S FOLEY URINE C&S GRAFT C&S HICKMAN CATHETER C&S IMPLANT C&S LEFT EAR C&S LENS C&S NASAL C&S PERIPHERIAL IV CATHETER C&S RIGHT EAR C&S SPUTUM C&S SWAN-GANZ CATHETER C&S TRACHEAL ASPIRATE C&S URETHRAL SWAB C&S VALVE C&S WOUND C-1Q COMPLEMENT COMPONENT C-1Q IMMUNE COMPLEX C-22-3 Page 17 Reference ranges 2013 C-KIT MUTATION 19961 C-PEPTIDE (372) 0.8 3.1 ng/mL C-REACTIVE PROTEIN (prior to 2/11/03)) mg/dL C. DIFF (PCR) "NEGATIVE" C. DIFF CULTURE C. DIFF TOXIN A/B (DC'D 06/01/11) "NEGATIVE" C. DIFFICILE TOXIN A C. DIFFICILE TOXIN A C. DIFFICILE TOXIN A/B (CLEARANCE) C. NEOFORMANS ANTIGEN C. THRAC RECTAL 16505 "Not detected" C. TRACH DNA PROBE "Not detected" "Not detected" C. TRACH RNA TMA "Not detected" C. TRACH. PROBE 2602 "Not detected" "Not detected" C. TRACH. RNA, TMA "Not detected" "Not detected" C. TRACH./N. GONORR.RNA/TMA 11363 C. TRACHOMATIS DNA C. TRACHOMATIS DNA PROBE 2602 "Not detected" "Not detected" C. TRACHOMATIS DNA, SDA C. TRACHOMATIS IGA titer C. TRACHOMATIS IGG titer C. TRACHOMATIS IGM titer C. TRACHOMATIS, DNA PCR (URINE) (10236) C.PNEUMONIAE IgA C.PNEUMONIAE IgG C.PNEUMONIAE IgM C.PSITTACI IgA C.PSITTACI IgG C.PSITTACI IgM C.TRACH DNA/SDA17303 "NOT DETECTED" "NOT DETECTED" "NOT DETECTED" "NOT DETECTED" C.TRACH. (D-K)IgA C.TRACH. (D-K)IgG C.TRACH. (D-K)IgM C.TRACH. (L2)IgA C.TRACH. (L2)IgG C.TRACH. (L2)IgM C1 INHIBITOR (298) 11 26 mg/dL C100-3 C22:0 "<=96.3" umol/L C24:0 "<=91.4" umol/L C24:0/C22:0 "<=1.39" ratio C26:0 "<=1.30" umol/L C26:0/C22:0 "<=0.023" ratio C282Y CA 19-9 (4698) "<37" U/mL CA CARB CRYSTALS "NONE" CA CH. BINDING AB pmol/L CA ENCEPHALITIS VIRUS AB PANEL, IFA CA INTERPT. CA IgG titer CA IgM titer titer CA OXALATE CRYSTALS "NONE" CA PHOS CRYSTALS "NONE" CA++ OXALATE CRYSTALS (NE-GA) CA-125 (21382) "<=20" U/mL CA-125 (FLUID)(2106) CA-15-3 (2266*) U/mL Page 18 Reference ranges 2013 CADMIUM (2106) CAFFEINE (2106) CALCITONIN pg/mL CALCITONIN (382*) CALCIUM 100 300 mg/24hrs mg/12Hrs 8.5 10.9 mg/dL mg/dL 8.6 10.2 mg/dL 8.6 10.2 mg/dL 6.8 8.8 mg/dL 10.7 13.5 mg/dL 6.4 8.0 mg/dL 10.8 15.8 mg/dl 6.2 10.20 mg/dL 11.0 13.8 mg/dL 6.80 8.40 10.60 13.0 6.0 10.0 mg/dl 10.7 13.5 mg/dL 5.9 8.8 mg/dL 8.40 12.6 mg/dL 7.74 9.10 mg/dL 13.0 15.4 mg/dL
CALCIUM (NE-GA) 8.5 10.5 mg/dl CALCIUM (PTH) mg/dL CALCIUM OXALATE RS 2 2 CALCIUM STAIN CALCIUM, 24HR URINE CALCULATED OSMOLALITY 275 300 mOsmol/kg CALCULUS (758) CAMPYLOBACTER CULTURE CANDIDA PRECIPITANS (2106) CANDIDOSIS (ID) CANNABINOIDS CANNABINOIDS (2106)
CAP PTH 5.0 39.0 PG/ML CAP/CIP 1.1 6.9 RATIO CAR AUTOANTIBODY TEST CARBAMAZEPINE 4 12 ug/mL 4 12 ug/mL 2.6 3.90 UG/ML 7.80 11.80 UG/ML 12.1 18.1 UG/ML 2.8 4.2 UG/ML 9.2 10.5 UG/ML 12.3 18.4 UG/ML 1.5 4.5 ug/mL 10.7 20.7 ug/mL 1.80 5.40 12.50 20.00 13.6 18.8 ug/mL 2.99 4.15 ug/mL 8.33 11.49 ug/mL CARBOHYDRATE-DEF. TRANSF. 16985 CARBON TETRACHLORIDE CARBOXYHEMOGLOBIN % 36.10 39.70 % Page 19 Reference ranges 2013 33.9 37.5 % 33.00 39.00 % CARBOXYHEMOGLOBIN CARDIAC ISOENZYMES CARDIOLIPIN IGA 4661 "<10" APL U/mL CARDIOLIPIN IGG 4662 GPL U/mL CARDIOLIPIN IGM 4663 MPL U/mL CARISPRODAL (2106) CARNITINE (2645*) CARNITINE, ESTERS umol/L CAROTENE (072*) mcg/dL CASPOFUNGIN CAT SCRATCH AB PANEL (3511*) CATECHOLAMINE,T. (PRIOR TO 4/25/97) CATECHOLAMINES
CATECHOLAMINES (24HR. U.), TOTAL (2106) CATECHOLAMINES (PLASMA), FRACT. (14566*) CATECHOLAMINES (PLASMA),TOTAL(18463) CATECHOLAMINES (URINE), FRACT. (464*) CATECHOLAMINES PL,TOT.18463(DC'D09/12) CATECHOLAMINES TOT.P pg/mL CATECHOLAMINES, FRACT. (2106) CATECHOLAMINES, TOTAL 26 121 mcg/24 hr pg/mL pg/mL CBC CBC & MORPHOLOGY (NO DIFF) CBC (WITHOUT DIFF.) CBC PROFILE CBC w/o DIFF (NE-GA) CBC with DIFF (NE-GA) CBC with DIFF. (Automated) CBFB CD10 (ANTI-CALLA) 0 8 % 0 5 % 0 100 % CD10 CELLS/CMM 0 180 CELLS/CMM 0.0 150 CELLS/CMM 0 15000 CELLS/CMM 150 10000 CELLS/CMM CD10 MARKERS CD103 0 100 % 0 100 % 0 100 % CD103 CELLS/CMM 0 5000 CELLS/CMM 0 5000 CELLS/CMM 0 5000 CELLS/CMM 0 100 C/CMM CD103 MARKER CD11 6 30 % 5 30 % 0 100 % CD117 0 100 % 0 100 % 0 100 % CD117 CELLS/CMM 0 5000 CELLS/CMM 0 5000 CELLS/CM 0 5000 CELLS/CMM 0 514 CELLS/CMM CD117 MARKER CD11C CELLS/CMM 80 680 CELLS/CMM Page 20 Reference ranges 2013 70 750 CELLS/CMM 0 15000 CELLS/CMM 200 6700 CELLS/CMM CD11C MARKERS CD11b % % 0 100 % CD11b CELL/CMM CELLS/CMM CELL/CMM 0 15000 CELLS/CMM 2300 6400 CELLS/CMM CD11b MARKERS CD13 0 11 % 0.0 10 % 0 100 % CD13 CELLS/CMM 0 220 CELLS/CMM 0.0 250 CELLS/CMM 0 15000 CELLS/CMM 2200 6350 CELLS/CMM CD13 MARKERS CD138 0 100 % 0 100 % 0 100 % CD138 CELLS/CMM 0 5000 CELLS/CMM 0 5000 CELLS/CMM 0 5000 CELLS/CMM 0 651 CELLS/CMM CD138 MARKERS CD14 0 4 % 0.0 5 % 0 100 % CD14 CELLS/CMM 0 80 CELLS/CMM 0.0 125 CELLS/CMM 0 15000 CELLS/CMM 95 700 CELLS/CMM CD14 MARKERS CD15 % 0.0 7 % 0 100 % CD15 CELLS/CMM CELLS/CMM 0.0 200 CELLS/CMM 0 15000 CELLS/CMM 1600 6150 CELLS/CMM CD15 MARKERS CD16 % % 0 100 % CD16 CELLS/CMM CELLS/CMM CELLS/CMM 0 15000 CELLS/CMM 1730 6000 CELLS/CMM CD16 MARKERS CD16/56 % (NK CELLS) 4 24 % 4 24 % 5 24 % % 0 100 % 11.7 27.7 6.5 16.5 CD16/56 MARKERS CD16/56 NK CELLS/CMM 50 550 CELLS/CMM 50 550 CELLS/CMM Page 21 Reference ranges 2013 50 625 CELLS/CMM 0 15000 CELLS/CMM 177 591 143 481 CD19 (B-CELLS) 5 23 % 5 23 % 5 23 % 4 20 % 0 100 % 12.9 28.9 7.4 17.4 CD19 (B-CELLS/CMM) 50 600 CELLS/CMM 50 600 CELLS/CMM 50 600 CELLS/CMM 0 15000 CELLS/CMM 50 500 CELLS/CMM 195 599 162 490 CD19 MARKERS CD19+11C CELLS/CMM (dc'd 8/23/07) 0 240 CELLS/CMM 0.0 180 CELLS/CMM 0 15000 CELLS/CMM 0 150 CELLS/CMM CD19+11C% (dc'd 8/23/07) 0 11 % 0.0 6 % 0 100 % 0 3 % CD19+CD11C MARKERS CD2 (T-CELLS) 71 99 % 70 94 % 0 100 % CD2 MARKERS CD2 T-CELLS/CMM 800 2500 CELLS/CMM 800 2350 CELLS/CMM 0 15000 CELLS/CMM 50 3700 CELLS/CMM CD20 7 33 % 6 33 % 0 100 % CD20 CELLS/CMM 80 720 CELLS/CMM 70 800 CELLS/CMM 0 15000 CELLS/CMM 50 530 CELLS/CMM CD20 MARKERS CD20+11C CELLS/CMM 0 240 CELLS/CMM 0.0 180 CELLS/CMM 0 15000 CELLS/CMM 0 150 CELLS/CMM CD20+11C% (HCL) 0 11 % 0.0 6 % 0 100 % 0 3 % CD20+CD11C MARKERS CD22 (B-CELLS) 3 31 % 4 25 % 0 100 % CD22 B-CELLS/CMM 0 600 CELLS/CMM 40 650 CELLS/CMM 0 15000 CELLS/CMM 50 550 CELLS/CMM CD22 MARKERS CD23 0 6 % 0.0 12 % 0 100 % Page 22 Reference ranges 2013 CD23 CELLS/CMM 0 180 CELLS/CMM 0.0 300 CELLS/CMM 0 15000 CELLS/CMM 0 500 CELLS/CMM CD23 MARKERS CD24 % % 0 100 % 0 100 % 48 80 % CD24 CELLS/CMM CELLS/CMM CELLS/CMM CELLS/CMM 1860 5900 CELLS/CMM CD24 MARKERS CD25 0 11 % 0.0 10 % 0 100 % CD25 CELLS/CMM 0 220 CELLS/CMM 0.0 250 CELLS/CMM 0 15000 CELLS/CMM 20 1300 CELLS/CMM CD25 MARKERS CD3 (T-CELLS) 59.4 86 % 59 86 % 59 86 % 62.6 82.6 % 0 100 % 46.7 70.7 66.2 86.2 CD3 (T-CELLS/CMM) 670 2300 CELLS/CMM 670 2300 CELLS/CMM 670 2300 CELLS/CMM 0 15000 CELLS/CMM 400 3100 CELLS/CMM 708 1335 1453 2337 CD3 MARKERS CD3+HLA-DR % 0 26 % 0 26 % 0 100 % CD3+HLA-DR CELLS/CMM 0 670 CELLS/CMM 0 670 CELLS/CMM 0 15000 CELLS/CMM CD3+HLA-DR MARKERS CD30 % 0 6 % 0 5 % 0 100 % 0 0 % CD30 CELLS/CMM 0 180 CELLS/CMM 0 150 CELLS/CMM 0 15000 CELLS/CMM 0 2 CELLS/CMM CD30 MARKERS CD33 0 12 % 0.0 10 % 0 100 % CD33 CELLS/CMM 0 200 CELLS/CMM 0.0 220 CELLS/CMM 0 15000 CELLS/CMM 200 11000 CELLS/CMM CD33 MARKERS CD34 % 0.0 4 % 0 100 % Page 23 Reference ranges 2013 CD34 CELLS/CMM CELLS/CMM 0.0 125 CELLS/CMM 0 15000 CELLS/CMM 0 80 CELLS/CMM CD34 MARKERS CD36 0 100 % 0 100 % 0 100 % CD36 CELLS/CMM 0 5000 CELLS/CMM 0 5000 CELLS/CMM 0 5000 CELLS/CMM CD36 MARKER CD38 30 110 % 30 95 % 0 100 % CD38 CELLS/CMM 510 2710 CELLS/CMM 450 2400 CELLS/CMM 0 15000 CELLS/CMM 1000 14000 CELLS/CMM CD38 MARKERS CD38+CD138 % 0 100 % 0 100 % 0 100 % 0 0 % CD38+CD138 CELLS/CMM 0 5000 CELLS/CMM 0 5000 CELLS/CMM 0 5000 CELLS/CMM 0 0 CELLS/CMM CD38+CD138 MARKER CD38+CD19 % 0 100 % 0 100 % 0 100 % 0 5 % CD38+CD19 CELLS/CMM 0 5000 CELLS/CMM 0 5000 CELLS/CMM 0 5000 CELLS/CMM 0 350 CELLS/CMM CD38+CD19 MARKER CD4 (T-HELPER) 29 66 % 29 66 % 29 66 % 35 63 % 0 100 % 6.2 16.2 42.3 54.3 CD4 (T-HELPER/CMM) 500 1750 CELLS/CMM 500 1750 CELLS/CMM 500 1750 CELLS/CMM 0 15000 CELLS/CMM 100 2100 CELLS/CMM 89 309 928 1438 CD4 MARKERS CD41a % 0 100 % 0 100 % 0 100 % CD41a CELLS/CMM 0 5000 CELLS/CMM 0 5000 CELLS/CMM 0 5000 CELLS/CMM 0 2900 CELLS/CMM CD41a MARKER CD45 90 100 % 98 100.0 % 0 100 % Page 24 Reference ranges 2013 CD45 CELLS/CMM 700 3300 CELLS/CMM 1000 3000 CELLS/CMM 0 15000 CELLS/CMM 1000 15000 CELLS/CMM 1492 2292 2272 3072 CD45 MARKERS CD5 + CD19 CELLS % 0 11 % 0.0 7 % 0 100 % 0 1 % CD5 + CD19 CELLS/CMM 0 240 CELLS/CMM 0.0 170 CELLS/CMM 0 15000 CELLS/CMM 0 61 CELLS/CMM CD5 + CD19 MARKERS CD5 CELLS 63 87 % 60 87 % 0 100 % CD5 CELLS/CMM 530 2610 CELLS/CMM 650 2300 CELLS/CMM 0 15000 CELLS/CMM 40 3600 CELLS/CMM CD5 MARKERS CD55 % % 0 100 % 0 100 % 73 95 % CD55 CELLS/CMM CELLS/CMM CELLS/CMM CELLS/CMM 2800 7100 CELLS/CMM CD55 MARKERS CD56 % % 0 100 % CD56 CELLS/CMM CELLS/CMM CELLS/CMM 0 15000 CELLS/CMM 64 1011 CELLS/CMM CD56 MARKERS CD57 % 0 100 % 0 100 % 0 100 % CD57 CELLS/CMM 0 5000 CELLS/CMM 0 5000 CELLS/CMM 0 5000 CELLS/CMM CD57 MARKER CD59 % % 0 100 % 0 100 % 60 100 % CD59 CELLS/CMM CELLS/CMM CELLS/CMM CELLS/CMM 2500 7690 CELLS/CMM CD59 MARKERS CD61 % % % 0 100 % 0 42 % CD61 CELLS/CMM CELLS/CMM CELLS/CMM 0 15000 CELLS/CMM 0 3200 CELLS/CMM Page 25 Reference ranges 2013 CD61 MARKERS CD64 % 0 100 % 0 100 % 0 100 % 32 92 % CD64 CELLS/CMM 0 5000 CELLS/CMM 0 5000 CELLS/CM 0 5000 CELLS/CMM 1100 3200 C/CMM CD64 MARKER CD7 (T-CELLS) 61 93 % 60 93 % 0 100 % CD7 MARKERS CD7 T-CELLS/CMM 660 2460 CELLS/CMM 650 2350 CELLS/CMM 0 15000 CELLS/CMM 40 3900 CELL/CMM CD71 % % 0 100 % CD71 CELLS/CMM CELLS/CMM CELLS/CMM 0 15000 CELLS/CMM 0 74 CELLS/CMM CD71 MARKERS CD79a % 0 100 % 0 100 % 0 100 % 0 6 % CD79a CELLS/CMM 0 5000 CELLS/CMM 0 5000 CELLS/CMM 0 5000 CELLS/CMM 0 380 CELLS/CMM CD79a MARKERS CD8 (T-SUPPRESSOR) 11 37 % 11 37 % 11 37 % 11 39 % 0 100 % 32.7 50.7 18.9 30.9 CD8 + CD38 % 8 36 % 5 30 % 0 100 % CD8 + CD38 CELLS/CMM 160 420 CELLS/CMM 70 750 CELLS/CMM 0 15000 CELLS/CMM CD8 + CD38 MARKERS CD8 MARKERS CD8 T-SUPPRESSOR/CMM 180 950 CELLS/CMM 180 950 CELLS/CMM 180 950 CELLS/CMM 0 15000 CELLS/CMM 50 1050 CELLS/CMM 496 932 415 830 CDT (Q) 28.1 76.0 mg/dL CEA 0 5 ng/mL 0 5.0 ng/mL 0.52 1.08 NG/ML 12.48 17.48 NG/ML 0.52 1.08 ng/mL 22 34 ng/mL 0.61 1.83 Page 26 Reference ranges 2013 19.30 35.80
CEA (Prior to 1/19/00) 0 5 ng/ml 0 5 NG/ML 0 5 NG/ML 1.8 3.8 12.5 18.7 0.70 2.00 NG/ML 18.0 28.0 NG/ML 3.5 6.5 16.0 24.0 80.0 120.0 CEA-S, RIA CELL COUNT (FLUID) CELL COUNT (CSF) CELL COUNT (FLUID) (DC'D 03/07/12) CELL COUNT (SYNOVIAL) CELLS ANAL. FULL CELLS ANAL. PARTIAL CELLS ANALYZED CELLS KARY. FULL CELLS KARY. PARTIAL CELLS KARYOTYPED CELLULAR CAST "NONE" /LPF CELLULARITY CENTAUR HCT CENTROMERE B AB16088 CEP 12 CEP 8 CEPHAELINE CERULOPLASMIN (326) 18 53 mg/dL CHAFFEENSIS IGG TITER titer CHAFFEENSIS IGM TITER titer CHD RISK FACTOR 0 1 CHEM 12 CHEM 12 (PRIOR TO 12-2-96) CHEM 7 CHIMERIC ANTI TNF ANTIBODY mcg/mL CHLAMYDIA 4 258 DILS CHLAMYDIA CULTURE (2106) CHLAMYDIA DIR. AG DFA 6635 CHLAMYDIA GC DNA CERVICAL CHLAMYDIA GC DNA EYE CHLAMYDIA GC DNA PROBE URETHRAL SWAB CHLAMYDIA SMEAR (2106) CHLAMYDIA TACHROMATIS AB PNL (143262) CHLAMYDIA TITER CHLAMYDIA TITER (2017*) titer CHLAMYDIA TRACHOMATIS CHLAMYDIA/GC DNA PROBE (69198) CHLAMYDIA/N.GONORR. DNA, SDA 17305 CHLAMYDIA/NEISSERIA DNA, PCR (11852*) CHLORAL HYDRATE CHLORAMPHENICOL (2106) CHLORAZEPATE CHLORDANE CHLORDIAZEPOXIDE CHLORIDE 110 250 mmol/24hrs 96 106 mmol/L 85 250 mmol/L 96 106 mmol/L 99 111 mmol/L 118 132 mmol/L 96 106 mmol/L Page 27 Reference ranges 2013 119.5 128.5 mmol/L 91.5 99.5 mmol/L 75.6 85.6 mmol/L 84.9 104.9 mmol/L 100.9 128.9 mmol/L 94 142 mmol/L 59 89 mmol/L 96 146 mmol/L 170 202 mmol/L 122 131 MMOL/L 79 89 MMOL/L 94 102 MMOL/L 80 100 mmol/L 101.5 121.5 mmol/L 84.0 125.0 204.0 305.0 78 98 mmol/L 100.5 120.5 mmol/L 42 63 mmol/L 129 194 mmol/L 103 115 mmol/L 115 131 mmol/L
121.3 130.3 mmol/L 121.3 130.3 mmol/L 91.5 100.5 mmol/L 91.5 100.5 mmol/L CHLORIDE (NE-GA) 100 108 mmol/L CHLORIDE, 24HR URINE CHLORIDE, STOOL mEq/L CHLORPHENIRAMINE CHLORPROMAZINE CHLORPROPAMIDE CHOL PERITONL 175858 "<48" mg/dL CHOL. PLEURAL 175868 mg/dL CHOL/HDL RATIO (NE-GA) CHOLESTEROL 100 200 mg/dL 100 200 mg/dL 100 200 mg/dL mg/dL mg/dL mg/dL mg/dL 111 131 mg/dL 213 241 mg/dL 100 124 mg/dL 174 234 mg/dL 103 123 mg/dL 192 252 mg/dL mg/dL 96 116 mg/dL 162 198 mg/dL CHOLESTEROL (NE-GA) 0 200 mg/dl CHOLESTEROL CRYSTALS CHOLESTEROL SCREEN CHOLESTEROL, BODY FLUID (DC'D 06/10/10) CHOLESTEROL, TOTAL, S CHOLINESTERASE & DN (666)(DC'D 03/08/11) CHOLINESTERASE 335 IU/L Page 28 Reference ranges 2013 CHOLINESTERASE PLM IU/L CHOLINESTERASE RBC 9572 15031 IU/L CHOLINESTERASE SERUM IU/L CHOLINESTERASE W/DIBUC. 7961 CHOLINESTERASE, RBC & PLASMA 338 CHOLINESTERASE, RBC (409)(DC'D 03/09/11) U/mL IU/L CHOLYLGLYCINE (2106) CHORIONIC GONADOTROPIN , QUAL (653*) CHR. URTICARIA 16440 CHRM.NO GROWTH900245 CHROM.FERTILITY14596 CHROM.SOL.TUMOR14603 CHROMIUM (2106) CHROMIUM, PL 3484 CHROMOGRANIN A (7821* DC'D 07/27/10) 36.5 ng/mL CHROMOGRANIN A 16379 1.9 15.0 ng/mL CHROMOSOME ANALYSIS (EMORY) CHROMOSOME ANALYSIS (NON-NEOPLASTIC) CHROMOSOME ANALYSIS LYMPH NODE (14864) CHROMOSOME FRAGILE-X CHROMOSOME KARYOTYPE (DC'D) CHROMOSOME KARYOTYPE (DC'D) CHROMOSOME KARYOTYPE (DC'D) CHROMOSOMES PROPHASE CHROMOSOMES, TISSUE CHROMOSOMES: MOSAIC CHROMOSOMES: PH-1 CHROMOSOMES: ROUTINE CHROMOSOMES: SEX-MOS CHRON. VIRAL HEPATITIS PROFILE CHRONIC HEPATITIS B (SPECIAL) CHYLOMICRONS (2106) CHYLOMICRONS (LIPOPROTEIN S) CHYLOMICRONS CHOLESTEROL CHYLOMICRONS TRIGLYCERIDE CIE SCREEN (2106) CIE: GROUP B STREP (2106)
CIE: H. INFLUENZA (2106)
CIE: MENINGOCOCCUS (2106)
CIE: PNEUMOCOCCUS (2106)
CIMETIDINE CIP VALUE 2.5 29.0 PG/ML CITRATE PLATELET COUNT 150 400 K/cmm 150 400 K/cmm CITRIC ACID mg/24 hr
CITRIC ACID, 24HR URINE (21206*) CK MB CLADOSPORIUM HERBAR CLOMIPRAMINE ng/mL CLONAZEPAM (340) 30 60 mcg/L CLONAZEPAM (705*)(DC'D 8/21/12) ng/mL CLOTRIMAZOLE Page 29 Reference ranges 2013 CLOTRIMAZOLE MIC CLOZAPINE mcg/L CLOZAPINE & METABOLITE 72671 CLOZAPINE & METABOLITES CLOZAPINE (1769) CMT (ATHENA) 900211 CMV AB IGG (403) "<=0.90" CMV CF CMV DNA PCR (QUANT.)(DC'D 07/19/10) "<200" COPIES/ML CMV DNA QUAL PCR 10601 CMV DNA, QL PCR "Not detected" "Not detected" CMV DNA, QN PCR "<200" copies/mL CMV DNA, QUANT 12190 CMV EIA IGG (DC'D 11/2/10) CMV EIA IGM CMV IFA IGM CMV INTERPT CMV IgG AB (703*)(D'CD 12/09/10) CMV IgG, ELISA CMV IgM AB, EIA SERUM (8503) CMV IgM, ELISA CMV-PCR (QUAL.)(2106) CMV-PCR, EYE FLUID (QUEST/FOCUS) CO-OX ABG CO2 25 32 mmol/L mmol/L 25 32 mmol/L 22 32 mmol/L 28 32 25 29 20 24 11.1 14.3 mmol/L 24.1 32.1 mmol/L 9.6 15.2 mmol/L 26.9 34.9 mmol/L 9.00 15.0 mmol/L 24.7 32.7 mmol/L 12.5 15.7 mmol/L 27.1 34.3 mmol/l CO2 (NE-GA) 21 32 mmol/L CO2CT. (TCO2) 25 32 Meq/L 22.2 26.2 22.5 26.5 20.0 24.0 21 31 mmol/L COARSE GRAN. CASTS /LPF COBALT (2106) COBALT, BLOOD 35417 COC AB PNL CSF 111274 COCAETHYLENE ng/mL COCAINE
COCAINE & METABOLITES COCAINE (2106)
COCAINE (URINE) COCAINE (on or before 5/29/03) mA 221.6 301.6 mA 405 525 mA 340 400 mA 418 478 mA Page 30 Reference ranges 2013 COCAINE AND METABOLITES (1340) COCAINE METAB.(PM) COCAINE METABOLITE (URINE) ng/ml COCAINE METABOLITES BY GCMS (13407) COCAINE, ng/mL COCCI COCCIDIODES AB (PRIOR TO 3/20/96) COCCIDIODES COMPLEMENT COCCIDIODES PRECIPITIN COCCIDIODES SCREEN COCCIDIOIDES AB ID "Negative" COCCIDIOIDES AB, CF (CSF) "<1:1" COCCIDIOIDES AB, ID (CSF) "NEGATIVE" COCCIDIOIDES AG (GPHL) COCCIDIOIDES IDCF TITER COCCIDIOIDES IMMITIS (CF) COCCIDIOIDES IMMITIS (ID) COCCIDIOIDES IMMITIS (LTX) COCCIDIOIDES LPA TITER CODEINE (AML) (d'cd 12/10/08) @100 ng/mL CODEINE (DC'D10/16/12) CODEINE (PM) CODEINE (QUEST) ng/ml CODEINE (S) "None detected" ng/mL COHB% (2106) COLD AGGLUTININS 0 "1:16" COLD HEMAGGLUTININS "NONE DETECTED" COLLAGEN (PLT AGG) 83 % COLLAGEN CROSS-LINKED N-TELOPEPTIDE COLLAGEN TYPE I C-TELOPEPTIDE pg/ml COLOR
COLORADO TICK FEVER TITER COMMENT - COMMENT : COMP. METABOLIC PANEL (NE-GA) COMPLEMENT C2 (2106) COMPLEMENT C3 79 152 mg/dL mg/dL 71 95 mg/dL 150 198 mg/dL 59 89 mg/dL 151 227 mg/dL COMPLEMENT C4 13 42 mg/dL 14.00 21.00 mg/dL 29.4 44.2 mg/dL 13 19 mg/dL 38 56 mg/dL
COMPLEMENT C5 (2106) COMPLEMENT C6 COMPLEMENT CH50 618 31 60 U/mL COMPLEMENT DECAY RATE (2106) COMPLETE ATAXIA EVALUATION (ATHENA) COMPLETE MYOTONIC DYSTROPHY COMPONENT PREPARATION COMPREHENSIVE METABOLIC PANEL COMPUTED CREATININE CLEARANCE 70 160 ml/min 70 160 ml/min 70 160 ml/min ml/min Page 31 Reference ranges 2013 CONNECTIVE TISSUE MASSON STAIN CONVALESCENT CONVENTIONAL CLASS COOMBS, DIRECT/INDIRECT COPPER mcg/L 70 175 mcg/dL 70 175 mcg/dL COPPER, 24-HR URINE(DC'D 03/31/11) COPPER, 24HR URINE 15 60 mcg/24 h COPPER, 24HR URINE (365) COPPER, SERUM (363) COPROPORPHYRIN ug/24 hr
CORTICOSTERONE (2106)(DC'D 05/3/2010) CORTICOSTERONE 65478 ng/dL CORTISOL ug/dL ug/dL 4.10 5.50 ug/dL 31 45 ug/dL 6.20 10.20 ug/dL 29.64 41.64 ug/dL 5.29 11.41 ug/dL 40.48 70.48 ug/dL 10.94 14.46 ug/dL 24.08 31.92 ug/dL CORTISOL ug/dL CORTISOL (Prior to 11/2/99) UG/DL UG/DL 2.5 4.1 UG/DL 16.7 25.7 UG/DL 30 46 UG/DL CORTISOL 1 mcg/dL CORTISOL 2 ">=20.0" mcg/dL CORTISOL 3 ">=20.0" mcg/dL CORTISOL TOT 112818 mcg/dL CORTISOL, SALIVA (198978) mcg/dl COTININE COTININE (Q) "None detected" ng/mL "None detected" ng/mL COTININE, URINE ng/mL COXIELLA BURNETTI IgG AB (8519*) COXIELLA BURNETTI IgG AB, PHASE 1 titer COXIELLA BURNETTI IgG AB, PHASE 2 titer COXSACKIE A 1-10 TITER COXSACKIE A 130672 "<1:8" COXSACKIE A ANTIBODY PANEL, CF COXSACKIE A VIRUS COXSACKIE A-10 COXSACKIE A-16 COXSACKIE A-4 COXSACKIE A-9 COXSACKIE B 1-6 COXSACKIE B ANTIBODY PANEL, CF COXSACKIE B VIRUS COXSACKIE B(1-6)4022 COXSACKIE B-1 COXSACKIE B-2 COXSACKIE B-3 COXSACKIE B-4 COXSACKIE B-5 COXSACKIE B-6 COXSACKIE B1 AB "<1:8" COXSACKIE B2 AB "<1:8" COXSACKIE B3 AB "<1:8" COXSACKIE B4 AB "<1:8" COXSACKIE B5 AB "<1:8" COXSACKIE B6 AB "<1:8" Page 32 Reference ranges 2013 COXSACKIE/ECHOVIRUS TITER CPE SCREEN CPK 21 160 U/L $S(SEX="M":49,1:38) $S(SEX="M":397,1:234 IU/L 51 63 IU/L 526.6 551.4 IU/L 50.4 70.4 IU/L 545 625 IU/L 46 66 IU/L 555 615 IU/L 126 162 IU/L 382 486 IU/L CPK (NE-GA) 0 232 U/L CPK (PLASMA) CPK-MB 0.1 4.94 ng/mL 0 5.0 ng/mL 0.6 6.3 ng/mL 3.20 4.80 ng/mL 14.59 18.59 ng/mL 16.8 22.8 ng/mL 1.4 5.4 ng/mL 24 48 ng/mL 1.60 4.80 30.0 56.0 4.91 7.39 ng/mL 47.84 71.76 ng/mL CPK-MB (PRIOR TO 10/25/96) 0 7.5 nG/mL 0 7.5 nG/mL CPK-MB/CPK 0 6 % 0 6 % CREA 24 HR ng/dL CREAT. 24 HR 0.63 2.50 g/24 h CREAT. 24HR NTx g/24 h CREAT. RANDOM UR mg/dL CREATININE 600 2000 mg/24hrs mg/dL/12hr 0.7 1.4 mg/dL mg/dL 0.50 1.20 mg/dL .50 1.20 mg/dL mg/dL mg/dL mg/dL mg/dL 0.44 0.76 mg/dL 6.10 7.7 mg/dL 38 48 mg/dL 72 100 mg/dL 0.2 0.6 mg/dL 5.7 7.7 mg/dL 55.0 79.0 153.0 213.0 0.30 0.70 mg/dL 6.0 8.0 mg/dL 57 86 mg/dL 133 200 mg/dL mg/dL 1.00 1.28 mg/dL 3.49 4.45 mg/dL
CREATININE (AML) mg/dL mg/dL Page 33 Reference ranges 2013 mg/dL CREATININE (NE-GA) 0.6 1.3 mg/dl CREATININE (PM) 20 mg/dL CREATININE CLEARANCE CREATININE, 24HR URINE g/24h CREATININE, 24HR URINE CREATININE, ANCILLARY 0.6 1.3 mg/dl CREATININE, RANDOM URINE mg/dL CREATININE, U (AML) MG/L CREATININE/eGFR CRENATED RBC's /LPF CRH (2106) pg/mL CRYOCRIT CRYOFIBRINOGEN CRYOFIBRINOGEN (2106) CRYOGLOBULINS "NEGATIVE" CRYOGLOBULINS, QUANT. (SERUM) (4003*) "None detected" % CRYOPRECIPITATE - LAB CRYPTOCOCCAL ANTIGEN (2106) CRYPTOCOCCAL ANTIGEN (CSF) CRYPTOCOCCAL ANTIGEN (SERUM) CRYPTOCOCCUS ANTIGEN "NEGATIVE" "NEGATIVE" CRYPTOCOCCUS INDIA INK CRYPTOSPORIDIUM CRYPTOSPORIDIUM STOOL CRYSTALS
CRYSTALS (FLUID) CSF CYTOLOGY CSF IMMUNOGLOBULINS (1704) CSF1R/DS721/DS523 CT DNA PROBE
CT DNA PROBE, EYE (36628) CT/NG DNA PROBE "Not detected" "Not detected" CT/NG PROBE SCREEN CT/NG RNA,TMA,RECTAL 16506 CT/NG SCREEN "Not detected" "Not detected" CTNG DNA PROBE 69198 "Not detected" "Not detected" CTNG DNA PROBE W/ REFLEX 69198 CULTURE & SUSCEPTIBILITY CULTURE & SUSCEPTIBILITY (ANAEROBES) CULTURES STUDIED CV2 CX3 CALCIUM CX3 PROFILE CX5 PROFILE CX7 PROFILE CYANIDE, BLOOD (400)
CYCLIC AMP (2106) CYCLIC CITRULLINATED PEPTIDE (CCP) IgG "<20" Units CYCLOSERINE, SERUM (6750) ug/mL CYCLOSPORINE, BLOOD (1842*) ng/mL CYS,HIS,ORN,ANS,CAR CYSTATHIONINE CYSTIC FIBROSIS 140841 CYSTIC FIBROSIS, BLOOD (6533) CYSTINE CRYSTALS "NONE" CYSTINE, URINE (6016) mg/24 hr Page 34 Reference ranges 2013 CYTOCHROME P450 2C9&VKORC1 (161608) CYTOGEN. COM.(416) CYTOLOGY CYTOLOGY CELL BLOCK CYTOLOGY CYTOSPIN CYTOLOGY PREPARED SLIDES CYTOLOGY PREPARED SLIDES, GYN CYTOLOGY REPORTING CYTOLOGY SMEAR PREP CYTOLOGY SMEAR PREP,FNA CYTOLOGY SMEAR PREP,LAVAGE CYTOMEGALO IFA (2106) CYTOMEGALOVIRUS CYTOMEGALOVIRUS (2106) CYTOMEGALOVIRUS (CMV) CYTOMEGALOVIRUS AB PANEL, ELISA CYTOMEGALOVIRUS DNA PCR(DC'D 07/14/10) "Not detected" copies/mL CYTOSPIN CSF Cal. LDL (NE-GA) 0 130 mg/dl Chlamydia pneumoniae IgA titer Chlamydia pneumoniae IgG titer Chlamydia pneumoniae IgM titer Chlamydia psittaci IgA titer Chlamydia psittaci IgG titer Chlamydia psittaci IgM titer Chlamydia trachomatis IgA titer Chlamydia trachomatis IgG titer Chlamydia trachomatis IgM titer Coccidioides Ab, CF titer Combined Total Cw D- DIMER 229 ng/mL DDU 0.21 0.44 UG/ML FEU 2.01 2.46 UG/ML FEU 0.21 0.44 UG/ML FEU 2.01 2.46 UG/ML FEU D-DIMER D-DIMER (4/06) ug/ml D-DIMER (DIC) "Cut off <230 ng/ml ng/mL DDU 229 ng/ml DDU D-DIMER (QC ONLY) 0.20 0.44 FEU 0.12 0.48 DDU 2.1 2.90 DDU 0.12 0.48 DDU 2.09 2.91 DDU 335 455 ng/dL 698 978 ng/dL 660 940 ng/dL 335 455 NG/DL D-DIMER (QUEST) "<0.50" mcg/mL FEU D. BILIRUBIN (NE-GA) 0.00 0.40 mg/dl D/LMETHORP UR 661217 "Not detected" ng/mL D/LMETHORPH S/P 6621 ng/mL D13S25 D7S486/CEP7 DARK FIELD MICROSCOPIC EXAM DECALCIFICATION TISSUE DECONGESTANT TYPE (2106) DELAVIRIDINE MUTATIONS DELTA AB HEPATITIS B (2106) DELTA ALA, 24HR UR 0.03 0.54 mg/dL DELTA AMINO-LEVULINIC ACID
Page 35 Reference ranges 2013 DENGUE FEV.IGG 37579 DENGUE FEVER (GPHL) DENGUE FEVER AB (IGG,IGM)(5674) DENGUE IgG (ELISA) DENGUE IgM (ELISA) DEOXYCORTICOSTERONE (2106)(dc'd 9/18/07) DEOXYPYRIDINOLINE DERMATOPHAG. FARINAE DERMATOPHAG. PTERON. DESETHYLAMIODARONE DESIPRAMINE mcg/L DESMETHYLCLOMIPRAMINE ng/mL DESMETHYLDOXEPIN mcg/L DESMOGLEIN 1&3 16033 DHEA (2106) DHEA-S (145*) ug/dL DIALYSIS (HEPATITIS) DIALYSIS ROUTINE DIAZEPAM ug/mL DIAZEPAM, SERUM (511*) DIBUCAINE NUMBER % OF INHIB % OF INHIB DIC PANEL DIC PANEL (DC'D 08/31/10) DIC PANEL (F) DIC WORK-UP DIELDRIN DIFF COUNT (BLOOD) DIFF COUNT (FLUID) DIFF COUNT (NE-GA) DIFF QUICK, PREPARED SLIDES DIFF QUICK, SMEAR PREP DIGITOXIN (2106) DIGOXIN ng/mL ng/mL .31 .73 NG/ML 1.65 2.35 NG/ML 2.0 3.0 NG/ML .2 .75 NG/ML 1.94 2.78 NG/ML 2.4 3.6 NG/ML 0.41 1.29 ng/mL 1.90 3.50 ng/mL 0.30 0.90 1.70 3.20 0.68 0.96 ng/mL 1.85 2.57 ng/mL DIHYDROTESTOSTERONE (6996) DILANTIN ug/mL 10 20 ug/mL 4.3 6.4 UG/ML 14.30 17.50 UG/ML 17 25 UG/ML 4.3 6.5 UG/ML 14.7 17.9 UG/ML 16.5 24.7 UG/ML 4.8 14.4 ug/mL 25 47 ug/mL 4.20 12.60 19.00 36.00 21.9 30.3 ug/mL 5.69 7.85 ug/mL 12.3 17.1 ug/mL DILTIAZEM (2106) DIMETHADIONE DIPHENHYDRAMINE DIR. BILIRUBIN 0 .2 mg/dL Page 36 Reference ranges 2013 0 0.2 mg/dL 0.4 1.3 mg/dL 4.2 6.2 mg/dL 0.20 0.40 mg/dL 0.6 1.4 mg/dL 0.51 0.71 mg/dL 1.85 2.57 mg/dL DIRECT ANTIGLOBULIN TEST - LAB DIRECT CYTAPHERESIS DIRECT HDL 39 mg/dL 16 36 mg/dL 44.6 64.6 mg/dL 22 38 mg/dL 41 61 mg/dL 35.3 48.9 mg/dL 24.2 33.4 mg/dL DIRECT LDL 65 160 mg/dL 78 128 mg/dL 161 241 mg/dL 82.6 114.2 mg/dL 148 204 mg/dL DIRECTED CYTAPHERESIS DIRECTED PLASMAPHERESIS DIRECTED WB DONATION DISOPYRAMIDE (777) ug/mL DISULFIRAM DLV DNA AB, NATIVE (DS) (596*) IU/mL DNA MUTATION ANALYSIS DNA TYPING DNA/FEULGIN STAIN DNAse Sensitivity DOHLE BODIES DONOR ABO/RH RECHECK DONOR ABO/RH TESTING DONOR ALT DONOR ANTIBODY SCREEN DONOR COMPONENT PREPARATION DONOR DEFERRAL DONOR PHENOTYPING DONOR UNIT LABELING DONOR UNIT RELEASE DOPAMINE 52 480 mcg/24 hr pg/mL pg/mL DOPAMINE (P) pg/mL DOPAMINE(PLASMA) pg/ml DOXEPIN mcg/L DOXEPIN & N-DESMETHYLDOXEPIN DOXEPIN + DESMETHYLDOXEPIN 100 250 mcg/mL DOXEPIN, SERUM (894) DPD GENE MUT(15538) DQ DQA DQB DR DR DR. DEISS' DRB1 DRB3 DRB4 DRB5 DRPLA DRUG SCREEN DRUG SCREEN (OLD) DRUG SCREEN, COMPREHENSIVE (2106) DRUG SCREEN, MODIFIED (2106) DRVV Page 37 Reference ranges 2013 DRVV (33693) DRVV CONFIRMATION DRVV RATIO ratio DRVV TIME "<=42" sec. sec. DRVVT 1:1 MIX 197918 45 sec DRVVT CONFIRM.143593 DRVVT MIX INTERP. DRVVT SCR W/RFL33693 DRVVT SCREEN 45 sec DRW DXI INCOMPLETE DYSTONIA (ATHENA) DYT1 ALLELE 1 DYT1 ALLELE 2 E. CHAFFEENSIS DNA/PCR 122021 E. EQUINE ENCEPHALITIS AB PANEL E. HISTOLYTICA (129322) titer E2010 INCOMPLETE EBV DNA QUANT PCR(DC'D 12/09/10) "LESS THAN 200 Copie Copies/ml EBV DNA, QL PCR "Not detected" EBV DNA, QL PCR (34179) EBV DNA, QN PCR "<200" copies/mL EBV DNA, QN PCR(14625) EBV EARLY AG IGG "NEGATIVE" EBV NUCLEAR AG IGG "NEGATIVE" EBV QUAL PCR (DC'D 03/14/11) EBV VCA IGG "NEGATIVE" EBV VCA IGM "NEGATIVE" ECGONINE M E ng/mL ECHINOCOCCUS AB ECHINOCOCCUS AGGLUT. ECHO,14,18,20,25,28 TITER ECHO,2,3,4,7,8,11 TITER ECHO,6,9,16,30 TITER ECHOVIRUS (ECHO) ECHOVIRUS AB 130652 "<1:8" ECHOVIRUS ANTIBODY PANEL, CF ECHOVIRUS CF ECHOVIRUS TYPE 11 ECHOVIRUS TYPE 2 ECHOVIRUS TYPE 30 ECHOVIRUS TYPE 4 ECHOVIRUS TYPE 9 ECOHVIRUS TYPE 11 ECOHVIRUS TYPE 16 ECOHVIRUS TYPE 2 ECOHVIRUS TYPE 4 ECTOPARASITE EDDP (PM) EE INTERPT. EE IgG titer EE IgM titer titer EFAVIRENZ MUTATIONS EFV EGFR 60 ml/min EGFR MUTATION (16460) EGR1/D5S721/DS523 EHRLICHIA CHAFFEENSIS AB (2808*) EHRLICHIA CHAFFEENSIS BY PCR ELAPSED TIME Hrs Hrs ELASTIN TISSUE STAIN Page 38 Reference ranges 2013 ELECTROLYTE PANEL (NE-GA) ELECTROPHORESIS CK ISOENZYME (6422) ELISA ELLIPTOCYTES EM EMBEDDING EM LOG-IN EM PRINT/ENLARGEMENT EM SCAN AND PHOTO EMETINE EMETINE (3155) EML4-ALK, PCR(16344) EMPLOYEE DRUG SCREEN ENA (4272) ENDO 1,25 DIHYDROXY (16558) pg/ml ENDO FREE T4 0.6 1.3 ng/dL ENDO PTH AB 11824 "NEGATIVE" ENDO T-3 .8 2 nG/ML .8 2.0 nG/ML 0.75 1.15 ng/ml 2.3 3.7 ng/ml 5.26 7.89 ng/ml 1.06 1.46 ng/mL 2.18 3.17 ng/mL 0.66 1.19 2.30 3.50 1.61 2.13 ng/mL 3.12 4.32 ng/mL ENDO T-4 4.5 11.0 uG/DL 6.1 12.2 uG/DL .805 2.308 ug/dl 4.6 7.2 ug/dl 6.5 9.3 ug/dl 2.9 4.5 ug/mL 7.6 11.4 ug/mL 1.40 3.00 5.40 10.00 6.88 9.12 ng/mL 11.88 15.72 ng/mL ENDO T3 REVERSE 967 11 32 ng/dL ENDRIN (2106) ENOLASE (2106) ENTEROVIRUS ENTEROVIRUS PCR (15082) ENVIRONMENTAL CULTURE EO.MYELO/METAS 0 3 % EOSIN # 0.04 0.54 K/cmm EOSIN % 0.0 6.0 % EOSIN (NE-GA) % EOSINOPHILS 0 4 % % % % % % 0 4 % % % EOSINOPHILS (IN FLUIDS)
EPINEPHRINE 2 24 mcg/24 hr pg/mL pg/mL EPINEPHRINE (P) pg/mL EPINEPHRINE (PLASMA) pg/mL EPINEPHRINE (PLT AGG) 83 % Page 39 Reference ranges 2013 EPITHELIAL CAST "NONE" /LPF EPSTEIN-BARR VIRUS (EBV) EPX PROFILE EPXCHEM 7 ER/PR/HER2 109708 ERCC1, IHC (16979) ERCC1, IHC W/ INTERP ERYTHROPOIETIN (427) ERYTHROPOIETIN (EPO) mIU/mL ERYTHROPOIETIN (prior to 7/23/03) IU/L ESOPHAGEAL BRUSH CYTOLOGY ESOTERIC CONTROLS ESTRADIOL RECEPT ASSAY (2106) ESTRADIOL, 17-BETA (306*) pg/mL ESTRIOL (34883*) ng/mL ESTROGEN ug/g creat pg/mL ESTROGEN, TOTAL(2803*)(DC'D 09/27/10) ESTROGEN, TOTAL, 24-HR URINE (125) ESTRONE (23244) pg/mL ETHANOL 0 10 mg/dL 0 10 mg/dL 40 56 mg/dL 411 471 mg/dL ETHANOL (2106) "NONE DETECTED"
ETHANOL (BLD) "None detected" ETHCHLORVYNOL (2106)
ETHCHLORVYNOL (BLD) "None detected" ETHINAMATE ETHIONAMIDE (4713) mcG/mL ETHOTOIN ETHYL GLUC. (C) "<500" ng/mL ETHYL GLUC. (Q) "<500" ng/mL ETHYL GLUC. 90418 ETHYL GLUC.& E. SULFATE 16604(DC'D06/11) ETHYL GLUCURONIDE "<100" ng/mL ETHYL SULFATE "<50" ng/mL ETHYL SULFATE (Q) "<100" ng/mL ETHYLENE GLYCOL, BLOOD (138*) ug/mL ug/mL ETIOCHOLANOLONE ETO/AML1 EXIT EXTENSIVE GROSS SURGICAL EXTRA TUBE F VIII INHIB BETHESDA HUMAN "< 1.0" BU F VIII INHIB BETHESDA PORCINE "< 1.0" BU F&T TESTOS.(DIAL)(prior to 3/7/05) F. MONOMER (PLASMA) "NEGATIVE" F. RETIVIRGULA F8 ACT CHROM(16049) 65 179 % activity F8 INHIB PAN(40083) FACTOR II (331) 70 150 % FACTOR II MUTATION FACTOR II MUTATION (PROTHROMBIN)(30326) FACTOR IX ACTIVITY (2913*) % FACTOR V (2918*) % FACTOR V BETHESDA (EMORY) FACTOR V LEIDEN (22722) FACTOR V LEIDEN BY PCR (2106) FACTOR VII (2919*) % Page 40 Reference ranges 2013 FACTOR VIII ACT. ASSAY % FACTOR VIII ACTIVITY % 50 180 % FACTOR VIII ACTIVITY (835*) FACTOR VIII ACTIVITY (EMORY) 50.0 150.0 % FACTOR VIII INHIBITOR SCREEN BU FACTOR VIII INHIBITOR SCREEN (4204) FACTOR VIII MULTIMER (2106) FACTOR X FACTOR X (2920*) % FACTOR XI (2914*) % FACTOR XII 50 150 % FACTOR XII (2915*) % FACTOR XIII (14884*) % FAST LTT FASTING GTT mg/dL FASTING GTT (URINE) mg/dL FAT DROPLETS FAT, NEUTRAL/NILE BLYE STAIN FAT, URINE "NONE" FAT. FECAL QL1311851 FATTY ACIDS, FREE (44989) mEq/L mEq/L FATTY CASTS "NONE" /LPF FBG (prior to 12/23/03) FDP UG/ML FDP (DIC) 5 ug/mL 5 ug/mL FDP (PLASMA) "NEGATIVE" FDP NEGATIVE CONTROL FDP POSITIVE CONTROL FEBRILE AGGLUTININS FEBRILE AGGLUTINS FECAL ELECTROLYTES (4945) FECAL FAT FRACTIONATION (130) FECAL LEUKOCYTES FECAL LEUKOCYTES (LACTOFERRIN) FECAL LEUKOCYTES STOOL (DC'D 07/19/11) FECAL PORPHYRINS (QUAL.) FENTANYL AND NORFENTANYL, SERUM (40065) FENTANYL PRESUMPTIVE SC, SERUM/PLASMA "NONE DETECTED" ng/ml "NONE DETECTED" ng/ml FENTANYL QNT, URINE 16900 FENTANYL QNT,UR 16900(DC'D10/12) FENTANYL, QN URINE "<0.50" ng/mL FERRITIN 20 250 nG/ML 30 250 nG/ML 24 336 nG/ML 13.3 20 ng/ml 124 185 ng/ml 209 371 ng/ml 13.3 20.1 ng/mL 320.95 456.95 ng/mL 12.04 18.56 271.00 406.00 57.44 76.16 ng/mL 27.86 36.94 ng/mL FETAL CELLS FETOMATERNAL HEMORRHAGE FIBRIN MONIMER (QUEST) FIBRIN MONOMER (DIC)(DC'D11/08/12) "NEGATIVE" "NEGATIVE" FIBRIN MONOMER(DC'D11/08/12) FIBRINOGEN FIBRINOGEN 218 488 mg/dL 245.27 272.15 SEC 100.13 124.33 MG/DL 105.67 151.39 SECS Page 41 Reference ranges 2013 243.46 275.31 SECS 267 315 MG/DL 267 315 MG/DL 142 164 MG/DL 142 164 MG/DL 234 326 MG/DL 234 326 NG/DL 76 108 MG/DL 76 108 MG/DL FIBRINOGEN (DIC) 218 488 mg/dL 218 488 mg/dL FIBRINOGEN (Prior to 3/31/[email protected].) 200 400 mg/dL 247.05 278.85 MG/DL 77.4 87.0 MG/DL FIGLU FINE GRAN. CAST /LPF FINE NEEDLE ASPIRATE W/XRAY FINE NEEDLE ASPIRATE WO/XRAY FIO2 % % FIP1L1-PDGFRA GENE REARRANGEMENT "NEGATIVE" FISH, 1p/19q DELETION (900009) FISH, ALK,2P23 16114 FISH, AML M4, CBFB/MYH11(10635) FISH, AML, AML1/ETO (10106) FISH, BCELL CLL16864 FISH, BCL6 16851 FISH, EOSIN. 90665 FISH, FOLLICULAR LYMPHOMA (14503) FISH, IGH/MAF 16965 FISH, M5,9,15(19619) FISH, MANTLE CELL LYMPHOMA (14493) FISH, MDS/MYELOID PANEL (19799) FISH, MLL, 11q23 (14494) FISH, MULTIPLE MYELOMA (16077)(DC'D) FISH, MYC-BA, 8q24 (14706) FISH, MYELOMA(19722) FISH, PDGFRA 16837(DC'D05/25/12) FISH, RARA BA 14544 FISH,AML M3,PML/RARA (14617) FISH,BURKIT/NHL13636 FISH,HER2/NEU14620 FISH,IGH/FGFR2 16872 FISH,LUNG 2P23 91028 FISH,SYN SARCOM19773 FLECAINIDE LEVEL (1910) 0.20 1.00 ug/mL FLT3 MUTATIONS (ITD AND D835)(90574) FLUCONAZOLE FLUCONAZOLE (2106) FLUCONAZOLE MIC FLUCYTOSINE FLUCYTOSINE (5684) FLUOR ANTINUCLEAR AB FLUORIDE (2106) FLUOXETINE mcg/L FLUPHENAZINE-PROLIXN FLURAZEPAM FLURAZEPAM METABOLITE FLUVOXAMINE, SERUM (6566) FM NEGATIVE CONTROL FM POSITIVE CONTROL FMC7 0 100 % 0 100 % 0 100 % Page 42 Reference ranges 2013 FMC7 CELLS/CMM 0 5000 CELLS/CMM 0 5000 CELLS/CMM 0 5000 CELLS/CMM 30 500 CELLS/CMM FMC7 MARKER FOBT NOT PERFORMED: FOLATE 3 18 NG/ML nG/ML 3 18 nG/ML 0.2 1.2 ng/ml 3.7 7.4 mg/ml 6.10 9.0 ng/ml 0.20 1.20 ng/mL 6.09 9.01 ng/mL 0.60 3.20 8.80 14.30 FOLATE, NEW 2.4 3.6 10.3 16.3 18.0 30.0 2.4 3.6 18 30 4.61 7.01 26.89 46.89 14.28 19.72 ng/mL 5.65 9.61 ng/mL FOLATE, SERUM ">5.8" ng/mL FOLLICULAR LYMPHOMA, BCL-2/JH t (15007) FOREIGN MATERIAL FOSCARNET MUTATIONS FOSCARNET SENSITIVITY
FOUR TUBES FRAG. INTERP: FRDA1 FREE & TOTAL TESTOSTERONE(36170) FREE & WEAKLY BOUND TESTOSTERONE FREE + TOTAL TESTOSTERONE FREE CARNITINE umol/L FREE DILANTIN (23692) 1.0 2.0 mg/L FREE FATTY ACIDS g/24 hr FREE HCL FREE HGB FREE K/L RATIO 0.26 1.65 FREE K/L RATIO (IN-HOUSE) 0.26 1.65 RATIO FREE K/L RATIO (Q) 0.26 1.65 FREE KAPPA 3.3 19.4 mg/L FREE KAPPA (IN-HOUSE) 3.30 19.40 mg/L FREE KAPPA CHAIN FREE KAPPA, SERUM 3.3 19.4 mg/L FREE LAMBDA 5.7 26.3 mg/L FREE LAMBDA (IN-HOUSE) 5.71 26.30 mg/L FREE LAMBDA CHAIN FREE LAMBDA, SERUM 5.7 26.3 mg/L FREE LIGHT CHAINS (DC'D 01/13/11) FREE LIGHT CHAINS (IN-HOUSE) FREE METANEPHRINE P "<=57" pg/mL FREE PSA ng/mL FREE T-3 (prior to 10/8/03) FREE T3 2.1 3.9 pg/mL FREE T4 (prior to 10/8/03) ng/dL Page 43 Reference ranges 2013 ng/dL
FREE T4 BY DIALYSIS(35167) 0.8 2.7 ng/dL FREE TESTOSTERONE pg/mL FREE TRIIODOTHYRONINE pg/mL FRESH FROZEN PLASMA - LAB FROZEN SECTION ADDITIONAL CUT FROZEN SECTION ADDITIONAL H&E FROZEN SECTION BLOCK NOT RUSH FROZEN SECTION BLOCK RUSH FROZEN SECTION BLOCK RUSH ADD FROZEN SECTION H & E FRUCTOSAMINE 200 280 umol/L 225 305 491 591 umol/L FRUCTOSAMINE (8340) 190 270 umol/L FRUCTOSE FSH 1.5 4.6 mIU/mL 1.3 19.3 mIU/mL
FSH (prior to 7/22/03) 1.4 18.1 mIU/ML 1.4 18.1 mIU/ML 3.5 5.2 mIU/ml 19.4 29.2 mIU/ml 34.0 48.0 mIU/ml 3.8 5.6 mIU/mL 47 67 mIU/mL 3.40 5.70 42.52 66.52 7.65 11.49 mIU/mL 27.76 41.64 mIU/mL FTA (DC'D 07/25/12) "NON REACTIVE" FTA-ABS (0622) "NONREACTIVE" FTA-ABS CSF 17088 "Nonreactive" FTA-ABS, CSF (336)(DC'D 5/27/10) FTC MUTATIONS FUNGAL AB ID 2922 FUNGAL AB SCR (ID)292(DC'D 04/30/2010) FUNGAL IDENTIFICATION FUNGAL SEROLOGY FUNGAL SEROLOGY ANTIGENS FUNGAL SUSCEPTIBILITY, MIC (17823) FUNGAL SUSCEPTIBILITY, MIC (5660) FUNGUS ANTIBODY SCREEN CF, SERUM (4372*) FUNGUS CULTURE AQUEOUS FLUID FUNGUS CULTURE ASPIRATE FUNGUS CULTURE BLOOD FUNGUS CULTURE BRONCHIAL BRUSH FUNGUS CULTURE BRONCHIAL WASH FUNGUS CULTURE BRONCHOALVEOLAR LAVAGE FUNGUS CULTURE CATHETER URINE FUNGUS CULTURE CERVICAL FUNGUS CULTURE CLEAN CATCH URINE FUNGUS CULTURE CORNEA DONOR FUNGUS CULTURE CORNEA RECIPIENT FUNGUS CULTURE CORNEAL SCRAPINGS FUNGUS CULTURE CSF FUNGUS CULTURE EXUDATE FUNGUS CULTURE EYE FUNGUS CULTURE FOLEY URINE FUNGUS CULTURE HAIR FUNGUS CULTURE HAIR OF PUBIS FUNGUS CULTURE HAIR OF SCALP Page 44 Reference ranges 2013 FUNGUS CULTURE LEFT EAR FUNGUS CULTURE LEFT NEPHROSTOMY FUNGUS CULTURE NAIL FUNGUS CULTURE NAIL FIFTH FINGER FUNGUS CULTURE NAIL FIFTH TOE FUNGUS CULTURE NAIL FOURTH FINGER FUNGUS CULTURE NAIL FOURTH TOE FUNGUS CULTURE NAIL GREAT TOE FUNGUS CULTURE NAIL INDEX FUNGUS CULTURE NAIL OF FINGER FUNGUS CULTURE NAIL SECOND TOE FUNGUS CULTURE NAIL THIRD FINGER FUNGUS CULTURE NAIL THIRD TOE FUNGUS CULTURE NAIL THUMB FUNGUS CULTURE NAIL TOE FUNGUS CULTURE PERICARDIAL FUNGUS CULTURE PERITONEAL FUNGUS CULTURE PLEURAL FUNGUS CULTURE RIGHT EAR FUNGUS CULTURE RIGHT NEPHROSTOMY FUNGUS CULTURE SKIN FUNGUS CULTURE SPUTUM FUNGUS CULTURE SUPRAPUBIC URINE FUNGUS CULTURE SYNOVIAL FUNGUS CULTURE TISSUE FUNGUS CULTURE TRACHEAL ASPIRATE FUNGUS CULTURE TRANSTRACHEAL FUNGUS CULTURE URETHRAL SWAB FUNGUS CULTURE VITREOUS FLUID FUNGUS CULTURE WOUND FUNGUS/SILVER STAIN FUROSEMIDE G-6-PD (500) 4.6 13.5 U/g Hgb G-6-PD, QUANTITATIVE .26 .64 nU/RBC 0.402 0.618 nU/RBC 0.16 0.28 nU/RBC GABABENTIN (3557) ug/mL mcg/mL GAD65 ANTIBODY 34878 "<=1.0" U/mL GALACTOSEMIA GAMMA GLOBULIN 0.60 1.60 g/dL .7 1.5 g/dL 0.7 1.3 1.0 1.6 g/dL 2.4 3.0 g/dL 0.59 0.71 1.21 1.52 GAMMA GLOBULIN (Q) 0.6 1.6 g/dL GAMMA GLOBULINS 24HR % GAMMA GLOBULINS RANDOM URINE % GAMMA-GTP 8 69 IU/L 7 50 IU/L 14.0 20.0 IU/L 114 138 IU/L 10 30 IU/L 108 148 IU/L 15.0 23.0 IU/L 116 144 IU/L 34.2 43.4 IU/L 156 200 IU/L GANCICLOVIR SENSITIVITY
GARDNERELLA "NEGATIVE" "NEGATIVE" Page 45 Reference ranges 2013 GAST. 0CC. BLD GASTRIC ANALYSIS GASTRIC BRUSH CYTOLOGY GASTRIN "<101" pg/mL pg/mL GASTRIN (478) GC CULTURE GC CULTURE CERVICAL SWAB GC CULTURE CERVICAL T-M GC CULTURE EYE GC CULTURE RECTAL SWAB GC CULTURE THROAT GC CULTURE URETHRA T-M GC CULTURE URETHRAL SWAB GENOTYPE GENOTYPING GENTAMICIN (on of before 5/30/03) ug/mL uG/ML 1.21 1.81 UG/ML 4.10 7.10 UG/ML 7.3 10.9 UG/ML 1.14 2.35 UG/ML 5.20 6.30 UG/ML 7.3 10.9 UG/ML 0.47 1.43 ug/mL 5.4 10.0 ug/mL 0.76 2.27 6.10 10.00 GENTAMICIN-PEAK 5 10 mcg/mL GENTAMICIN-RANDOM 0 10 mcg/mL 6.13 8.81 ug/mL 2.36 3.24 ug/mL 4.69 6.49 ug/mL GENTAMICIN-TROUGH 0 2 mcg/mL GGT (NE-GA) 0 55 U/L GI FRACTION GIANT PLATELETS GIARDIA AG, EIA "Not detected" GIARDIA AG, EIA 8625 GIARDIA SPECIFIC AG-65(DC'D 03/18/11) GIEMSA STAIN GILLIBRAND SYNDROME GLIADIN ANTIBODIES(35022) GLIADIN IGA ANTIBODY units GLIADIN IGG ANTIBODY units GLIPIZIDE GLITTER CELLS /LPF GLOBULIN 2.6 4 g/dL 2.6 4 g/dL 2.6 4 g/dL 1.41 2.05 g/dL 2.3 3.5 g/dL
GLOVE LATEX EXTRACT (GL)* U/ml GLUCAGON 50 300 PG/ML GLUCAGON (519) pg/mL "< OR = 134" pg/mL GLUCOSE 0 500 mg/24hrs 70 110 mg/dL mg/dL 70 110 mg/dL 70 110 mg/dL 40 75 mg/dL mg/dL mg/dL mg/dL Page 46 Reference ranges 2013 mg/dL 70 110 mg/dL 72 86 mg/dL 181 211 mg/dL 265 315 mg/dL 36 48 mg/dL 213 281 mg/dL 47 70 mg/dL 27 41 mg/dL 85 105 mg/dL 278 338 mg/dL 76 90 MG/DL 275 325 MG/DL 180 210 MG/DL 37 49 mg/dL 241 289 mg/dL 14.0 22.0 230.0 345.0 36 48 mg/dL 234 294 mg/dL 15 26 mg/dL 222 334 mg/dL mg/dL 76.2 93.0 mg/dL 213 261 mg/dL
73 87 mg/dL 73 87 mg/dL 255 305 mg/dL 255 305 mg/dL GLUCOSE MONITOR (NE-GA) 60 120 mg/dl GLUCOSE TOLERANCE (URINE) GLUCOSE TOLERANCE TEST GLUCOSE, 0-HOUR 70 99 mg/dL GLUCOSE, 24HR URINE GLUCOSE, 2HR P. LOAD 70 139 mg/dL GLUCOSE, 2HR PP mg/dL GLUCOSE, FASTING 70 99 mg/dL GLUCOSE, OTHER GLUTAMIC AC DECARB (DC'D 10/5/11) GLUTAMINE (801) mg/dL GLUTAMYL TRANSFERASE GLUTATHIONINE GLUTEN GLUTETHIMIDE (2106) GLY A % 0 100 % 0 100 % 0 100 % GLY A CELLS/CMM 0 5000 CELLS/CMM 0 5000 CELLS/CMM 0 5000 CELLS/CMM 0 871 CELLS/CMM GLY A MARKER GLY,ASP,HCY,HPR,CIT GLYBURIDE GLYCOGEN STAIN GMS MICROWAVE STAIN GMS STAIN FOR FUNGUS GOLD Page 47 Reference ranges 2013 GONADOTROPINS GONORRHEA SCREEN GPHL INFLUENZA A AB TITER, ACUTE titer GPHL INFLUENZA A AB TITER, CONVALESCENT titer GRAM STAIN GRAM STAIN AQUEOUS FLUID GRAM STAIN ASPIRATE GRAM STAIN BRONCHIAL WASH GRAM STAIN BRONCHOALVEOLAR LAVAGE GRAM STAIN CERVICAL SWAB GRAM STAIN CSF GRAM STAIN EXUDATE GRAM STAIN EYE GRAM STAIN LEFT EAR GRAM STAIN LEFT NEPHROSTOMY GRAM STAIN NASAL GRAM STAIN PERICARDIAL GRAM STAIN PERITONEAL GRAM STAIN PLEURAL FLUID GRAM STAIN RECTAL SWAB GRAM STAIN RIGHT EAR GRAM STAIN RIGHT NEPHROSTOMY GRAM STAIN SPUTUM GRAM STAIN SUPRAPUBIC URINE GRAM STAIN SYNOVIAL GRAM STAIN TISSUE GRAM STAIN TRACHEAL ASPIRATE GRAM STAIN TRANSTRACHEAL GRAM STAIN URETHRAL SWAB GRAM STAIN VITEOUS FLUID GRAM STAIN WOUND GRAM STAIN, HISTO GRAM STAIN: URETHRAL-FOR GC ONLY (NE-GA) GRAM STAIN: VAGINAL-FOR GC ONLY (NE-GA) GRAN % 42.2 75.2 % GRAN (NE-GA) 37 80 %G GRAN. AGGLT. ASSAY GRAN. IF ASSAY GRANULAR CAST (NE-GA) "NONE" /LPF GRANULAR CASTS "NONE" /LPF GRID EM GRISEOFULVIN GROCOTT/SILVER METH STAIN GROUP B CULTURE GROUP B-1 GROUP B-2 GROUP B-3 GROUP B-4 GROUP B-5 GROUP B-6 GROWTH DISORDER PANEL (2106) GROWTH HORMONE (521) ng/mL "<=10.0" ng/mL GROWTH HORMONE 2 SPECIMENS 21422 GRP GUAIAC (OCCULT BLOOD)* GUANASE GUINEA PIG EPITHELIA GW YEAST (2106) Glu,Gln,Thr Group B/E coli Kl
Groups A/Y
Groups C/W135
Page 48 Reference ranges 2013 H & E STAIN H & E STAIN, CYTO H. CAPSULATUM (MYCELIAL), CF titer titer H. CAPSULATUM (YEAST), CF titer titer H. CAPSULATUM (YEAST)CF H. CAPSULATUM H BAND H. CAPSULATUM M BAND H. PYLORI (NE-GA) "NEGATIVE" H. PYLORI AG (Prior to 1/19/01) H. PYLORI IgG AB (3341)(dc'd 9/6/07) H. PYLORI IgG ANTIBODY "NEGATIVE" H. SIMPLEX I H. SIMPLEX II H. capsulatum (mycelial), CF titer H. capsulatum (yeast), CF titer H. influenzae type b Antigen H.I.P. AB H.influenzae type b
H63D HACA ASSESSMENT (PROMETHEUS) HALOPERIDOL (670*) ng/mL HAM'S TEST HANTA VIRUS TITER (2106) HANTAAN VIRUS IgG HANTAAN VIRUS IgM HAPTOGLOBIN 11 136 mg/dL 57 85 mg/dL 137 205 mg/dL 54 82 mg/dL 149 224 mg/dL HAPTOGLOBIN (502) 43 212 mg/dl HAVAB IGM HAVAB TOTAL "NEGATIVE" "NEGATIVE" HAVAB TOTAL (2106) HB & HCT HB (HGB) $S(SEX="M":13.7,1:11 $S(SEX="M":17.5,1:15 g/dL 10.3 11.7 16.7 18.0 $S(SEX="M":14,1:12) $S(SEX="M":18,1:16) g/dL $S(SEX="M":13.7,1:11 $S(SEX="M":17.5,1:15 g/dL 7.2 8.8 G/DL 13.5 16.5 G/DL 20.6 25.20 G/DL 9.7 12.7 g/dL 9.7 12.7 g/dL 14.6 17.6 g/dL 14.6 17.6 g/dL HB(HGB) HBCAB "NEGATIVE" "NEGATIVE" HBCAB CONTROL 1.269 2.114 0.079 0.364 HBCAB(IgM) (4848) "Nonreactive" HBD (2106) HBSAB "NEGATIVE" Page 49 Reference ranges 2013 "NEGATIVE" HBSAB CONTROL 0.004 0.037 0.237 0.524 HBSAG "NEGATIVE" "NEGATIVE" HBSAG CONTROL 0.010 0.038 0.294 0.477 HBV DNA "<29 IU/mL" IU/mL HBV DNA (COPIES/ML) "<169 copies/mL" copies/mL HBV DNA (QUAL.)(2106) HBV DNA (QUANT.)(8369) HBV DNA PCR, (QUANT.)(14546) copies/mL HBV DNA, QUAL. PCR (34181*) HBeAB (556) HBeAG (555) HBsAG HBsAG (2106) HBsAG Confirmation HCG BETA - QUALITATIVE HCG BETA, QUAL. "NEGATIVE" "NEGATIVE" HCG BETA, QUANT. (Prior to 11/17/99) HCG BETA, URINE "NEGATIVE" HCG NEGATIVE CONTROL HCG POSITIVE CONTROL HCT $S(SEX="M":40.1,1:34 $S(SEX="M":51.0,1:44 % $S(SEX="M":40,1:37) $S(SEX="M":52,1:47) % HCT HCT (BG)(DC'D11/27/12) 40 52 % % 31 35 % 49 54 % 31.0 35.0 % 48 53 % 33 38 % 33 38 % 45 51 % 45 51 % HCT (FOLATE ONLY) HCT (HEMOGLOBINOPATHY EVAL.) % HCT (NE-GA) $S(SEX="M":43.5,1:37 $S(SEX="M":53.7,1:47 % HCT(BG) $S(SEX="M":40,1:34) $S(SEX="M":51,1:45) % $S(SEX="M":40,1:34) $S(SEX="M":51,1:45) % HCT, FOLATE $S(SEX="M":40,1:37) $S(SEX="M":52,1:47) % HCT-BF % % % % % % HCV CONTROL 0.012 0.030 Page 50 Reference ranges 2013 1.641 2.883 HCV GENOTYPING (Prior to 4/13/00) HCV RNA (IU/mL) IU/mL IU/mL IU/mL HCV RNA (copies/ml)(dc'd 9/28/07) HCV RNA (log IU/mL) HCV Ultraquant HDL 45 75 mg/dL 45 75 mg/dL 18 38 mg/dL 68 92 mg/dL 13 25 mg/dL 48.8 72.8 mg/dL HDL (NE-GA) HDL (NE-GA) 32 96 mg/dl HDV AG (11196*)(DC'D10/12) HDV RNA, QUAL 121942 "Not detected" HEALTH FAIR SCREEN HEAVY METALS HEAVY METALS GROUP, BLOOD (7655) HEAVY METALS GROUP,URINE(720)(DC'D09/12) HEAVY METALS PANEL, 24HR URINE (7206) HEAVY METALS PANEL, RANDOM URINE (7507) HEAVY PARAPROTEIN
HEINZ BODY STAIN HELICOBACTER PYLORI (2106) HELICOBACTER PYLORI AG 34838 HELICOBACTER PYLORI IGA HELICOBACTER PYLORI IGG HELICOBACTER PYLORI IGM HELICOBACTOR PYLORI AG "Not detected" HELMET CELLS HELPER/SUPPRESSOR RATIO HELPER/SUPPRESSOR T CELL RATIO HEMATOLOGY HEMOCCULT (NE-GA) "NEGATIVE" HEMOCHROMATOSIS (prior to 3/5/99) HEMOCHROMATOSIS DNA (DC'D 08/31/10) HEMOGLOBIN HEMOGLOBIN A ">96.0" % HEMOGLOBIN A1 HEMOGLOBIN A1C HEMOGLOBIN A1C (2106) (DC'D 06/29/2010)
HEMOGLOBIN A1C (496) "<5.7" % HEMOGLOBIN A1C (NEW) 4.0 6.0 % HEMOGLOBIN A2 1.8 3.5 % HEMOGLOBIN A2 PRIME % HEMOGLOBIN A2* HEMOGLOBIN BARTS % HEMOGLOBIN C "NEG" "NEG" % HEMOGLOBIN D % HEMOGLOBIN E % HEMOGLOBIN E or O % HEMOGLOBIN F "<2.0" % HEMOGLOBIN G % HEMOGLOBIN LEPORE % HEMOGLOBIN O-ARAB % HEMOGLOBIN S "NEG" "NEG" % HEMOGLOBIN VARIANTS Page 51 Reference ranges 2013 HEMOGLOBINOPATHY EVAL. (135651) HEMOGRAM (HEMOGLOBINOPATHY EVAL.) HEMOLYSIS HEMOPEXIN HEMOSIDERIN HEP C VIRUS PCR 5175 "Not detected" HEP C VIRUS/QUANT/bDNA (dc'd 9/19/07) MEq/mL HEPARIN ANTI-Xa 0.28 0.44 IU/ML 0.53 0.85 IU/ML 0.48 0.77 IU/ML 1.23 1.83 IU/ML 0.53 0.85 IU/ML 0.48 0.77 IU/ML 1.23 1.83 IU/ML 0.28 0.44 IU/ML HEPARIN ANTI-Xa LMWH IU/mL HEPARIN ANTI-Xa LMWH (118623) HEPARIN ASSAY (2106) HEPARIN INDUCED PLT AB "NEGATIVE" HEPATIC FUNCTION PANEL HEPATIC FUNCTION PANEL (NE-GA) HEPATITIS C - PCR (QL)
HEPATITIS C ANTIBODY "NEGATIVE" "NEGATIVE" HEPATITIS C GENOTYPING HEPATITIS C VIRUS AB BY RIBA (3288*) HEPATITIS PROFILE (2106) HEPTACARBOXYPORPHYRIN ug/24 hr
HER HEMOCHROM 10249 HER2,IHC W/REF 15547 HER2/NEU 14620 HEROIN HERPES ID: HERPES PCR "NOT DETECTED" "NOT DETECTED" "NOT DETECTED" HERPES SIMPLEX 1 (IgG) "NEGATIVE" HERPES SIMPLEX 2 (IgG) "NEGATIVE" HERPES SIMPLEX VIRAL CULTURE
HERPES SIMPLEX VIRUS CULTURE (2106) "NEGATIVE" HERPES SIMPLEX VIRUS PANEL HERPES SIMPLEX,COMMON AG TITER DILS HERPES VIRUS 6 16001 HERPES VIRUS 6, QL "Not detected" HERPES VIRUS 8 19803 HERPES VIRUS 8 DNA "NOT DETECTED" HERPES VIRUS BY PCR (LESION SWAB ONLY) HERPES VIRUSES BY PCR (CSF ONLY)(WH) HERPES VIRUSES BY PCR (EYE FLUID)(WH) HETEROPHIL HETEROPHIL AB DIFFERENTIAL HEXACARBOXYPORPHYRIN ug/24 hr
HEXAGONAL CONF143583 "NEGATIVE" HEXOSAMINIDASE HGB $S(SEX="M":13.7,1:11 $S(SEX="M":17.5,1:15 Page 52 Reference ranges 2013 g/dL HGB (FOR A1C ONLY) HGB (HEMOGLOBINOPATHY EVAL.) g/dL HGB (NE-GA) $S(SEX="M":14.1,1:12 $S(SEX="M":18.1,1:16 g/dl HGB A1C HGB A1C % 4.0 6.0 % 4.5 5.5 % 8.8 10.8 % 4.10 5.20 % 8.20 10.00 % 5.2 6.0 % 10.3 11.9 % 4.0 6.0 % 4.6 6.2 % 9.4 12.7 % HGB D, G or Lepore % HGB ELECTROPHORESIS HGB ELECTROPHORESIS WITH A2 (118) HGB F, DIFF. STAIN HGB S POST TRANSFN 135251 HGB SERUM FREE HGB/HCT (NE-GE) HISTAMINE (2106) HISTAMINE (24HR URINE) ng/mL HISTAMINE REL. 16838 "<16" HISTAMINE, 24 HR URINE ug/g creat HISTAMINE, 24HR URINE (15869) HISTOCOMPATIBILITY (VAMC NASHVILLE) HISTONE-REACTIVE AB (901*) units HISTOPATH CONST35418 HISTOPATH GROSS SPC HISTOPATHOLOGY TISSUE/BIOPSY (7740) HISTOPLASMA AB HISTOPLASMA AB, ID "Negative" HISTOPLASMA AG IMMUNOASSAY(34441)
HISTOPLASMA CAPSULATUM (CF) (169*) HISTOPLASMA CAPSULATUM (HISTO) CF HISTOPLASMA CAPSULATUM (ID) HISTOPLASMA COMPLEMENT(PRIOR TO 3/20/96) HISTOPLASMA MYCELIAL CF HISTOPLASMA PRECIPITIN HISTOPLASMIN HIT (EMORY) HIT AB (414) HIT AB (ELISA) 414 (DC'D 12/13/11) HIT OD HIT RESULT HIV QUANT RT PCR "<20" COPIES/ML HIV CONTROL 0.006 0.031 0.268 0.714 HIV PHENOTYPE (11319) HIV QUANT RT PCR(DC'D 11/3/11) COPIES/ML HIV RNA PCR COPIES/ML HIV RNA PCR (PRIOR TO 2/13/97) HIV SCREEN "NEGATIVE" HIV VIRAL LOAD, CSF (PCR) (EMORY) Copies/mL HIV VIRTUAL PHENOTYPE HIV W. BLOT (1872)(D'CD 05/05/2010) HIV, ANCILLARY HIV, POC "NON-REACTIVE" HIV-1 (EIA) (dc'd 10/04/07) HIV-1 (IFA) HIV-1 (WESTERN BLOT) HIV-1 ANTIGEN (P24) Page 53 Reference ranges 2013 HIV-1 GENOTYPING 11509 HIV-1 PLASMA GENOTYPING HIV-1 PROVIRAL GENOTYPING (2106) HIV-1 RNA BY bDNA (131293) copies/mL HIV-1 RNA PCR HIV-1 RNA PCR (PROGRESSIVE) (8874) HIV-1 RNA, ULTRASENSITIVE (8834) COPIES/ML HIV-1 W. BLOT 18272 (DC'D 05/28/2010) "Negative" HIV1 W.BLT/RFL 37708 "Negative" HIV2 AB EIA "Nonreactive" HIV2 AB IMMUNOBLOT "Negative" HLA AB TYPING (ARC) HLA ABC LOCI (ARC) HLA ANTIBODY SCREEN HLA B27 (528) HLA COMPLETE (A,B,C,DR,DQ)(140361) HLA Class I TYPING BY PCR (8309) HLA TYPING HLA- DR 5 45 % 5 45 % 0 100 % HLA-A (AB) HLA-A (ARC) HLA-A ANTIGENS HLA-A TYPING LOCI 1 HLA-A TYPING LOCI 2 HLA-A29 DNA 16773 HLA-A29 TYPING "Negative" HLA-ABC PHENOTYPE PANEL (ARC) (2106) HLA-ABC TYPING HLA-B (AB) HLA-B (ARC) HLA-B ANTIGENS HLA-B TYPING LOCI 1 HLA-B TYPING LOCI 2 HLA-B*5701 TYPING HLA-C (ARC) HLA-C ANTIGENS HLA-C TYPING LOCI 1 HLA-C TYPING LOCI 2 HLA-DQ ANTIGENS HLA-DR HLA-DR ANTIGENS HLA-DR CELLS/CMM 100 900 CELLS/CMM 100 1200 CELLS/CMM 0 15000 CELLS/CMM 320 1850 CELLS/CMM HLA-DR MARKERS HLA-DR TYPING LOCI 1 HLA-DR TYPING LOCI 2 HOMOCYSTEINE HOMOCYSTEINE (31789) "<11.4" umol/L $S(SEX="M":2,1:2) $S(SEX="M":11.4,1:10 umol/L HOMOCYSTEINE (PLASMA)(prior to 5/30/03) 5 15 umol/L 5.25 8.75 umol/L 10.0 15.0 umol/L 20.0 30.0 umol/L 4.7 7.1 umol/L 18.5 27.7 umol/L
HOMOCYSTEINE, URINE (339) HOMOGENISTIC ACID HOMOLOGOUS CYTAPHERESIS Page 54 Reference ranges 2013 HOMOLOGOUS PLASMAPHERESIS HOMOLOGOUS WB DONATION HOMOVANILLIC ACID (2106) HOWELL JOLLY BODIES HPV DNA HIGH RISK HPV DNA LOW RISK HPV DNA, HIGH RISK (10161) HPV DNA,RECTAL 17185 HPV GENOTYPE 16933 HPV ISH 90546 HS PNEUMONITIS MIXED PANEL (41562) HS PNEUMONITIS STD. PANEL (168) HS PNEUMONITIS THERM. PANEL (978) HS-CRP 0.00 5.00 mg/L 0.00 7.50 mg/L 0.80 1.40 mg/L 2.98 4.46 mg/L HSP-70 ANTIBODY (ANTI-68 KD ANTIGEN) "NEGATIVE" HSV 1 DNA HSV 1 IgG INDEX HSV 1 IgG INTERPT. HSV 1/2 IgM & TYPE-SPECIFIC IgG HSV 1/2 IgM CONFIRM. HSV 1/2 IgM INDEX HSV 1/2 IgM INTERPT. HSV 2 DNA HSV 2 IgG INDEX HSV 2 IgG INTERPT. HSV DNA HSV-PCR (14426*) HSV-PCR (Prior to 11/12/99) HSV-PCR (Prior to 11/22/99) HSV-PCR, EYE FLUID (QUEST/FOCUS) HTLV I/II AB (36175) HTLV I/II PCR 34177 HTLV-1/2 ANTIBODY (EIA) HUMAN ANTI-MOUSE AB(1468) ng/ml HUNTINGTON DM 111991 HUNTINGTON'S DISEASE DNA TEST (ATHENA) HYALINE CAST (NE-GA) "0-2/LPF" /LPF HYALINE CASTS "NONE" /LPF HYBRITECH TSH 0 8 uIU/ML 0 8 uIU/ML HYDROCODONE (6689) HYDROCODONE (AML) (d'cd 12/10/08) @100 ng/mL HYDROCODONE (PM) HYDROCODONE (QUEST) ng/ml HYDROCODONE (S) "None detected" ng/mL HYDROGEN ION CONC. mmol/L HYDROMORPHONE (AML) (d'cd 12/10/08) @100 ng/mL HYDROMORPHONE (PM) HYDROMORPHONE (QUEST) ng/ml HYDROMORPHONE (S) "None detected" ng/mL HYDROXYITRACONAZOLE LEVEL ug/ml HYDROXYPROLINE, FREE (762) mg/24 hr HYDROXYPROLINE, TOTAL (413) mg/24 hr HYPERSEGMENTED NEUTROPHILS HYPHAE YEAST "NONE" HYPNOTIC/SEDATIVES EVAL. HYPNOTICS (2106) HYPNOTICS (BLD) "None detected" HYPO (NE-GA) HYPOCHROMIA HYPOGLYCEMIC PNL4425 Page 55 Reference ranges 2013 Her-2 Hu Ab, IFA Hu Ab, Titer Hu Ab, Western Blot Hu and Ri AB (132062) IBD CONFIRMATORY TEST (PROMETHEUS) IBD FIRST STEP (PROMETHEUS) IBD PROMETHEUS 90807 ICTERUS IDV IEF CONFIRMS RESULT IFA Pattern IGA 66 436 mg/dL .15 .95 mg/dL 89 133 mg/dL 244 366 mg/dL 93 140 mg/dL 286 429 mg/dL IGA(CSF) "<1.8" mg/dL IGAB IGD IGE (542) kU/L IGE (prior to 9/2/03) U/mL IGF BP3 (34458) IGF-I (16293)(DC'D 09/1/11) 121 423 ng/mL IGF-I, LC/MS ng/mL IGF-I, LC/MS 16293 IGG 650 1600 mg/dL .35 8.4 mg/dL 371 503 mg/dL 1002 1356 mg/dL 3.2 4.0 mg/dL 6.7 7.9 mg/dL 735 1102 mg/dL 1771 2656 mg/dL IGG & IGM ANTI-IGA ANTIBODIES (2106) IGG 1 382 929 mg/dL IGG 2 241 700 mg/dL IGG 3 22 178 mg/dL IGG 4 4.0 86.0 mg/dL IGG ANTI-IGA AB IGG BY LINE BLOT IGG INDEX, CSF "<0.66" IGG SUBCLASSES (22672) IGG SYNTHESIS RATE IGG SYNTHESIS RATE (13924) IGG(CSF) 0.8 7.7 mg/dL IGG, ACUTE IGG, CONVALESCENT IGG, CSF 0.8 7.7 mg/dL IGG, CSF 6444 0.8 7.7 mg/dL IGG, SERUM 694 1618 mg/dL IGG/IGA IND IF 16690 IGH HC REARRANGEMENT/PCR
IGH/BCL2 IGH/C-MYC IGH/CCND1 IGH/CND1XT IGH/FGFR3 IGM 43 279 mg/dL .03 .65 mg/dL 33 49 mg/dL 134 200 mg/dL 46 69 mg/dL 157 235 mg/dL Page 56 Reference ranges 2013 IGM ANTI-IGA AB IGM BY LINE BLOT IGM(CSF) "<1.8" mg/dL IGM, ACUTE IGM, CONVALESCENT IGRE ILE,LEU IM. PPT-LA MIX 18536 IMIPRAMINE mcg/L IMIPRAMINE (892) IMMED. PT MIX 18534 11.5 sec IMMUNE COMPLEX-CLQ (2106) IMMUNE STATUS (HBV) "IMMUNE" "IMMUNE" IMMUNO-REACTIVE INSULIN (2106) IMMUNOELECTROPHORESIS IMMUNOFIX. ELECTROPHORESIS IMMUNOFIXATION IMMUNOFIXATION (UPEP) IMMUNOFIXATION, RANDOM URINE IMMUNOFIXATION, SERUM (549) "No monoclonal prote IMMUNOFIXATION, URINE (213) IMMUNOFLUORESCENCE, INDIRECT (EMORY) IMMUNOGLOBULINS INC.PTT-LA MIX 18537 INDIA INK CSF INDIA INK PREP INDINAVIR MUTATIONS INDINAVIR (TDM) ug/mL INDIRECT AB TITER INDOLE3 ACETIC ACID INFLU. TYPE A SPECIFIC AG INFLU. TYPE B SPECIFIC AG INFLUENZA A (GPHL) INFLUENZA A&B VIRUS AB (4892) INFLUENZA A, CHILE (TITER) INFLUENZA A, MISSISSIPPI INFLUENZA A,BANGKOK TITER INFLUENZA A,ENGLAND TITER INFLUENZA A,PHILLIPINES TITER INFLUENZA B (GPHL) INFLUENZA B, ANN ARBOR (TITER) INFLUENZA B,SINGAPORE INFLUENZA C INFLUENZA DIRECT FA INFLUENZA TYPE A & B INFLUENZA TYPE A VIRUS (TITER) INFLUENZA TYPE B VIRUS (TITER) INFLUENZA TYPES A&B AB, CF INFLUENZA VIRUS "NOT DETECTED" INFLUENZA VIRUS TYPE A AB TITER INFLUENZA VIRUS TYPE B AB TITER INHIBIN A 6535 pg/mL INHIBIN B 137152 pg/mL INR 0.82 1.18 INR (2106) INR (NE-GA) INR (Prior to 3/31/99 @ 10 a.m.) INR (QUEST) 0.9 1.1 sec INR I-STAT .83 1.38 Ratio INSTRUMENT DIFF INSULIN (561) "<17 uIU/mL" uIU/mL INSULIN AB 118532 "<0.4" U/mL INSULIN BINDING INSULIN, BOUND uU/mL Page 57 Reference ranges 2013 INSULIN, BOVINE INSULIN, FREE uU/mL INSULIN, FREE & TOTAL (1844) INSULIN, FREE (900046)(DC'D 09/20/10) 1.4 14.0 uIU/mL INSULIN, FREE 36700 1.5 14.9 uIU/mL INSULIN, PORCINE INSULIN, TOTAL uU/mL INSULIN, TOTAL (473) INTEGRA INCOMPLETE INTEGRASE GENOTYPE INTERLEUKIN-6 (7259) 0.31 0.50 pg/mL INTERNAL CONTROL INTERNAL CONTROL,HCG INTERP. (MTHFR) INTERP. BCR-ABL1 INTERP. BRAF MUT. INTERP. CYST. FIB. INTERP. PLT INTERP1 INTERP2 INTERP3 INTERPRET.: INTERPRETATION INTERPRETATION : INTERPRETATION JAK2 INTERPRETATION: INTERPRETATION: INTERPRETATION: INTERPRETATION: INTERPRETATION:SPEP INTERPRETATION:UPEP INTERPRETATION:UPEP (R) INTERPRETIVE COMMENT INTRA KAPPA INTRA LAMBDA INTRINSIC FACTOR AB(568) "Negative" IODIDE
IODIDE (5432) IODINE CONCENTRATION ug/L IODINE, 24HR URINE (16602) IODINE, INORGANIC IODINE, TOTAL IODINE, U ug/spec IONIZED CALCIUM 1.13 1.33 mmol/L 1.13 1.33 mmol/L 1.13 1.33 mmol/L 1.40 1.60 0.90 1.06 0.48 0.60 1.10 1.35 mmol/L 1.38 1.58 MMOL/L 0.45 0.57 MMOL/L 0.99 1.15 MM0L/L 1.03 1.19 mmol/L 1.03 1.19 mmol/L 1.50 1.74 mmol/L 1.50 1.74 mmol/L IONIZED CALCIUM PANEL IONIZED MAGNESIUM mmol/L mmol/L 0.87 1.17 MMOL/L 0.29 0.41 MMOL/L 0.48 0.62 MMOL/L IP ACTIN IP ACTIN/SMOOTH MUSCLE IP ALPHA-1 ANTICHYMOTRYPSIN Page 58 Reference ranges 2013 IP ALPHA-1 ANTITRYPSIN IP ALPHA-1 FETOPROTEIN IP B CELL/CD45R(PARAFFIN) IP B-1/CD20 IP B-HCG IP BCL2 IP CALCITONIN IP CALRETININ IP CARCINOEMBRYONIC ANTIGEN IP CD3 (CD3 T CELL RECEPTOR) IP CD34 IP CD68 IP CHROMOGRANIN IP CYCLIN D1 IP CYTOKERATIN 20 IP CYTOKERATIN 7 IP CYTOKERATIN 903 IP CYTOKERATIN AE1 IP CYTOKERATIN AE1/3 IP CYTOKERATIN AE3 IP CYTOKERATIN CAM5.2 IP CYTOMEGALOVIRUS IP DESMIN IP EGFR IP EPITHELIAL MEMBRANE AG IP FACTOR 8 IP GLIAL FIBRIL ACIDIC PROT IP HERPES I IP HERPES II IP HERPES TYPES I AND II IP HMB45 IP KAPPA LIGHT CHAIN IP KI-1 RSC(CD30) BER H-2 IP KI-67 IP LAMBDA LIGHT CHAIN IP LEU M1/CD15 IP LEUCOCYTE COMMON AG/CD45 IP MELAN-A IP MYOSIN IP NCL-MUC-1 IP NCL-MUC-1 CORE IP NEUTRON SPECIFIC ENOLASE IP PAN B/L26(PARAFFIN) IP PAN CYTOKERATIN IP PAN T/UCHL(PARAFFIN) IP PAPILLOMA VIRUS IP PROLIFERATING CELL NUCLEAR AG IP PROSTATE SPECIFIC ANTIGEN IP PROSTATIC ACID PHOSPHATASE IP REED STERNBERG CELL IP RUN1 IP RUN2 IP RUN3 IP RUN4 IP RUN5 IP S100 IP SYNAPTOPHYSIN IP T CELL IMMUNO/CD43(PARA) IP T CELL,OPD4(PARAFFIN) IP THYROGLOGULIN IP THYROID STIMULATING HORMONE IP TTF1 IP VIMENTIN IPF % IRF $S(SEX="M":0.023,1:0 $S(SEX="M":0.134,1:0 Fraction IRF (prior to 11/20/03) $S(SEX="M":2.3,1:3.0 Page 59 Reference ranges 2013 $S(SEX="M":13.4,1:15 % of Retic IRON GROUP IRON GROUP (NEW) IRON INDEX umol/g/yr IRON SATURATION 17 50 % 17 50 % 17 50 % IRON STAIN IRON STORES IRON, LIVER TISSUE ug/g dry w IRON, LIVER TISSUE (3893) ISLET CELL AB (1820) titer ISLET CELL AB SCREEN "NEGATIVE" ISLET CELL AB TITER ISLET CELL RFL 36741 ISOCITRIC-DEHYDROGENASE ISONIAZID ISOPROPANOL (2106) "NONE DETECTED"
ISOPROPANOL (BLD) "None detected" ITRACONAZOLE ITRACONAZOLE LEVEL BY HPLC ug/ml ITRACONAZOLE LEVEL, HPLC ITRACONAZOLE MIC IVE ABOVE (2106) IVE BELOW (2106) Ig SUBCLASS (OTHER)
IgA KAPPA
IgA LAMBDA
IgG KAPPA
IgG LAMBDA
IgH HEAVY CHAIN GR/PCR (EMORY) IgM KAPPA
IgM LAMBDA
JAK2 EXN12&13(18800) JAK2 EXON 12 MUT. JAK2 EXON 13 MUT. JAK2 MUTATIONAL ANALYSIS JAK2 V617F - JAK2 V617F MUTATION, QUAL (16539) JC POLYOMA QNT 18268 JC POLYOMA VIRUS QNT "<500" copies/mL Page 60 Reference ranges 2013 JC VIRUS DNA, QL PCR "Not detected" "Not detected" JO-1 AB (prior to 5/27/03) EUs JO-1 ANTIBODY "<1.0" AI JO-1 ANTIBODY (23932) KALETRA LEVEL 15531 "<0.2" mcg/mL KANAMYCIN KAPPA "<5.0" mg/dL 598 1329 mg/dL 358 438 mg/dL 975 1175 mg/dL 648 973 mg/dL 1630 2445 mg/dL KAPPA + CD19 % 2 14 % 2 15 % 0 100 % 0.4 5.7 % KAPPA + CD19 CELLS/CMM 20 320 CELLS/CMM 20 375 CELLS/CMM 0 15000 CELLS/CMM 15 235 CELLS/CMM KAPPA + CD19 MARKERS KAPPA + CD38 % % 0 5 % 0 100 % 0 1 % KAPPA + CD38 CELLS/CMM CELLS/CMM 0 75 CELLS/CMM 0 15000 CELLS/CMM 0 25 CELLS/CMM KAPPA + CD38 MARKERS KAPPA POSITIVE 4 12 % 4.0 12.0 % 0 100 % KAPPA POSITIVE C/CMM 120 360 CELLS/CMM 120.0 360.0 CELLS/CMM 0 15000 CELL/CMM KAPPA POSITIVE MARKERS KAPPA+CD20 CELLS/CMM 0 5000 CELLS/CMM 0 5000 CELLS/CMM 0 5000 CELLS/CMM 30 250 C/CMM KAPPA+CD20 MARKER KAPPA+CD20% 0 100 % 0 100 % 0 100 % 0.3 3.0 % KARYOTYPE (14600) KETOCONAZOLE KETOCONAZOLE (5682) ug/mL ug/mL KETOCONAZOLE MIC KLEIHAUER BETKE KOH (NE-GA) "NO YEAST SEEN" "NO YEAST SEEN" "NO YEAST SEEN" KOH FUNGAL PREP KOH FUNGAL PREP SPUTUM KOH FUNGAL PREP TISSUE KOH FUNGAL PREP TRACHEAL ASPIRATE KOH FUNGAL PREP TRANSTRACHEAL KOH PREP BRONCHIAL WASH KOH PREP BRONCHOALVEOLAR LAVAGE KOH-CFW FUNGAL PREP KOH: SKIN SCRAPING (NE-GA) KOH: URETHRAL (NE-GA) KOH: VAGINAL (NE-GA) Page 61 Reference ranges 2013 KRAS MUT. "NOT DETECTED" KRAS MUT. ANALYSIS (16510) KYNURENIC ACID L-E SYNDROME (MAYO)(DC'D09/12) L-E SYNDROME AB(113068) LAA (2106) LACTIC ACID 0.5 2.2 mmol/L .5 2.2 mmol/L 0.5 2.2 mmol/L .05 .15 .05 .15 .075 .125 1.1 2.3 3.2 7.2 1.20 1.80 mmol/L 3.4 6.6 mmol/L 1.30 1.66 mg/dL 2.65 3.37 mg/dL LACTOSE TOLERANCE LAMBDA "<5.0" mg/dL 280 665 mg/dL 188 228 mg/dL 472 592 mg/dL 277 416 mg/dL 748 1122 mg/dL LAMBDA + CD19 % 1 9 % 1 10 % 0 100 % 0.2 3 % LAMBDA + CD19 CELLS/CMM 10 210 CELLS/CMM 10 250 CELLS/CMM 0 15000 CELLS/CMM 8 174 CELLS/CMM LAMBDA + CD19 MARKERS LAMBDA + CD38 % % 0 5 % 0 100 % 0 1 % LAMBDA + CD38 CELLS/CMM CELLS/CMM 0 75 CELLS/CMM 0 15000 CELLS/CMM 0 25 CELLS/CMM LAMBDA + CD38 MARKERS LAMBDA POS CELLS/CMM 60.0 180.0 CELLS/CMM 60.0 180.0 CELLS/CMM 0 15000 CELLS/CMM LAMBDA POSITIVE 2 6 % 2.0 6.0 % 0 100 % LAMBDA POSITIVE MARKERS LAMBDA+CD20 CELLS/CMM 0 5000 CELLS/CMM 0 5000 CELLS/CMM 0 5000 CELLS/CM 10 175 C/CMM LAMBDA+CD20 MARKER LAMBDA+CD20% 0 100 % 0 100 % 0 100 % 0.1 2.5 % LAMOTRIGINE (22060) 4.0 18.0 mcg/mL LARGE PLATELETS LASA (2106) LATEX (k82) IU/mL LATEX FIXATION LATEX IGE (2106)(Prior to 2/11/99) LATEX SPECIFIC IGE PANEL (11361) LATEX SPECIFIC IGE PANEL (15326) LCM AB, IFA (SERUM) (696) Page 62 Reference ranges 2013 LCM INTERPRT. LCM IgG titer LCM IgM titer LCM, IFA LD 100 225 U/L 100 225 IU/L LD ISOENZYME PANEL (1122) LD, TOTAL 120 250 U/L LD-1/LD-2 RATIO LD-2 30 43 % LD-3 16 26 % LD-4 3 12 % LD-5 3 14 % LD1 17 70 U/L U/L LDH 100 225 IU/L IU/L 100 225 IU/L 100 200 IU/L IU/L IU/L IU/L IU/L IU/L 63 83 IU/L 346 406 IU/L 62 82 IU/L 355 379 IU/L 63 83 IU/L 351 371 IU/L IU/L 149 189 IU/L 218 278 IU/L LDH (GAINSVILLE ONLY) 100 200 U/L LDH (NE-GA) 313 618 U/L LDH1/LDH 38 % LDL CHOLESTEROL (2106) LDL-CHOL(CALCULATED) 65 160 mg/dL 65 160 mg/dL LDL/HDL RATIO 0 2.5 ratio 0 2.5 ratio LDL/HDL RATIO (NE-GA) LE PREP LEAD ug/L ug/dL ug/dL LEAD (Heavy Metal Panel) "<10" ug/dL LEAD, 24-HR URINE (429*)(DC'D 03/11/11) LEAD, 24HR URINE "<125" mcg/24 h LEAD, 24HR URINE 17846 LEAD, BLOOD (599X)(DC'D 12/01/10) LEAD, BLOOD(599) "<10" mcg/dL LEAD, RANDOM URINE mcg/g gr LECITHIN/SPHINGOMYELIN RATIO LEGIONELLA AB LEGIONELLA ANTIGEN "NEGATIVE" LEGIONELLA CULTURE LEGIONELLA DFA LEGIONELLA IF STAIN LEGIONELLA, DFA (961) LEGIONNAIRE LEISHMANIA AB (8308) LEISHMANIA BRAZILIENSIS LEISHMANIA DONOVANI LEISHMANIA TITER LEISHMANIA TROPICA LEISHMANIASIS TITER Page 63 Reference ranges 2013 LEPTIN (37109) ng/mL LEPTOSPIRA AB (015)(DC'D 09/30/11) titer LEPTOSPIRA AB 16529 LEPTOSPIRA AGGLT 0 "1:20" LEPTOSPIRA CULTURE LEPTOSPIRA SMEAR LEPTOSPIRAL CULTURE AND SMEAR (410) LEUCINE CRYSTALS "NONE" LEUKEMIA/LYMPHOMA BLOOD DRAW LEUKOCYTE ALK PHOS SCORE 30 90 UNITS LEVETIRACETAM 15142 mcg/mL LGV ANTIBODIES (Prior to 3/4/02) LGV DNA PROBE LGV, SERUM AB PNL 11706(DC'D06/6/12) LGV, SERUM AB PNL 117062 LH 1.7 8.6 mIU/mL $S(SEX="M":1.2,1:"CO $S(SEX="M":8.6,1:"CO mIU/mL
LH (prior to 7/22/03) 1.3 12.9 mIU/ML 1.3 12.9 mIU/ML 3.799 5.519 mIU/ml 23.5 31.5 mIU/ml 61.307 89.307 mIU/ml 4.20 6.60 mIU/mL 37.12 51.12 mIU/mL 4.00 6.00 50.00 75.00 8.42 11.18 mIU/mL 46.36 61.44 mIU/mL LIDOCAINE MG/L MG/L LIDOCAINE
LIDOCAINE (684) LIMULUS (LAL) TEST EU/mL LIMULUS A. LYSATE085 LINING CELLS % % LIPASE 13 51 U/L 13 60 U/L LIPASE (NE-GA) 23 300 ug/dl LIPASE (prior to 11/25/03) U/L LIPEMIA LIPID PANEL (NE-GA) LIPID PHENOTYPE EVAL. (2106) LIPID PROFILE LIPIDS, QUALITATIVE LIPIDS, TOTAL (2106) LIPOPROTEIN A (2970*) mg/dL LIPOPROTEIN PROFILE (MAYO) LIPOPROTEIN, ALPHA (2106) LIPOPROTEIN, BETA (2106) LIPOPROTEIN, PRE-BETA (2106) LIQUIFACTION 0 60 min LITHIUM .5 1.5 mmol/L .5 1.2 MMOL/L 1.97 2.25 MMOL/L Page 64 Reference ranges 2013 0.30 0.50 mmol/L 0.91 1.23 mmol/L 2.47 2.99 MMOL/L LIVER FUNCTION LOG COPIES/ML LOG COPIES/ML (ULTRA) LONG ACTING THYROID HORMONE LONG CHAIN ACYLCARNITINE LOPINAVIR (AML) (13690)(DC'D 07/30/12) ug/mL LOPINAVIR (TDM) ug/mL LORAZEPAM LORAZEPAM (PM) LOXAPINE LOXAPINE (2106) LPV LRV (2106) LSD LUPUS ANTI PNL 3373 LUPUS ANTI PROFILE(3373)(DC'D 08/09/10) LUPUS ANTICOAGULANT - PNP LUPUS ANTICOAGULANT - PNP (1857) LUPUS ANTICOAGULANT SCREEN (14357) LUPUS TYPE ANTICOAGULANT(DC'D 11/2/10) 1.2 1.2 LX4201 PROFILE LYM (NE-GA) 10 50 %L LYME 18 KD IGG LYME 23 KD IGG LYME 23 KD IGM LYME 28 KD IGG LYME 30 KD IGG LYME 39 KD IGG LYME 39 KD IGM LYME 41 KD IGG LYME 41 KD IGM LYME 45 KD IGG LYME 58 KD IGG LYME 66 KD IGG LYME 93 KD IGG LYME AB SCREEN "<=0.90" Index LYME AB, EIA 6646 LYME AB, ELISA LYME ANTIBODY LYME DISEASE LYME DISEASE (BEFORE 4/12/96) LYME DISEASE AB (IGG)WESTERN BLOT 29772 LYME DISEASE AB PANEL (DC'D 06/14/10) LYME DISEASE IGG/IGM WB 8593 LYME DISEASE IgG & IgM WB(DC'D 09/29/11) LYME DISEASE IgG AB WB(29772)(DC'D05/12) LYME DISEASE SEROLOGY (2976) LYME EIA LYME EIA SCREEN "NEGATIVE" LYME IFA LYME IGM ANTIBODIES LYME IgG AB WB "Negative" LYME IgM AB WB LYME TEST, CSF (6387) U/mL LYME VALUE LYME VALUE (Q) "<=0.90" LYMPH /CU MM LYMPH # 1.32 3.57 K/cmm LYMPH % 20 55.5 % % LYMPH (NE-GA) % LYMPH GRAN VEN LYMPHOBLAST % LYMPHOCHORIOMENINGITIS Page 65 Reference ranges 2013 LYMPHOCHORIOMENINGITIS (2106) LYMPHOCYTE ATYPIA, MEAN LYMPHOCYTE ATYPIA, STA DEV LYMPHOCYTE PROFILE (IMMUNODEFICIENCY) LYMPHOCYTE PROFILE, LEUKEMIA/LYMPHOMA LYMPHOCYTES 15 41 % 40 80 % % % % % 1 10 % % % LYSOZYME (2106) LYTES LYTES, 24HR URINE LYTES, PLASMA LYTES, URINE Lp(a) Lp(a) CHOLESTEROL Lp(a) TRIGLYCERIDE M-ALB/CREAT RATIO 0 30 mg/G 0 30 mg/G M-ALBUMIN 0.2 30 mg/24hrs 0.2 1.9 mg/dL 0.94 1.32 mg/dL 3.47 5.21 mg/dL 0.47 0.67 mg/dL 3.50 5.10 mg/dL 0.80 1.60 mg/dL 3.2 4.4 mg/dL 0.4 1.4 mg/dL 1.8 3.0 mg/dL M-TP (Ordered prior to 6/12/03) mg/24hrs 0 1350 mg/L 15 45 mg/dl mg/dL mg/dl 25 49 mg/dL 62 102 mg/dL 79 109 mg/dL 139 169 mg/dL 11.0 20.0 46.0 69.0 6.1 18.1 mg/dL 57 86 mg/dL M-TP (PE) mg/24hrs. 0 13.5 mg/dL M-TP (TOTAL PROTEIN) 50 100 mg/24hrs. 0 14.0 mg/dL 15 45 mg/dL
M-TP, 24 HR URINE M-TP, 24hr Urine (PE) M. AVIUM COMPL 19796 M.E.M. VIRAL AB EVAL (7203) M.TUBERCULOSIS COMPLEX BY PCR (UT) M:E RATIO "1:1" "1.3" MACHADO-JOS. 127771 MACRO (NE-GA) Page 66 Reference ranges 2013 MACROAMYLASE QL MACROCYTOSIS MACROGLOBULINS MACROHEPATIC ISOENZYMES % MACROPHAGES % % % % % % % MAGNESIUM 72.9 121.5 mg/24hrs 1.8 2.4 mg/dL mg/dL 1.6 2.6 mg/dL 1.6 2.6 mg/dL 0.8 1.2 mg/dL 3.4 4.4 mg/dL 3.7 5.5 mg/dL 9.2 11.2 mg/dL 0.77 1.37 mg/dL 3.2 4.4 mg/dL 5.9 8.9 11.3 16.9 0.70 1.30 mg/dL 3.5 4.5 mg/dL 4.4 6.6 mg/dL 9.9 14.8 mg/dL 2.1 2.5 mg/dL 4.01 4.69 mg/dL
MAGNESIUM, 24HR URINE MAINA MALARIA FORMS MALARIA SMEAR MALARIA THICK SMEAR "NEGATIVE" MALARIA THIN SMEAR "NEGATIVE" MALARIA-BINAX "NEGATIVE" MALIGNANT CELLS MANGANESE (626) ug/L MANUAL LIVER MAP2 (2106) MAPROTILINE-LUDIOMIL (2106) MARIJUANA (BLD) "None detected" MARIJUANA CONFIRMATION BY GCMS "NONE DETECTED" ng/mL MARIJUANA MET. (PM) MARIJUANA MET. P MARIJUANA METAB. "<5" ng/mL MARIJUANA METABOLITE (2106)
MARIJUANA QNT(16917) MARIJUANA SCREEN
MARIJUANA SCREEN (on or before 5/29/03) 447 mA 273 393 mA 395 515 mA 360 440 mA 438 518 mA MASSON TRICHROME STAIN MAST CELL STAIN MAUVE SPOT MB (Isoenzyme) % Page 67 Reference ranges 2013 MCH 25.7 32.2 pg MCH (HEMOGLOBINOPATHY EVAL.) pg MCH (NE-GA) 27 31.2 pg MCHC 32 37 g/dL MCHC (NE-GA) 31.8 35.4 g/dl MCV $S(SEX="M":80,1:81) $S(SEX="M":100,1:99) fL MCV (HEMOGLOBINOPATHY EVAL.) fL MCV (NE-GA) 80 97 fL MDA MDEA MDMA MDPV MDRO SCREEN "NEGATIVE" MDRO/GNR/SURVEIL "NEGATIVE" MEASLES AB INTERPT. MEASLES AB PANEL, IFA MEASLES IgG, IFA titer MEASLES IgM, IFA titer MEASLES-RUBEOLA (IgG) 0 "1:4" MEASLES-RUBEOLA TITER MEGAKARYOCYTE MEGAKARYOCYTES MEGAKARYOCYTIC MELANIN MELANIN STAIN MELANOMA, BRAF V600 MUT, COBAS 90956 MEN1 EVAL.(ATHENA 818) "No mutation detecte MEN2 AND FMTC 11573 MENINGITIS ANTIGEN SCREEN MEPERIDINE MEPERIDINE, URINE "<100" ng/mL MEPHEDRONE MEPHOBARBITAL MEPROBAMATE (2106) MERCURY ng/mL "<=10" ug/L MERCURY, 24HR URINE "<=20" mcg/L MERCURY, RANDOM UR mcg/g cr MESANTOIN MESORIDAZINE MESOTHELIAL % % % % % % META (NE-GA) % METAL METAMYELOCYTE # # METAMYELOCYTES % 13 32 % METANEPHRINES 90 315 ug/24 hr "<=57 pg/ml" pg/mL METANEPHRINES, 24 HR URINE (14962) METARUBRICYTE 10 30 % METFORMIN, S/P (11888) METHADONE 182.59 242.59 mA 280.26 360.26 mA METHADONE P METHADONE (1901*) Page 68 Reference ranges 2013 METHADONE (PM) METHADONE, QUANT (SERUM) (208) 100 400 ng/mL METHADONE, URINE ng/mL METHAMPHETAMINE METHAMPHETAMINE (PM) METHAMPHETAMINE GCMS ng/ml METHANOL (2106) "NONE DETECTED"
METHAPYRILENE METHAQUALONE METHARBITAL METHB% (2106) METHEMALBUMIN (2106) METHEMOGLOBIN 0.0 2.0 % 4.10 7.10 % 4.7 7.1 % 5.60 8.00 % METHEMOGLOBIN METHEMOGLOBIN (1981) METHEMOGLOBIN (QUEST) g/dL METHGB % 0.0 1.6 % METHL GREEN PYRONIN STAIN METHOCARBAMOL METHOD METHOTREXATE uMol/L METHOTREXATE (648) umol/L METHOTREXATE (EMORY) umol/L METHSUXIMIDE METHYL ALCOHOL (BLD) "None detected" METHYLMALONIC 16508 "<=2.7" mmol/molCr METHYLMALONIC ACID mg/24 hr 87 318 nmol/L 87 138 nmol/L METHYLMALONIC ACID (24 HR URINE)(200) METHYLMALONIC ACID, SERUM (34879) METHYLMALONIC ACID/HOMOCYSTEINE (2106) METHYLMALONIC/HOMOCYSTEINE(PRE-3/17/97) METHYLONE METHYPRYLON METOPROLOL LOPRESSOR MEXILETINE (1806) ug/mL MHA-TP "NONREACTIVE" MIC/MBC (BC) MIC/MBC (MI) MICAFUNGIN MICONAZOLE MICRO (NE-GA) MICROALBUMIN (NE-GA) "NEGATIVE" mg/l "NEGATIVE" mg/l MICROALBUMIN (Ordered prior to 11/15/01) MICROALBUMIN PANEL (24HR URINE) MICROALBUMIN PANEL (URINE) MICROBIOLOGY TEST LIST MICROCYTOSIS MICROSCOPIC MICROSPORIDIA (5676) MIDAZOLAM (PM) MILLER FISHER 90128 MISC SEND OUT 5578 MISCELLANEOUS MISCELLANEOUS CYTOLOGY MITO AB TITER 18574 "<1:20" Page 69 Reference ranges 2013 MITOCHONDRIAL AB 259 "Negative" MITOTANE (2106) MCG/ML MIXED CASTS /LPF MIXING INTERP. 18538 MIXING STUDY (8922) MIXING STUDY NOTE MJD ALLELE 1 (dc'd 9/7/07) MJD ALLELE 2 (dc'd 9/7/07) MKC442 MUTATIONS MLA 1000 CONTROLS MLA 1600 CONTROLS MLA 900 CONTROLS (DAY) MLA 900 CONTROLS (NIGHTS) MLH1 AND MSH2 MUTATIONS, HNPCC (15585) MLH1&MSH2 (DEL&DUPL)(16051) MLL MM (Isoenzyme) % MN% % % % MODERATE ADP 74 % MODERATE RISTOCETIN 80 % MODIFIED CLASS MODULAR PROFILE MONILIA CULTURE MONO # 0.30 0.82 K/cmm MONO % 2.5 12.0 % MONO (NE-GA) % MONO TEST "NEGATIVE" MONO TEST (NE-GA) "NEGATIVE" MONOBLAST 0 1 % MONOCLONAL PROTEIN g/dL g/dL g/dL g/dL MONOCYTES 2 10 % 15 39 % % % % % 0 1 % % % MORPHINE MORPHINE (AML) (d'cd 12/10/08) @100 ng/mL MORPHINE (PM) MORPHINE (QUEST) ng/ml MORPHINE (S) "None detected" ng/mL MOTILITY % 40 100 % MOTILITY GRADE 2 4 MPA GLUCURONIDE 35.0 100.0 mcg/mL MPL S505 MUTATION MPL W515 MUTATION MPL W515&S505 16184 MPO MPV 9.4 12.4 fL fL MPV (NE-GA) 99.8 fL MRSA SCREEN (ADMISSION) MRSA SCREEN (ADMIT) MRSA SCREEN (DISCHARGE) MRSA SCREEN (DISCHARGE/TRANSFER) MRSA SCREEN (RE-SCREEN) MRSA SCREEN (TRANSFER) MRSA SURVL NARES AGAR "NEGATIVE" "NEGATIVE" MRSA SURVL NARES DNA "NEGATIVE" Page 70 Reference ranges 2013 "NEGATIVE" MRSA SURVL OTHER AGAR "NEGATIVE"
MRSA SURVL OTHER DNA "NEGATIVE"
"NEGATIVE" MSH6 MUTATION 14983 MTB-PCR (2106) MTHFR (36165) MTHFR (D'CD 05/10/12) MUCIN CLOT MUCOPOLYSACCHARIDES MUCOPROTEIN MUCOR RACEMOSUS MUMPS MUMPS AB INTERPT. MUMPS AB IgG, IFA titer MUMPS AB IgM, IFA titer MUMPS AB PANEL, IFA MUMPS AB PNL 53152 MUMPS SOLUBLE MUMPS VIRAL DILS MUMPS VIRUS (S AND V) MUSK AB (14626) MUTATION ANALYSIS MUTATION TYPE MUTATIONS/POLIMORPH. MYASTHENIA PN3 68512 MYCELIAL PHASE MYCO PNEUM-IGG EIA "<790" U/mL MYCO PNEUM-IGM EIA "<770" U/mL MYCO PNEUMONIAE-IGG "NEGATIVE (<1:16)" MYCO PNEUMONIAE-IGM "NEGATIVE (<1:16)" MYCOBACTERIAL IDENTIFICATION MYCOBACTERIUM, BC MYCOBACTERIUM, BC (4161) MYCOLOGY CULTURE MYCOLOGY SMEAR MYCOPHENOLIC ACID 1.0 3.5 mcg/mL MYCOPHENOLIC ACID 10662 MYCOPLASMA (Prior to 12/15/00) DILS MYCOPLASMA IGG/IGM EIA MYELIN BASIC MYELIN BASIC PROTEIN (136) MYELIN/LUXOL FAST BLUE STAIN MYELOCYTE # # MYELOCYTES % 5 19 % MYELOPEROXIDASE AB "<6" U/mL MYOGLOBIN (PLASMA) nG/mL
79.96 110.4 ng/mL 864 1296 ng/mL MYOGLOBIN (URINE) "NEGATIVE" MYOGLOBIN URINE 661 "<28" mcg/L MYOGLOBIN, SERUM (660) Ma1 Ma2 Page 71 Reference ranges 2013 N-ACETYL ug/mL uG/ML 3.7 5.6 UG/ML 12.3 17.6 UG/ML 9 14 UG/ML 3.8 5.7 UG/ML 12.4 16 UG/ML 9.3 13.9 UG/ML 2.10 6.30 ug/mL 17 33 ug/mL 1.90 5.60 16.00 30.00 7.56 10.44 ug/mL 1.52 2.08 ug/mL 3.22 4.46 ug/mL N-DESAKYL FLURAZEPAM N-DESMETHYLDOXEPIN (2106) N-TELOPEPTIDE NTx24 N. GONOR. RNA TMA "Not detected" N. GONORR. RNA, TMA "Not detected" "Not detected" "Not detected" N. GONORRHOEAE DNA N. GONORRHOEAE DNA P "Not detected" "Not detected" N. GONORRHOEAE DNA PROBE 2668 "Not detected" "Not detected" N. GONORRHOEAE DNA, SDA N. meningitis Antigens, Latex Aggl. N.G. DNA/SDA17304 "NOT DETECTED" "NOT DETECTED" "NOT DETECTED" "NOT DETECTED" N.G. TMA RECTAL16504 N/G DNA PROBE N/G DNA PROBE 2668 "Not detected" "Not detected" NAFCILLIN NAPA (QUEST) mg/L NARCOLEPSY EVALUATION NARCOTICS (2106) NARCOTICS (BLD) NAVANE (2106) NCDP (12305) NEG. CONTROL (SP.#2) NEG. CONTROL (SP.#3) NEGATIVE CONTROL NEGATIVE CONTROL NEISSERIA GONORRHEA NELFINAVIR MUTATIONS NELFINAVIR (TDM) ug/mL NETTLE NEUROGENIC VIRAL SCREEN NEUROMYELITIS OPTICA AUTOANTIBODY 90382 "NEGATIVE" NEURONAL NUCLEAR (Hu) ANTIBODY (3505) NEUROTENSIN (POLYPEPTIDE) NEUTRAL FATS g/24 hr NEUTRALIZATION FOR HBsAG NEUTRO # 1.4 6.5 K/cmm NEUTRO AUTO AB NEUTRO FUNC (18191) ">=90" % NEUTRO SP N AUTO AB NEUTROPHIL MATURITY, MEAN NEUTROPHIL MATURITY, STA DEV NEUTROPHIL-BANDS 0 5 % 10 32 % NEUTROPHIL-SEGMENTED 40 75 % Page 72 Reference ranges 2013 0 6 % % % % % 7 30 % % % NEVIRAPINE MUTATIONS NFV NICKEL NICOTINE & MET. SER/PLAS 90642 NICOTINE (1931) NICOTINE (19317) NICOTINE (DC'D 04/30/2010) NICOTINE (Q) "None detected" ng/mL "None detected" ng/mL NICOTINE AND COTININE, URINE 90646 NICOTINE, URINE ng/mL NIRVANOL NITRITE, URINE "NEGATIVE" NITROGEN (2106) NITROGEN, TOTAL (2106) NOCARDIA SUSCEPTIBILTY (2106) NOCARDIA/STREPTOMYCES SUSCEPT. (6929) NON SMAC CHEMISTRIES NON-SQUAMOUS EPITH. "NONE" /HPF NONNUCLEOSIDE RTI "NO" MUTATIONS NORCLOMIPRAMINE NORCLOZAPINE 25 400 mcg/L NORDIAZEPAM ug/mL NORDIAZEPAM (PM) NORDIAZEPAM (URINE) NORDOXEPIN (2106) NOREPINEPHRINE 15 100 mcg/24 hr pg/mL pg/mL NOREPINEPHRINE (P) pg/mL NOREPINEPHRINE PLM pg/mL NORFENTANYL, QN UR "<0.50" ng/mL NORFLUOXETINE mcg/L NORM+PT MIX (IMMED) secs NORM+PT MIX (INC) secs NORMAL (IMMED) secs NORMAL (INC) secs NORMAL FORMS 40 100 % NORMAL GLOBULIN LATEX NORMALIZED CALCIUM mmol/L mmol/L 1.13 1.33 mmol/L NORMEPERIDINE, URINE "<100" NORMETANEPHRINE FREE "<=148" pg/mL NORMETANEPHRINES 122 676 ug/24 hr "<=148 pg/ml" pg/mL NORMETHSUXIMIDE NORMOCHROMIC NORMOCYTIC NOROVIRUS (NORWALK)(GPHL) NORPROPOXYPHENE mg/L mg/L mg/L mg/L NORPROPOXYPHENE (PM) NORTRIPTYLINE 50 140 mcg/L NORTRIPTYLINE (272) NOT PERFORMED TROPONIN-I Page 73 Reference ranges 2013 NOVA GLUCOSE CONTROL NOVA STAT PROFILER LYTES NOVEL H1N1 (SWINE-LIKE) NPM MUT. CELL BASED "NEGATIVE" NPM(EXON 12)MUT (16158)(DC'D 08/12) NPM(EXON 12)MUTATION ANALYSIS 16158 NS5 (Gene Region NS5) NTX, 24HR UR 36421 NTx, URINE (14466*) NUCLEATED RBC/100WBC /100WBC NUCLEOSIDE RTI "NO" MUTATIONS NULL NVP NYSTATIN NYSTATIN MIC Neuronal Nuc Ab (Ri), IFA O2 SAT (c) 94 100 % % O2 SATURATION 95.0 98.0 % 50.0 85.0 % 37.4 43.9 % 92.7 98.7 % 47.3 50.3 % 47.5 49.9 % 47.0 49.40 % 38.3 44.3 % 94.2 100.2 % 54.7 63.7 % 54.7 63.7 % 88.9 96.9 % 88.9 96.9 % O2CT. % OCCULT BL. (SPEC.#1) OCCULT BL. (SPEC.#2) OCCULT BL. (SPEC.#3) OCCULT BLOOD CARD #1 "NEGATIVE" OCCULT BLOOD CARD #2 "NEGATIVE" OCCULT BLOOD CARD #3 "NEGATIVE" OCCULT BLOOD TEST OIL RED O STAIN OLIGOCLONAL BANDS OLIGOCLONAL BANDS (CSF) OLIGOCLONAL BANDS (DC'D09/20/11) OLIGOCLONAL,CSF 1418 "No bands" ONCOTYPE DX (5578) ONE TUBE OPIATE METABOLITES (2772) OPIATES
OPIATES (2106) OPIATES (PM) OPIATES (on or before 5/29/03) 487 mA 115 195 mA 466 586 mA 426 466 mA 508 548 mA OPIATES C. SER 20902 OPIATES CONFIRMATION BY GCMS OR BLOOD GAS ORCHARD GRASS ORGANISM OROSO MUCOID (2106) OSMOLARITY 273 1093 mOs/kg 273 1093 mOs/kg 282 298 mOs/kg mOs/kg Page 74 Reference ranges 2013 253 381 443 667 288 292 mOsm 627 707 935 1055 284 426 mOsm/kg 630 946 mOsm/kg 352 432 742 842 mosmol/L 301 451 mOsm/kg 614 921 mOsm/kg 280.00 419.00 mOsm/kg 649.00 974.00 mOsm/kg 302 314 mOsm/kg 532 552 mOsm/kg 444 464 mOsm/kg 781 821 mOsm/kg OSMOTIC FRAGILITY OSTEOMARK (6228) OTHER OTHER CELLS % % % % % % OTHER (2106)
OTHER - LAB OTHER CELLS------O OTHER COAG RESULTS--O OTHER D-DIMER N// OTHER GAS TEST------O OTHER GAS TEST--O OTHER GAS TEST-0 OTHER HEM TEST------O OTHER RESULTS------O OTHER TOSOH TEST----O OVAL FAT BODIES "NONE" OVALOCYTES OXALATE (681) mg/24 hr OXAZEPAM OXAZEPAM (PM) OXAZEPAM (URINE) OXIDANT OXIMETRY OXYCODONE OXYCODONE (AML) (d'cd 12/10/08) @100 ng/mL OXYCODONE (PM) OXYCODONE (QUEST) ng/ml OXYCODONE (S) "None detected" ng/mL OXYCODONE P OXYGEN SATURATION PANEL OXYHEMOGLOBIN 94.0 100.0 % 40 70 % 26.10 29.10 % 27.3 29.7 % 25.80 29.40 % OXYMORPHONE (PM) OXYPURINOL P-TAU/T-TAU 113354 P16,IHC W/INTP.19251 P190 BCR-ABL1 91118 P210 BCR-ABL1 91119 P50 (Mayo Clinic) mm Hg Page 75 Reference ranges 2013 PA+NAPA 5.0 30.0 mg/L PAB 18 38 mg/dL 11.9 17.9 mg/dL 31.60 45.8 mg/dL 10.10 15.20 mg/dL 25.1 37.7 mg/dL PAI-1 ACTIVITY 10491 (DC'D 11/29/11) IU/mL PAI-1 AG 59766 4 43 ng/mL PAIN MANAGEMENT,MEPERIDINE,QNT,UR(16905) PAIN MGT METHADONE W/CONF, URINE 16890 PAIN MGT PROF1 (16454) PAIN MGT PROF1 16856 PAIN MGT.HEROIN METAB 16911 PANCREATIC ISOAMYLASE U/L PANCREATIC PEPTIDE PANEL REACTIVE ANTIBODY 0 100 % PAP (PRIOR TO 4/1/98) 0 3 nG/ML 1.50 2.50 24.0 36.0 37.5 62.5 PAP SMEAR PAP SMEAR PAP STAIN, CYTOSPIN PAP STAIN, GYN PAP STAIN, PREPARED SLIDES PAP STAIN, RAPID PAP STAIN, SMEAR PREP PAPPENHEIMER BODIES PARA-AMINOBENZOIC ACID (2106) PARAFFIN BLK NUMBER PARAFFIN BLOCK PARAFFIN BLOCK, ADDITIONAL CUT PARAINFLUENZA PARAINFLUENZA 1 PARAINFLUENZA 1 (GPHL) PARAINFLUENZA 2 PARAINFLUENZA 2 (GPHL) PARAINFLUENZA 3 PARAINFLUENZA 3 (GPHL) PARAINFLUENZA VIRUSES PARALDEHYDE ug/mL PARALDEHYDE LEVEL (6570) PARAMETHADIONE PARANEOP. CSF 133804 PARANEOPLASTIC SYNDROME AB (68562) PARAPROTEIN
PARASITE EXAM PARASITE EXAM STOOL PARASITE IDENTIFICATION (MISC) (1323) PARIETAL CELL AB (2106) PARIETAL CELL AB TITER PARIETAL CELL ANTIBODY (209*) Units PAROXETINE (4431) ng/mL PARTIAL THROMBOPLASTIN TIME PARTIAL THROMBOPLASTIN TIME (MLA) PARVOVIRUS B19 ANTIBODIES(8946) PARVOVIRUS B19 DNA)(5319)(DC'D 07/11/11) PARVOVIRUS B19 DNA, QL PCR(5319) PARVOVIRUS B19 IGG ABS PARVOVIRUS B19 IGM ABS PARVOVIRUS B19 PCR "Not detected" PAS STAIN PAS WITH DIASTASE STAIN PATIENT O.D. Page 76 Reference ranges 2013 PATIENT (IMMED) secs PATIENT (INC) secs PATIENT O.D. PATIENT PHENOTYPING PCB-POLYCHLORINATED PCCP (2106) PCO2 35 45 mmHg 58.2 68.2 37.2 43.2 19.7 24.7 41 51 mmHg 41 51 mmHg 53.1 63.1 MMHG 19.0 24.0 MMHG 38.4 44.4 MMHG 52.1 62.6 mmHg 52.1 62.6 mmHg 37.6 44.6 mmHg 37.6 44.6 mmHg 22.4 27.9 mmHg 22.4 27.9 mmHg PCO2 AT PT. TEMP PCP SCREEN (7107) PCR-LEDI TESTING 0 2000 iu 0 2000 IU PDGRFB/TEL TRANSLOCATION (5578) PEDIATRIC UNIT PREPARATION PEMA PENICILLIN G PENICILLIN V PENICILLIUM NOTATUM PENTACARBOXYPORPHYRIN ug/24 hr
PENTAZOCINE PENTOBARBITAL ng/mL ng/mL ng/mL PENTOBARBITAL (985) ug/mL PENTOBARBITAL (PM) PENTOBARBITAL, URINE "Negative" ng/mL PEPSINOGEN PEPSINOGEN 1 PERICARDIAL FLUID CYTOLOGY PERITONEAL FLUID CYTOLOGY PEROXISOMAL P. 79152 PEROXISOMAL PANEL 79152 (DC'D 06/17/10) PFA ADP secs PFA EPI secs PFA-ADP 62 117 SEC PFA-EPI 85 185 SEC 80 184 SEC PH 7.35 7.45
7.35 7.45 7.128 7.180 7.348 7.400 7.566 7.618 7.35 7.45 7.35 7.45 7.32 7.42 7.167 7.217 Page 77 Reference ranges 2013 7.646 7.696 7.432 7.482 7.203 7.253 7.203 7.253 7.413 7.463 7.413 7.463 7.537 7.591 7.537 7.591 PH (PM) 4.5 9.0 PH (SEMEN) 7.5 8.0 PH AT PT. TEMP PHAGOCYTIC FCTN TEST PHANTOM 12 PHANTOM 2010 PLASMA PHANTOM ABG FOR NORMAL PHANTOM ABG QC PHANTOM ABG QC (HCT/O2 SAT) PHANTOM ABG/HCT/SO2 PHANTOM ACS PHANTOM ACS 2 PHANTOM AXSYM CONTROLS PHANTOM BLOOD CULTURE PHANTOM CALIBRE URINE PHANTOM CCX ABG CONTROL 1 & 3 PHANTOM CCX ABG CONTROL 2 PHANTOM CCX CHEM LEVEL 4 & 5 PHANTOM CENTAUR PHANTOM CHEM PHANTOM CHEMISTRY CONTROLS PHANTOM CO-OX PHANTOM CSF PHANTOM DAT PANEL PHANTOM DAU PANEL PHANTOM ETOH/NH3 PHANTOM FUNGUS PHANTOM IMMUNO PHANTOM INTEGRA 400 PHANTOM MICRO PHANTOM PARASITE PHANTOM RIA PHANTOM SPCH CX7 PHANTOM TDM-I PHANTOM TDM-II PHANTOM TDM/HITACHI PHANTOM ULTRA CONTROLS PHANTOM ULTRA HCT/O2 CONTROLS PHANTOM URICHEM TRAK URINE PHENACETIN PHENCYCLIDINE P PHENCYCLIDINE (2106)
PHENCYCLIDINE (PCP) PHENCYCLIDINE (PCP)B PHENCYCLIDINE (PM) PHENCYCLIDINE 7102 "NONE DETECTED" PHENOBARBITAL ug/mL uG/ML 8.8 13.1 UG/ML 28.0 39.0 UG/ML 46 69 UG/ML 8.9 13.3 UG/ML 31 36 UG/ML 43 65 UG/ML 8.5 25.7 ug/mL 37.0 71.0 ug/mL 8.50 25.40 Page 78 Reference ranges 2013 40.00 74.00 43.1 59.5 ug/mL 8.14 11.26 ug/mL 21.0 29.0 ug/mL PHENOBARBITAL ng/mL ng/mL ng/mL PHENOBARBITAL (PM) PHENOBARBITAL, URINE "Negative" ng/mL PHENOL PHENOLPHTHALEIN PHENOLPHTHALEIN, URINE (2106) PHENOLSULFONPHTHALEIN PHENOTHIAZINE PHENOTHIAZINE (BLD) "None detected" PHENOTHIAZINES (2106) PHENOTHIAZINES (6574)
PHENOTYPE PHENSUXIMIDE PHENYLPROPANOLAMINE (2106) PHOSPHATASE,ACID PHOSPHOLIPIDS PHOSPHORUS mg/dL PHOSPHORUS (NE-GA) 2.5 4.6 mg/dl PHYTANIC ACID "<=9.88" umol/L PIGEON SERUM PIMARCIN PINWORM EXAM PINWORM EXAM STOOL PLA-1 TYPING (ARC) PLACENTAL ISOENZYME PLASMA CELLS % % % % % % 0 4 % % % PLASMA HEMOGLOBIN (514) 0.0 6.9 mg/dL PLASMA METANEPHRINE (19548) PLASMA METANEPHRINES (D'CD 06/15/10) PLASMA PORPHYRINS PLASMA PORPHYRINS (4629) PLASMINOGEN ACTIVITY 19333 65 176 % 65 176 % PLASMINOGEN ANTIGEN (2106) PLASTIC SECTION PLATELET AGGREGATION (AML) PLATELET AGGREGATION (EMORY) PLATELET COUNT PLATELET FUNCTION SCREEN (EMORY) PLATELET FUNCTION TEST PLATELETS - LAB PLEASE NOTE PLEASE NOTE : PLEASE NOTE: PLEASE NOTE:SOURCE PLEURAL FLUID CYTOLOGY PLT 150 400 K/cmm 150 400 K/cmm PLT (ESTM) "Adq" PLT (NE-GA) 142 424 K/uL PLT AB SCR INDIRECT 16288 Page 79 Reference ranges 2013 PLT AB:GP IIb/IIIa "Negative" PLT AB:GP Ia/IIa "Negative" PLT AB:GP Ib/IX "Negative" PLT AB:HLA CLASS I "Negative" PLT COUNT (PLT AGG) PLT EST (NE-GA) PM-1 & JO-1 AB PANEL (2106) PM-1 ANTIBODY PM-1 ANTIBODY (2106) PML/RARA PML/RARA QNT(15318) 0.000 ratio PMN PMN% % % % PMP-22 ALLELE 1 PMP-22 ALLELE 2 PNEUMOCOCCAL AB, 12 SERO (6785) PNH PANEL (112441) PO2 80 90 mmHg 55.1 67.1 95.3 107.3 132.3 152.3 20 40 mmHg 20 40 mmHg 52.0 64.0 MMHG 123.0 143.0 MMHG 92.0 104.0 MMHG 52.0 68.0 mmHg 52.0 68.0 mmHg 100.0 116.0 mmHg 100.0 116.0 mmHg 129.0 153.0 mmHg 129.0 153.0 mmHg PO2 AT PT. TEMP PO4 400 1300 mg/24hrs 2.5 4.5 mg/dL mg/dL 2.4 4.7 mg/dL 2.4 4.5 mg/dL 1.56 2.24 mg/dL 5.90 7.90 mg/dL 6.2 11.2 mg/dL 11.2 21.0 mg/dL 1.40 2.60 mg/dL 6.7 8.7 mg/dL 24.0 37.0 39.0 59.0 1.80 2.60 mg/dL 6.6 8.6 mg/dL 21 31 mg/dL 34 53 mg/dL 3.04 3.72 mg/dL 5.38 6.58 mg/dL
PO4, 24HR URINE POC-BE -2 +3 mmol/L -2 +3 mmol/L POC-GLUCOSE 70 110 mg/dl 70 110 mg/dl POC-HCO3 18 23 mmol/L 18 23 mmol/L POC-HEMATOCRIT (HCT) 40 52 % 40 52 % POC-HEMOGLOBIN (HB) 14 18 g/dl Page 80 Reference ranges 2013 14 18 g/dl POC-IONIZED CALCIUM (CA) 1.13 1.33 mmol/L 1.13 1.33 mmol/L POC-O2 SAT 95 98 % % POC-PCO2 35 45 mmHg 35 45 mmHg POC-PH 7.35 7.45 7.35 7.45 POC-PO2 80 90 mmHg mmHg POC-POTASSIUM (K) 3.5 5.3 mmol/L 3.5 5.3 mmol/L POC-SODIUM (NA) 138 148 mmol/L 138 148 mmol/L POC-TCO2 25 32 mmol/L 25 32 mmol/L POIK (NE-GA) POIKILOCYTOSIS POLIO AB 141612 POLIO VIRUS 1 POLIO VIRUS 2 POLIO VIRUS 3 POLY (NE-GA) POLYCHROMASIA PORCINE PORPHOBILINOGEN 24HR PORPHOBILINOGEN QNT 24HR 14525 PORPHOBILINOGEN, URINE, QUAL. (228) PORPHOBILINOGEN, URINE, QUANT. (285) mg/24 hr mg/dL PORPHYRIN RNDM 36592 PORPHYRINS, FECAL, QUAL.(355) PORPHYRINS, FRACTIONATION,PLASMA (14987) PORPHYRINS, QNT 4116 POS. CONTROL (SP.#2) POS. CONTROL (SP.#3) POSACONAZOLE POSITIVE CONTROL POSITIVE CONTROL POST-DIALYSIS BUN 8 23 mg/dL POTASSIUM 25 120 mmol/24hrs 3.5 5.3 mmol/L 25 120 mmol/L 3.5 5.1 mmol/L 3.6 5.1 mmol/L 3.5 5.3 mmol/L 5.590 6.090 mmol/L 3.650 4.050 mmol/L 1.76 2.16 mmol/L 2.75 3.35 mmol/L 6.68 7.88 mmol/L 2.00 3.2 mmol/L 3.0 5.0 mmol/L 33 53 mmol/L 63 83 mmol/L 5.67 6.17 mmol/L 1.69 2.29 mmol/L 4.15 4.65 mmol/L 2.7 3.3 mmol/L 6.3 8.3 mmol/L 23.0 35.0 72.0 109.0 2.80 3.40 mmol/L 6.0 8.0 mmol/L 25 37 mmol/L 65 98 mmol/L Page 81 Reference ranges 2013 2.98 3.38 mmol/L 5.68 6.40 mmol/L
3.72 4.22 mmol/L 3.72 4.22 mmol/L 6.10 6.70 mmol/L 6.10 6.70 mmol/L POTASSIUM (NE-GA) 3.6 5.2 mmol/L POTASSIUM, 24HR URINE POTASSIUM, STOOL mEq/L PPT-LA W/REFLEX 17408 PRAZEPAM PRE-BETA VERY LOW DENSITY PRE-BETA VLD CHOL PRE-BETA VLD TRIG PREALBUMIN (2106) mg/dL PREALBUMIN-BOUND T4 ug T4/dL PREALBUMIN-BOUND T4/PREALBUMIN ug/mg PREGNANCY TEST URINE, ANCILLARY PREGNANCY TEST, POC "NEGATIVE" PREGNANEDIOL (2106) PREGNANETRIOL (2106) PRIMARY TUMOR SITE PRIMIDONE, SER 40751 5.0 12.0 mg/L uG/ML 3.1 4.6 UG/ML 11.6 17.3 UG/ML 3.1 4.6 UG/ML 10.3 13 UG/ML 11.6 17.3 UG/ML PRIOR RESULT: PRISTANIC ACID "<=2.98" umol/L PRISTANIC/PHYTANIC "<=0.39" ratio PRO MYLO (NE-GA) % PRO,BAIB PROCAINAMIDE ug/mL uG/ML 2.2 3.3 UG/ML 8.3 11.3 UG/ML 8.5 14.1 UG/ML 2.0 3.0 UG/ML 8.3 10.5 UG/ML 8.5 12.8 UG/ML 1.1 3.5 ug/mL 10.4 19.4 ug/mL 0.90 2.80 10.30 19.20 9.9 13.9 ug/mL 1.32 1.84 ug/mL 6.04 8.36 ug/mL PROCAINAMIDE & N-ACETYL PROCAINAMIDE (74388) PROCAINAMIDE (QUEST) 4.0 10.0 mg/L PROGESTERONE (745) ng/mL PROGRESSIVE LYME PROINSULIN (7091) pmol/L pmol/L PROLACTIN 3.4 24.1 nG/ML $S(SEX="M":2.6,1:"CO $S(SEX="M":13.1,1:"C nG/ML Page 82 Reference ranges 2013 5.6 8.3 ng/ml 15.2 26 ng/ml 27.0 39.0 ng/ml 4.5 6.7 ng/mL 25 37 ng/mL 5.14 7.86 28.00 42.00 7.35 9.75 ng/mL 25.8 34.2 ng/mL PROLYMPHOCYTES % % PROMYELOCYTE # # PROMYELOCYTES 0 0 % 1 8 % PROPERDIN FACTOR B PROPOXYPHENE mg/L mg/L mg/L mg/L PROPOXYPHENE (5902) PROPOXYPHENE (PM) PROPOXYPHENE BY GC/MS URINE (5907) PROPOXYPHENE MET. "NEGATIVE" PROPOXYPHENE UR "NEGATIVE" PROPRANOLOL (957) ng/mL PRORUBRICYTE 3 10 % PROS 0 0 % 1 8 % PROSTATIC ACID PHOSPHATASE (781) ng/mL PROSTATIC SP. Ag. 0 4 nG/ML 0 4.00 nG/ML 0.34 0.54 ng/ml 9 13 ng/ml 14.07 18.07 ng/ml 0.35 0.75 ng/mL 16.64 20.64 ng/mL 0.71 1.06 29.00 43.40
PROTAMINE SULFATE PROTEASE ACTIVITY (COAG. CENTER) PROTEASE INHIBITOR "NO" MUTATIONS PROTEIN C & S PANEL (2106) PROTEIN C ACTIVITY (1777) 70 180 % PROTEIN C ANTIGEN (19673) % 70 140 % PROTEIN ELECTROPHORESIS D'CD 09/14/09 PROTEIN S (TOTAL & FREE)36457 PROTEIN S ACTIVITY (1779) % PROTEIN S ANTIGEN (2106) PROTEIN S, FREE % PROTEIN S, TOTAL % PROTEIN, TOTAL (Q) 6.2 8.3 g/dL PROTEIN, TOTAL 24HR URINE "<150" mg/24h PROTEIN, TOTAL, RANDOM URINE mg/dL PROTEIN,TOTAL 6.4 8.2 g/dL 6.4 8.2 g/dL 6.1 7.9 g/dL g/dL g/dL g/dL g/dL 3.90 4.70 g/dL 6.90 8.50 g/dL 3.6 4.4 g/dL Page 83 Reference ranges 2013 6.5 8.5 g/dL 3.70 4.50 g/dL 6.60 8.60 g/dL g/dL 4.93 5.77 g/dL 4.42 5.18 g/dL PROTEIN/CREATININE RATIO "<=84" mg/g creat PROTEIN/CREATININE RATIO (RU) mg/g creat PROTEINASE-3 AB "<6" U/mL PROTEUS OX19 (2106) PROTEUS OX2 (2106) PROTEUS OXK (2106) PROTHROMBIN FRAGMENT 1.2 41 372 pmol/L PROTHROMBIN TIME (2106) PROTHROMBIN TIME (INR INCLUDED) PROTHROMBIN TIME (MLA) PROTHROMBIN TIME WITH INR (8847) PROTOPORPHYRIN ug/dL "<100" mcg/dL PROTOPORPHYRIN, BLOOD 248 PROTRIPTYLINE PROZAC (8389) PRP PLAT. CT 10e3uL PSA (NE-GE) 0.00 4.01 NG/ML PSA PANEL, TOTAL/FREE (31348) PSEUDOCHOLINESTERASE U/mL U/mL u/mL PSEUDOCHOLINESTERASE (082)(DC'D03/07/11) PSITTACOSIS PT 9.1 13.2 SEC 12.21 13.11 SEC 39.09 46.50 SEC 11.89 12.98 SECS 38.72 42.69 SECS 13.0 15.0 SECONDS 12.5 14.3 SECONDS 34.0 40.0 SECONDS 33 39 SECONDS 11.0 13.0 SECS 33.0 39.0 SECS 11.0 13.0 SECS 33 39 SECS PT (NE-GA) PT (1HR INC) SEC PT (2106) sec. PT (MIXING STUDY) 11.5 sec PT (NE-GA) 11 13 SEC. PT (Prior to 3/31/99 @ 10 a.m.) 10.5 13.4 SECS 12.7 13.9 SECS 30.9 33.3 SECS 29.4 32.8 SECS. 12.5 13.5 SECS. 12.5 13.5 SEC. 29.4 32.8 SECS. 11.29 12.09 SEC 24.98 28.22 SEC 11.41 12.56 SEC 25.35 30.12 SEC PT (QUEST) 9.0 11.5 sec PT CONTROL SECS SECS SECS PT CONTROL (1HR INC) SEC PT I-STAT 11.9 15.2 SECS PT SUB TEST Page 84 Reference ranges 2013 PT SUB. (1HR INC) SEC PT SUBSTITUTION SEC PT SUBSTITUTION TEST (F) PT WITH MIX PT&PTT (FUTURA) PT-FIBRINOGEN PT. TEMP Celcius PT/INR, ANCILLARY PTAH STAIN PTH (C-TERMINAL) (2106) PTH (INTACT) pg/mL PTH (INTACT) (1316) PTH (N-TERMINAL) (2106) PTH-INTACT 15 65 pg/mL 12.0 88.0 pg/mL PTH-INTACT (INTRAOPERATIVE) 12.0 88.0 pg/ml PTH-RELATED PROTEIN (34478) pmol/L PTT 23.3 36.6 SEC 26.43 28.59 SEC 51.23 54.55 SEC 27.11 29.53 SECS 52.28 55.48 SECS 32 38 SECONDS 33 38 SECONDS 73.9 84.1 SECONDS 73.9 84.1 SECONDS 28.5 32.5 SECS 63.8 70.2 SECS 28.5 32.5 SECS 63.8 70.2 SECS PTT (HEPARIN DRIP ONLY) PTT (Prior to 3/31/99 @ 10 a.m.) 22.9 34.5 SECS 25.4 27 SECS 48.5 51.7 SECS 48 51 SECS. 24.9 26.5 SECS. 24.9 26.5 SECS. 48 51 SECS. 23.43 24.87 SEC 68.77 72.09 SEC 22.2 24.4 SEC 69.70 73.96 SEC PTT CONTROL 73.0 84.0 SECS SECS PTT CONTROL(1HR INC) SECS PTT MIXING STUDY + HEPZYME (EMORY) PTT(1HR INC) 23.3 36.6 SECS PTT- LA 40 sec PTT-LA secs. PTT-LA MIXING STUDY (185358) PTT-LA SCREEN "<=40" sec PULM. BLOOD GASES PURKINJE CELL CYTOPLASMIC AB (3898) ratio PUUMALA VIRUS IgG PUUMALA VIRUS IgM PYRIDINOLINE PYRIMIDINE 5' NUCLEOTIDASE (2106) PYRUVATE (2106) PYRUVATE KINASE (2106) PYRUVATE KINASE 6681 6.7 14.3 U/g Hb Phenylalanine Pn IgG Type 1 Pn IgG Type 12 (12F) Pn IgG Type 14 Pn IgG Type 19 (19F) Pn IgG Type 23 (23F) Pn IgG Type 26 (6B) Page 85 Reference ranges 2013 Pn IgG Type 3 Pn IgG Type 4 Pn IgG Type 51 (7F) Pn IgG Type 56 (18C) Pn IgG Type 8 Pn IgG Type 9 (9N) Q FEV IGG PH I TITER "<1:16" Q FEV IGG PHASE I SC "NEGATIVE" Q FEV IGG PHASEII SC "NEGATIVE" Q FEV IGG PHII TITER "<1:16" Q FEV IGM PH II TIT "<1:16" Q FEV IGM PHASE I SC "NEGATIVE" Q FEV IGM PHASEI TIT "<1:16" Q FEV IGM PHASEII SC "NEGATIVE" Q FEVER IGG PHASE I TITER 900949 Q FEVER IGG PHASE II TITER 900950 Q FEVER IGM PHASE I TITER 900951 Q FEVER IGM PHASE II TITER 900952 Q FEVER W/RFL 85192 Q-FEVER (ACUTE) TITER Q-FEVER (ACUTE)(CF) DILS Q-FEVER IFA PHASE 1 "<1:16 (NEGATIVE)" Q-FEVER IFA PHASE 2 "<1:16 (NEGATIVE)" Q-FEVER PHASE I IgG titer Q-FEVER PHASE II IgG titer QCS ASTRA QCS CO-OX QCS CX3 QCS EPX PROFILE QUANTIFERON "Negative" QUANTITATIVE CULTURE QUEST INT. NUMBER QUINIDINE (766) 2.0 5.0 mg/L QUINIDINE (DC'D 06/14/12) ug/mL uG/ML .9 1.35 UG/ML 2.90 4.30 UG/ML 4.5 6.8 UG/ML .94 1.56 UG/ML 2.90 4.30 UG/ML 5.1 7.6 UG/ML 0.6 1.8 ug/mL 4.20 8.00 ug/mL 0.56 1.67 4.00 7.40 QUININE R. TYPHI IGG "Not detected" R. TYPHI IGG TITER "<1.64" R. TYPHI IGM "Not detected" R. TYPHI IGM TITER "<1:64" RA PRECIPITIN AB RABIES TITER (18232) titer RAJI CELL ASSAY RAPAMYCIN (122721) 3.0 18.0 ng/mL RAPID INFLUENZA (NASOPHARYNGEAL) RAPID INFLUENZA (THROAT) RAPID INFLUENZA TEST RAPID STREP (NE-GA) "NEGATIVE" RBC $S(SEX="M":4.63,1:3. $S(SEX="M":6.08,1:5. M/cmm #/cmm #/cmm #/cmm #/cmm RBC (HEMOGLOBINOPATHY EVAL.) x10 12/L Page 86 Reference ranges 2013 RBC (NE-GA) $S(SEX="M":4.69,1:4. $S(SEX="M":6.13,1:5. M/uL RBC CAST (NE-GA) /LPF RBC CLUMPS "NONE" RBC FOLATE ">366" ng/mL RBC FOLATE (Prior to 10/24/02) 225 700 NG/ML 225 700 nG/ML RBC FOLATE* RBC FRAGILITY (139731) RBC MORPHOLOGY RBC-BF #/cmm #/cmm #/cmm #/cmm #/cmm #/cmm #/cmm RDW 11.6 16.5 % RDW (HEMOGLOBINOPATHY EVAL.) % RDW (NE-GA) 11.6 14.8 % REACTION PH REAGENT STRIP (NE-GA) RECEPTOR BINDING AB "<=0.30" nmol/L RED BLOOD CELLS - LAB REFLEX DRVVT ADD-ON REFLEX HIV PROGRESSIVE (DON'T ORDER) REFLEX PROG. HIV-1 RNA ULTRA REFLEX PTT-LA ADD-ON REFLEX TESTING LUPUS PROFILE RELATIVE SUPERSATURATION RENAL EPITHELIAL CELLS "NONE" HPF RENAL TUBE EPITH RENIN ACTIVITY (16846) 0.25 5.82 ng/mL/hr RENIN ACTIVITY (2106) RENIN, DIRECT uU/mL Micro U/mL RENIN, DIRECT (10537*) REPORT COMMENTS REPORTED ETHNICITY REPTILASE TIME RESEARCH VENIPUNCTURE RESP SYNCYTIAL VIRUS TITER DILS RESPIRATORY SYNCYTIAL VIRUS RESPIRATORY VIRAL BATTERY (CF) RESULT (MTHFR) RESULT CYSTIC FIBROSIS RESULTS REV'D BY: RETIC # 2.84 12.12 10E4/uL RETICULIN STAIN RETICULOCYTE RETICULOCYTE % 0.51 1.81 % RETICULOCYTES & CBC RETICULUM CELL 0 2 % RETINOL BINDING PROTEIN (2106) REVEAL NEG. CONTROL REVEAL POS. CONTROL REVEAL RAPID HIV REVEAL RAPID HIV TEST REVERSE T3 (579*) ng/mL REVIEWER REVIEWER (MTHFR) RH GENOTYPING RH TITER Page 87 Reference ranges 2013 RHEUM CRP 0.8 mg/dL 0.3 0.7 mg/dL 2.2 3.4 mg/dL RHEUMATOID FACT 3752 "<14" IU/mL RHEUMATOID FACTOR (Prior to 5/1/00) RHEUMATOID FACTOR (QUANTITATIVE) 20 IU/ML 31.2 81.2 IU/ML 139 259 IU/ML 18.6 24.2 IU/mL 45.8 56.2 IU/mL RIA SET RICKETTSIA AB TITER, IGG 900955 RICKETTSIA AB TITER, IGM 900962 RICKETTSIA PNL W/RFL TO TITERS 37507 RICKETTSIAL ANTIBODY PANEL (468) RICKETTSIAL DISEASE PANEL 37478 RICKETTSIAL PANEL (prior to 6/6/01) RICKETTSIAL PNL37478 RIFAMPIN (30304) RING FORMS RISTOCETIN A (PLT AGG) RISTOCETIN COFACTOR 42 200 % of Norm. RISTOCETIN COFACTOR (34173) RISTOCETIN COFACTOR (U/mL) U/mL U/mL RITONAVIR MUTATIONS RMSF AB TITER, IGG 900953 RMSF AB TITER, IGM 900954 RMSF IGG "Not detected" RMSF IGG ANTIBODIES RMSF IGG TITER "<1:64" RMSF IGM "Not detected" RMSF IGM ANTIBODIES RMSF IGM TITER "<1:64" RMSF IgG titer RNP (prior to 9/19/03) EUs ROCKY MT SPOTTED FEVER "<1:16 (NEGATIVE)" ROULEAUX ROUTINE GROSS SURGICAL RPI (dc'd 9/17/07) RPR "NON REACTIVE" RRV (2106) RSV ANTIGEN TEST (2106) RTV RUBELLA (2106) RUBELLA AB, IgG (802) ">=1.10" Index RUBELLA IgG AB (prior to 9/1/03) IU/mL RUBELLA TITER (2106) RUBEOLA (2173*) ">=1.10" Index RUBRIBLAST 1 8 % RUBRICYTE 7 32 % RVP (GPHL) RVP (NASOPHARYNGEAL) RVP (THROAT) Recombx Hu Ri Ri Ab Titer Ri Ab, Western Blot S&M CHAIN ACYLCARNITINE S. VIRIDIS S. pneumoniae Ag
S. pneumoniae Antigens, Latex Aggl. SACCH CER IGG 138712 SALICYLATE 15 30 mg/dL mg/dL Page 88 Reference ranges 2013 105 157 UG/ML 298 399 UG/ML 478 717 UG/ML 100 151 MG/DL 320 400 MG/DL 450 680 MG/DL 10.1 30.1 mg/mL 434 802 mg/mL 7.00 21.00 427.00 793.00 35.3 48.9 mg/dL 2.33 3.21 mg/dL 13.1 18.3 mg/dL SALICYLATE (2106)
SALICYLATES (BLD) "None detected" SALINE TITER SALIVARY ISOAMYLASE U/L SALMONELLA A-H TITER SALMONELLA A-O TITER SALMONELLA AGGLUTINATION SALMONELLA B-H TITER SALMONELLA B-O TITER SALMONELLA C-H TITER SALMONELLA C-O TITER SALMONELLA D-O TITER SALMONELLA GROUP A SALMONELLA GROUP B SALMONELLA GROUP C SALMONELLA GROUP D SALMONELLA GROUP E SALMONELLA H ANTIGEN SALMONELLA O ANTIGENS SALMONELLA TYPHI-H TITER SAMPLE ID SAMPLE TO NEG CONT. DIFF (dc'd 9/17/07) SAQUINAVIR MUTATIONS SAQUINAVIR (TDM) ug/mL SC NEGATIVE CONTROL SC POSITIVE CONTROL SCA 6 ALLELE 2 (dc'd 09/10/07) SCA 7 ALLELE 1 (dc'd 09/10/07) SCA 7 ALLELE 2 (dc'd 09/10/07) SCA1 SCA1 ALLELE 1 (dc'd 9/7/07) SCA1 ALLELE 2 (dc'd 9/7/07) SCA10 SCA17 SCA2 SCA2 ALLELE 1 (dc'd 9/7/07) SCA2 ALLELE 2 (dc'd 09/10/07) SCA3 (MJD) SCA6 SCA6 ALLELE 1 (dc'd 0/10/07) SCA7 SCA8 SCA8 ALLELE 1 (dc'd 09/10/07) SCA8 ALLELE 2 (dc'd 09/10/07) SCALE SCANTIBODIES (SCL) SCHISTOCYTES SCHISTOSOMA AB (444) titer SCHISTOSOMA HAEMATOBIUM EXAM SCL-70 SCLERODERMA AB(4942) "<1.0" AI SCLERODERMA AB (prior to 8/17/03) EUs SCREEN, ALCOHOLS (2106) Page 89 Reference ranges 2013 SCREEN, TOXICOLOGY SCREEN-P. FALCIFARUM "NEGATIVE" SCREEN-P. NON-FALCIP "NEGATIVE" SCREENING PANEL SECOBARBITAL ng/ml ng/mL ng/mL SECOBARBITAL (PM) SECOBARBITAL, URINE "Negative" ng/mL SED RATE (NE-GA) mm/Hr SEG % 37.5 75.5 % SEG (NE-GA) % SELENIUM (62968) ng/mL SEMEN ANALYSIS SEMEN ANALYSIS (PRIOR TO 3/12/97) SEROLOGY SEROTONIN RELEASE ASSAY, UFH (14627) SEROTONIN, SERUM(29851) ng/mL 26 165 ng/mL ng/mL SEROTYPE 11 SEROTYPE 16 SEROTYPE 2 SEROTYPE 4 SERUM FOLIC ACID (265) ng/mL SERUM GLUCOSE (NE-GA) 70 115 mg/dl SERUM HCG (NE-GA) "NEGATIVE" SEX CHROMATIN TEST (2106) SEX HORMONE BINDING GLOBULIN (30740) 22 77 nmol/L SGOT (AST) (NE-GA) 0 48 U/L SGPT (ALT) (NE-GA) 30 65 U/L SIC/SBC SICKLE CELL PREP SICKLE CELL PREP (BLOOD) "NEGATIVE" "NEGATIVE" SICKLE CELL SCREEN SICKLE CELLS SICKLE SOLUBILITY SIDEROBLASTS SJOGREN'S ANTIBODIES (7832) SKIN DIRECT IF18899 SLIDE MAKER MANUAL SLIDE MAKER XE-2100 SM AB (prior to 9/19/03) EUs SM ANTIBODY INDEX SM/RNP ANTIBODY INDEX SMEAR PREP SACCOMANNO SMUDGE CELLS SOD SODIUM 40 220 mmol/24hrs 136 145 mmol/L 40 220 mmol/L 136 145 mmol/L 136 145 mmol/L 138 148 mmol/L 154.3 162.3 134 142 116.5 124.5 116.4 136.4 mmol/L 147.8 179.8 mmol/L 140 172 mmol/L 110 134 mmol/L 108 130 mmol/L 172 212 mmol/L 154.7 162.7 MMOL/L 120.9 128.9 MMOL/L 128.9 136.9 MMOL/L Page 90 Reference ranges 2013 118 130 mmol/L 152 172 mmol/L 76.0 115.0 163.0 244.0 117 129 mmol/L 150 170 mmol/L 67 100 mmol/L 138 207 mmol/L 148 168 mmol/L 142 162 mmol/L
136.0 144.0 mmol/L 136.0 144.0 mmol/L 110.5 118.5 mmol/L 110.5 118.5 mmol/L SODIUM (NE-GA) 138 148 mmol/L SODIUM URATE RS 2 2 SODIUM, 24HR URINE SODIUM, STOOL mEq/L SOLID TUMOR CUL.4474 SOMATOSTATIN SOURCE SOURCE : SOURCE : SOURCE (Q) SOURCE : SOURCE B. PERTUSSIS SOURCE BRAF MUT. SOURCE CMV SOURCE CMV QUANT. SOURCE GIARDIA AG SOURCE HERPES VIRUS6 SOURCE JAK2 SOURCE KRAS SOURCE MPL SOURCE MYCOBACTERIUM SOURCE PARVOVIRUS SOURCE T. GONDII SOURCE- SOURCE-BKV QNT SOURCE-EBV DNA SOURCE-EBV DNA QL SOURCE-HERPES VIR8 SOURCE-JC POLYOMA SOURCE-LIMULUS AMEB. SOUTHGATE'S MUCICARMINE STAIN SP SPECIMEN SPEC BLK/NUMBER SPEC. GRAVITY (PM) 1.003 SPEC1 GROWTH HORMONE ng/mL SPEC2 GROWTH HORMONE ng/mL SPECIFIC GRAVITY "1.010 - 1.025" SPECIFIC GRAVITY (NE-GA) "1.003 - 1.040" SPECIMEN INDICES SPECIMEN SENDOUT SPECIMEN SOURCE SPECIMEN SOURCE NPM: SPECIMEN VALIDITY TEST PANEL (16278) SPECIMEN: SPEP Page 91 Reference ranges 2013 SPEP RFX IFX 131682 SPERM COUNT "=>10 M/ML" M/ML SPERM IN URINE "NONE" SPERM IN URINE (NE-GA) SPG4 DNA SEQUENCING (ATHENA) SPHERO (NE-GA) SPHEROCYTES SPINAL CULTURE SPIROCHETE STAIN SPONTAN 9 % SPOROTRICHOSIS SPUN SPUTUM CYTOLOGY SPUTUM CYTOLOGY (SACCOMANNO) SPUTUM SCREEN SQUAMOUS EPITHELIAL "<5" /LPF SQV SSA "<1.0" AI SSB "<1.0" AI STACLOT-LA STARCH GRANULES STD PROBE PANEL STERILITY TEST STL INTERPT. STL IgG titer STL IgM titer titer STL. ENCEPHALITIS VIRUS SEROLOGY, IFA STOOL CULTURE STOOL CULTURE STOOL STORAGE MITE STRAIN SPECIFIC AG, BEIJING STRAIN SPECIFIC AG, GUANGDONG STRAIN SPECIFIC AG, JOHANNESBURG STRAIN SPECIFIC AG, TAIWAN STRAT. JCV(TM) AB INHIB90259 "Negative" STRATIFY JCV(TM) AB 90257 "Negative" STREP SCREEN STREP SCREEN THROAT STREP. PNEUMO URINARY ANTIGENS "NOT DETECTED" STREPTOMYCIN (1339) mcg/mL STREPTOZYME STRIATED MUSCLE AB "<1:10" ratio STRIATIONAL AB titer STROKE-BMP STROKE-CBC with DIFF. (Automated) STROKE-CMP STROKE-PT STROKE-PTT STRONG ADP 79 % STRONG RISTOCETIN 77 % STRONGYLOIDES IGG (2106) STRONGYLOIDES IGG AB, ELISA (28072) "<1.00" STRYCHNINE SUBSTANCE-P SUBSTITUTION 23.3 36.6 SECS SUBSTITUTION(1HR INC) 23.3 36.6 SECS SUDS HIV-1 SUDS HIV-1 TEST SUDS NEGATIVE CONTROL SUDS POSITIVE CONTROL SUGAR WATER TEST SULFA CRYSTALS SULFHEMOGLOBIN (2106) SULFONAMIDES Page 92 Reference ranges 2013 SUM PROCAIN + NAPA uG/ML SUPPRESSOR T CELLS SURG PATH REPORT PREP SURGICAL PATH REPORTING SURGICAL PATHOLOGY SURGICAL PATHOLOGY LOG-IN SYN. RATE IGG, CSF -9.9 +3.3 mg/day SYNERGY--MIC SYNERGY--MIC/MBC SYNOVIAL LINING CELLS % SYNT.CANNABINOID MET.91222 SYNTH CANNABINOID MET. CONF91224 SYNTHETIC NARCOTICS (2106)
Streptococcus, Group B Ag T AND B LYMPHOCYTES T CELLS ALPHA/BETA % % % 0 100 % 10 32 % T CELLS ALPHA/BETA CELLS/CMM CELLS/CMM 0 15000 CELLS/CMM 350 3100 C/CMM T CELLS ALPHA/BETA MARKERS T CELLS GAMMA/DELTA % % % 0 100 % 0.2 6 % T CELLS GAMMA/DELTA CELLS/CMM CELLS/CMM CELLS/CMM 0 15000 CELLS/CMM 7 240 C/CMM T CELLS GAMMA/DELTA MARKERS T UPTAKE (NE-GA) 31.0 39.0 % T-3 (Prior to 06/2003) .8 2 nG/ML .8 2 nG/ML T-4 (Prior to 06/2003) 4.5 11.0 uG/DL 4.5 11.0 uG/DL T-B PROTEIN ELECTROPHORESIS (11276) T-CELL REC GR (EMORY) T-CELL RECEPTOR (2361)
T. BILIRUBIN (NE-GA) 0.00 1.00 mg/dl T. CANDIDUS T. PALLIDUM IgG AB T. PALLIDUM IgM AB T. PROTEIN (NE-GA) 6.0 8.3 g/dl T. VULGARIS #1 T. VULGARIS #2 T.PALLIDUM CSF 17088 "NON-REACTIVE" T.V. PORPHOBILINOGEN mL T3 (2106) (dc'd 8/24/07) T3 UPTAKE (248*) T4 (2106) ug T4/dL T4 (NE-GA) 4.7 13.3 ug/dl T4 BINDING PROTEINS PANEL (471) TACROLIMUS LEVEL (70007) 5.0 20.0 ng/mL TALC CRYSTALS TARGET (NE-GA) TARGET CELLS TBG ug T4/dL TBG (435) ug/mL TBG-BOUND T4 ug/dL Page 93 Reference ranges 2013 TBG-BOUND T4/TBG ug/mg TCA (MG/G CREAT.) MG/G CREAT TCA (MG/L) MG/L TDT TEARDROPS TECHNICAL ASSISTANCE SURGICAL TEGRETOL ug/ml TEICHOIC ACID AB (2106) TEMAZEPAM TEMAZEPAM (PM) TEMP 7 (NEGA) TESTOSTERONE 280 800 ng/dL $S(SEX="M":178,1:"<1 $S(SEX="M":746,1:90) ng/dL 47 143 ng/dl ng/dl 800 1200 ng/dl 56.74 116.74 ng/mL 800 1200 ng/mL 32.00 95.00 522.00 969.00 4.92 7.4 ng/mL 2.19 3.31 ng/mL TESTOSTERONE (Prior to 10/23/99) 2.41 8.27 nG/ml .48 .88 ng/ml 4.57 6.43 ng/ml 8.57 12.86 ng/ml TESTOSTERONE (Prior to 7/1/95) 2.7 11 nG/ML 2.7 11 nG/ML TESTOSTERONE, BOUND ng/dL TESTOSTERONE, FREE pg/mL TESTOSTERONE, TOTAL ng/dL TETANUS AB EIA 53952 ">0.15" IU/mL TETANUS AB TITER IU/mL TETANUS AB, POSTIMM(3753)(DC'D 03/25/11) TETANUS AB, PREIMM(1826)(DC'D 03/25/11) TETANUS ANTIBODIES (2106) TETRACYCLINE TFV THALAS &HGB 12658 THALLIUM THEOPHYLLINE ug/mL 8 20 ug/mL 4 5.9 UG/ML 12.35 15.55 UG/ML 16 25 UG/ML 4.0 6.0 UG/ML 12.5 14.6 UG/ML 16 25 UG/ML 2.8 8.4 ug/mL 16.0 30.0 ug/mL 2.60 7.70 15.30 28.30 24.7 33.9 ug/mL 3.86 5.34 ug/mL 12.3 17.1 ug/mL THERAPEUTIC CYTAPHERESIS THERAPEUTIC PHLEBOTOMY THERAPEUTIC PLASMAPHERESIS THERMOSTABLE FRACTION U/L THERMOSTABLE FRACTION % % THIAMINE THIAZIDE (2106) THICK SECTION EM THIOCYANATE (2106) THIOPENTAL THIOPURINE MT 115431 Page 94 Reference ranges 2013 THIORIDAZINE THIORIDAZINE-MELLARI (2106) THREE TUBES THROAT CULTURE THROAT THROM. MARKER PNL (39476) THROMBIN TIME 5 60 Sec THROMBIN TIME (2893) 16 23 sec. THROMBIN-ANTITHROMBIN TAT "<4" mcg/L THYROGLOB. FNA 16559 "<0.1" ng/mL THYROGLOBULIN AB IU/mL THYROGLOBULIN PROFILE (1127*) THYROGLOBULIN QUANT. ng/mL THYROID GROUP THYROID PANEL (NE-GA) THYROID PANEL with TSH (NE-GA) THYROXINE, TOTAL ug/dL TIBC 259 462 ug/dL TIBC (on or before 5/29/03) 259 448 ug/dl 259 448 ug/dl TICK ID (6907) TIME 1 (ACTH) TIME 2 (ACTH) TIME 3 (ACTH) TIME1 GROWTH HORMONE TIME2 GROWTH HORMONE TOBRAMYCIN (3012) mg/L TOBRAMYCIN (on of before 5/30/03) ug/mL uG/ML .66 1.38 UG/ML 3.80 6.80 UG/ML 7.3 10.9 UG/ML .84 1.26 UG/ML 4.30 6.40 UG/ML 6.8 9.2 UG/ML 0.72 2.16 ug/mL 5.90 10.90 ug/mL 0.81 2.44 6.60 10.00 TOBRAMYCIN-PEAK 5.0 10.0 mcg/mL TOBRAMYCIN-RANDOM mcg/mL 7.3 10.5 ug/mL 0.98 1.42 ug/mL 3.37 4.85 ug/mL TOBRAMYCIN-TROUGH 1.0 2.0 mcg/mL TOCAINIDE (1807) TOLAZAMIDE TOLBUTAMIDE TOT. BILIRUBIN 0.2 1.2 mg/dL 0.2 1.2 mg/dL 0.3 1.2 mg/dL 1.09 1.57 mg/dL 6.4 8.0 mg/dL 1.08 1.88 mg/dL 5.8 9.8 mg/L 1.10 1.90 mg/dL 5.70 9.70 mg/dL 0.8 1.04 mg/dL 4.46 5.66 mg/dL TOTAL ng/mL TOTAL A & N ng/mL TOTAL ALKALINE PHOSPHATASE U/L TOTAL ALP U/L TOTAL CARNITINE umol/L TOTAL CAT.(N+E) pg/mL TOTAL CK U/L Page 95 Reference ranges 2013 TOTAL EOSINOPHILS EOS/CU MM TOTAL ESTROGEN (439) pg/mL TOTAL FECAL FATTY ACIDS "<7" g/24 hr TOTAL FECAL FATTY ACIDS (13217) TOTAL FREE(MN+NMN) "<=205" pg/mL TOTAL METANEPHRINES 224 832 ug/24 hr "<=205 pg/ml" pg/mL TOTAL NUCLEATED CELL 0 5 #/cmm #/cmm #/cmm #/cmm #/cmm #/cmm #/cmm TOTAL PLASMA HOMOCYSTEINE (2106) TOTAL POLYPEPTIDE PANEL (2106) TOTAL PROTEIN - PE 0 1350 mg/L 6.2 8.3 g/dL mg/dL 6.0 7.6 5.60 7.0 g/dL 6.10 9.20 g/dL 5.9 7.1 4.7 5.9 TOTAL PSA ng/mL TOTAL PTH 14.0 66.0 PG/ML TOTAL TESTOSTERONE ng/dL TOTAL VOLUME mL TOTAL VOLUME COPPER mL/24 h TOTAL VOLUME LEAD mL/24 h TOTAL VOLUME NTx mL TOTAL VOLUME ZINC mL/24 h TOTAL VOLUME, 24HR HM mL TOTAL WHITE COUNT ON CYTOPREP TOTAL(FLUOX+NORFLUO) 300 1150 mcg/L TOTAL(IMIPRAMINE+DESIPRAMINE) mcg/L TOX AB IGG/IGM (8636) TOX IGG AB "<=90" EIA value TOX IGM AB "Negative" TOX SCR, BLOOD (4420) TOX SCR, URINE (40607) TOXIC GRAN (NE-GA) TOXIC GRANULATION TOXICOLOGY SCREEN (299) TOXOCARA AB (2106) TOXOCARA AB IGA TOXOCARA AB IGG TOXOCARA AB IGM TOXOPLASMA DNA, QL "Not detected" TOXOPLASMA IgG AB (CSF Only) "NEGATIVE" TOXOPLASMA PCR 34451 TOXOPLASMA SCREEN (SERUM) TOXOPLASMA TITER TPMT (MAYO) DISCONTINIED 10/08/09 U/mL RBC TPMT ACTIVITY 18831 TPMT, ERYTHROCYTES(DC'D 12/16/2010) ">17.0" U/mL RBC TPV TRAMADOL ng/mL TRAMADOL, UR 16906 TRANQUILIZERS (2106) TRANQUILIZERS (BLD) "None detected" TRANSFERRIN 185 330 mg/dL 185 330 mg/dL 118 176 mg/dL 266 400 mg/dL 116 173 mg/dL 266 399 mg/dL Page 96 Reference ranges 2013 TRANSFERRIN (Q) 188 341 mg/dL TRANSFUSION REACTION C & S TRANSFUSION REACTION WORKUP - LAB TRANSFUSION REQUEST TRANSITIONAL EPITHELIAL CELLS "NONE" HPF TRANXENE TRAZODONE (1312) ng/mL TREPONEMA PALLIDUM IGG & IGM (11785) TRI CYCLIC ACID TRI PHOSPHATE CRYSTALS "NONE" TRI PHOSPHATE CRYSTALS (NE-GA) TRICHINELLA AGGLUTINATION TRICHLOROACETIC ACID, URINE (6246) TRICHOMONAS "NONE" TRICHOMONAS (NE-GA) TRICHOMONAS (T.VAG.) "NEGATIVE" "NEGATIVE" TRICHOMONAS, CULTURE TRICHROME STAIN TRICHROME STAIN STOOL TRICYCLICS (2106) TRIGLYCERIDE 10 190 mg/dL 0 199 mg/dL mg/dL mg/dL mg/dL mg/dL 73 109 mg/dL 142 190 mg/dL 66 86 mg/dL 106 166 mg/dL 59 95 mg/dL 119 167 mg/dL mg/dL 98 122 mg/dL 164 200 mg/dL TRIGLYCERIDE (NE-GA) 30 200 mg/dl TRIGLYCERIDE, S TRIMETHADIONE (2106) TRIMIPRAMINE (37123) 150 250 ng/mL TROPISM ASSAY 18578 TROPONIN I (7901)(Prior to 3/1/05) TROPONIN I (Prior to 3/1/05) ng/mL TROPONIN T (Ordered prior to 3/1/05) ng/mL ng/mL 0.12 0.2 ng/mL 4.67 7.03 ng/mL TROPONIN-I ng/ml ng/ml 0 0.09 ng/mL 1.40 4.60 ng/ml 4.70 15.30 ng/ml 20.0 50.0 ng/ml TROPONIN-I, ANCILLARY 0 0.09 ng/ml TROPOTYPE RESULT TRP,MET TRYPSIN (662) TRYPSIN, SERUM (12215) 19 68 ng/mL TRYPTAMINE TRYPTASE, SERUM (12722) TRYPTOPHAN (2115) umol/L TSH 0.30 5 uU/ml 0.34 5.60 uIU/mL .08 .17 uU/ml 12.5 16.1 uU/ml 20.501 31.501 uU/ml Page 97 Reference ranges 2013 0.14 0.22 uIu/mL 28 42 uIu/mL 0.12 0.20 19.00 28.00 1.76 2.24 mIU/mL 9.26 11.34 mIU/mL TSH (NE-GA) 0.50 6.00 UIU/ML TSH 0 .3 5 uIU/ML TSH 120 uIU/ML TSH 30 uIU/ML TSH 60 pG/mL TSH 90 TSH STIMULATION TEST TSI (30551) "<140 % baseline" TUBE # TULAREMIA AGGL 116982 titer TURBIDITY TWO TUBES TYPE & SCREEN - LAB TYPE 1, COXSACKIE B titer TYPE 10, COXSACKIE A titer TYPE 11, ECHOVIRUS titer TYPE 16, COXSACKIE A titer TYPE 2, COXSACKIE A titer TYPE 2, COXSACKIE B titer TYPE 3, COXSACKIE B titer TYPE 30, ECHOVIRUS titer TYPE 4, COXSACKIE A titer TYPE 4, COXSACKIE B titer TYPE 4, ECHOVIRUS titer TYPE 5, COXSACKIE B titer TYPE 6, COXSACKIE B titer TYPE 7, COXSACKIE A titer TYPE 7, ECHOVIRUS titer TYPE 9, COXSACKIE A titer TYPE 9, ECHOVIRUS titer TYPES OF STUDY TYPHOID H TYPHUS AB TITER "<1:16 (NEGATIVE)" TYPHUS FEVER IgG titer TYPHUS IGG AB TYPHUS IGM AB TYROSINE CRYSTALS "NONE" Total Volume mL/24hrs Tyrosine U46619 83 % UDS CONFIRM. 19499 UDS2 UDS3 UDS4 UFH HD, 100 IU/mL % Release UFH LD, 0.1/mL % Release UFH LD, 0.5 IU/mL % Release UFH SRA RESULT "NEGATIVE" UIBC 24.2 32.2 mmol/L 31.4 41.8 mmol/L ULTRA OR BLOOD GAS ULTRASENSITIVE HIV RNA PCR UNCLASS. CRYSTAL "NONE" UNCLASSIFIED % UNCLASSIFIED CAST "NONE" /LPF UNIDENTIFIED CELLS /LPF UNIGOLD NEG. CONTROL UNIGOLD POS. CONTROL Page 98 Reference ranges 2013 UNIGOLD RAPID HIV TEST UNIGOLD RAPID-HIV "NEGATIVE" UNIT ABO RECHECK UNIT INVENTORY UNIT LOG-IN/SEND-OUT UNIT MODIFICATION UNIT PHENOTYPING UNIT RELEASE UNIT RELOCATION UNIT RH RECHECK UPEP 24 HR URINE (133566) UPEP, 24HR URINE (DC'D 09/14/09) UPEP, RANDOM URINE (133577) UPEP, RANDOM URINE (DC'D 09/14/09) UPPER LIMIT (CHOL) UPPER LIMIT (TRIG) UPPER LIMIT(B-LD CH) UR MISC UREA NITROGEN 12000 20000 mg/24hrs 11 24 mg/dL mg/dL 11 24 mg/dL 8 23 mg/dL 5.6 8.4 mg/dL 43 55 mg/dL 581 781 mg/dL 779 1179 mg/dL 5.6 9.6 mg/dL 40.3 52.3 mg/dL 440 540 607.0 911.0 6.0 10.0 mg/dL 43 55 mg/dL 340 460 mg/dL 697 817 mg/dL 15.7 19.3 mg/dL 56.1 69.9 mg/dL
UREA NITROGEN, 24 HR URINE UREA NITROGEN/CREATININE RATIO 12 20 Ratio 12 20 Ratio 12 20 Ratio UREAPLASMA UREALYTICUM, URINE (5499) UREASE TEST URETHRAL WET PREP URIC ACID 250 750 mg/24hrs mg/dL $S(SEX="M":2.4,1:2.2 $S(SEX="M":7,1:5.6) mg/dL $S(SEX="M":4.4,1:2.3 $S(SEX="M":7.6,1:6.6 mg/dL 4.1 5.3 mg/dL 7.7 10.1 mg/dL 12.3 18.3 mg/dL 7.1 8.5 mg/dL 4.3 5.5 mg/dL 7.7 9.7 mg/dL 4.7 10.5 14.4 21.7 4.40 5.60 mg/dL 8.10 10.10 mg/dL 5.4 13.4 mg/dL 12.6 19.6 mg/dL Page 99 Reference ranges 2013 3.78 4.62 mg/dL 9.6 11.6 mg/dL
URIC ACID (24HR URINE) URIC ACID (NE-GA) 2.6 7.2 mg/dl URIC ACID (URINE) URIC ACID CRYSTALS "NONE" URIC ACID CRYSTALS (NE-GA) URIC ACID RS 2 2 URINALYSIS URINE 5HIAA mg/24 hr URINE 5HIAA (2636) URINE APPEARANCE (NE-GA) URINE BACTERIA "NONE" URINE BACTERIA (NE-GA) "NEGATIVE" URINE BILIRUBIN "NEGATIVE" URINE BILIRUBIN (NE-GA) "NEGATIVE" URINE BLOOD "NEGATIVE" URINE BLOOD (NE-GA) "NEGATIVE" URINE CAST URINE CAST (NE-GA)(Y/N?) URINE CASTS URINE CELLS URINE COLOR "YELLOW" URINE COLOR (NE-GA) URINE CRYSTAL URINE CRYSTALS URINE CRYSTALS (NE-GA)(Y/N?) URINE CYTOLOGY URINE DENSITY URINE DRUG SCREEN 476 URINE EPITH. CELLS URINE EPITHELIAL (NE-GA) "FEW-MODERATE" URINE GLUCOSE "NEGATIVE" URINE GLUCOSE (NE-GA) "NEGATIVE" MG/DL URINE HCG (NE-GA) "NEGATIVE" URINE HEMOSIDERIN URINE IRON (2106) URINE KETONE (NE-GA) "NEGATIVE" mg/dl URINE KETONES "NEGATIVE" URINE LEGIONELLA ANTIGEN (8856) URINE LEUKOCYTE (NE-GA) "NEGATIVE" URINE LEUKOCYTE ESTERASE "NEGATIVE" URINE LYTES URINE MICRO URINE MICROSCOPIC (NE-GA) URINE MICROSCOPY URINE MUCUS "NONE" URINE MUCUS (NE-GA) URINE MYOGLOBIN URINE NITRITE (NE-GA) "NEGATIVE" URINE PH URINE PH (NE-GA) 5.0 9 URINE PROTEIN "NEGATIVE" URINE PROTEIN (NE-GA) "NEGATIVE-TRACE" MG/DL URINE PROTEIN ELECTRO. (BEFORE-8/31/05) URINE RBC (NE-GA) 0 2 /HPF URINE RBC CASTS "NONE" /LPF URINE RBC/HPF "0-2/HPF" /HPF URINE SCREEN URINE SULFONYLUREAS (2106) URINE WBC (NE-GA) 0 5 /HPF Page 100 Reference ranges 2013 URINE WBC CASTS "NONE" /LPF URINE WBC/HPF "0-5/HPF" /HPF URINE YEAST "NONE" URINE YEAST (NE-GA) /LPF URINE pH "pH 5 - 7" UROBILINOGEN "<2.0" EU/dL UROBILINOGEN (NE-GA) 0.1 1.1 MG/DL UROPORPHYRIN ug/24 hr
URORISK CALCIUM 250 mg/day 250 MG/DAY URORISK CITRATE 320 mg/day 320 MG/DAY URORISK CREATININE 800-2000 mg/day MG/DAY URORISK MAGNESIUM 60 mg/day 60 MG/DAY URORISK OXALATE 45 mg/day 45 MG/DAY URORISK PH 5.5 5.5 URORISK PHOSPHORUS 1100 mg/day 1100 MG/DAY URORISK POTASSIUM 19-135 meq/day MG/DAY URORISK SODIUM 200 meq/day 200 MEQ/DAY URORISK SULFATE 30 mmol/day URORISK TOTAL VOLUME 2 L/day 2 L/DAY URORISK URIC ACID 700 700 MG/DAY URORISK(R) DIAGNOSTIC PROFILE (15565) Urine Creatinine mg/dL Urine M-Albumin mg/dL Urine Volume mL/24hr V. ZOSTER VACUOLES (NE-GA) VAGINAL WET PREP VAGINITIS PANEL VALPROIC ACID ug/mL ug/mL 20.8 28.8 UG/ML 62.0 85.0 UG/ML 92 138 UG/ML 19.9 29.9 UG/ML 61 87 UG/ML 93 139 UG/ML 18.0 54.0 ug/mL 83 151 ug/mL 20.00 60.00 79.00 148.00 107.0 155.0 ug/mL 25.7 35.7 ug/mL 60.8 84.0 ug/mL VAN GIESON STAIN VANCOMYCIN (on of before 5/30/03) ug/mL uG/ML 11 16.6 UG/ML 33.0 43.0 UG/ML 50.0 76 UG/ML 11.8 19 UG/ML 32 53 UG/ML 54 82 UG/ML 4.40 13.40 ug/mL 28 52 ug/mL 8.80 11.30 Page 101 Reference ranges 2013 29.00 54.00 VANCOMYCIN-PEAK 20 40 mcg/mL VANCOMYCIN-RANDOM 5 40 mcg/mL mcg/ml 27.7 36.1 ug/mL 5.87 7.67 ug/mL 15.8 20.6 ug/mL VANCOMYCIN-TROUGH 5 10 mcg/mL VAP CHOLESTEROL TEST VAR LYM (NE-GA) % VARIANT HEMOGLOBIN % VARICELLA-ZOSTER VARICELLA-ZOSTER (VZ) VARICELLA-ZOSTER AB, CF VARICELLA-ZOSTER VIRUS AB titer VARICELLA-ZOSTER VIRUS PCR (6828) VASO ACTIVE PEPTIDE (966) pg/mL VASOACTIVATED POLYPEPTIDE(DC'D03/18/11) VBEC DONOR VBEC QA/QC VBEC UNIT PROCESSING VC YEAST (2106) (d'cd 8/30/07) VDRL "NONREACTIVE" DILS VENOUS BLOOD GASES VENTRICULAR LINING CELLS % VIABILITY % 50 100 % VIBRIO CULTURE VIP (9663) 20 42 pg/mL VIRAL COMP. (GPHL) VIRAL COMP. (GPHL) NASOPHARYNGEAL VIRAL COMP. (GPHL) PHARYNX VIRAL COMP. (WEST HAVEN) VIRAL CULTURE (CMV SUSPECTED)(2106) VIRAL CULTURE (HSV SUSPECTED)(2106) VIRAL CULTURE (VZV SUSPECTED)(2106) VIRAL CULTURE (WEST HAVEN) VIRAL CULTURE, HERPES (2106) VIRAL CULTURE, RESPIRATORY (WEST HAVEN) VIRAL HEPATITIS B (SUSPECTED) VIRAL SEROLOGY VISA SCREEN VISCOSITY (918) rel to H2O 1.5 1.9 rel to H2O VISCOSITY, SERUM (EMORY) VIT D, 1,25(OH)2 TOT 18 72 pg/mL VIT D2, 1,25(OH)2 pg/mL VIT D3, 1,25(OH)2 pg/mL VITAMIN A (921) 38 98 mcg/dL VITAMIN B1 nmol/L 87 280 nmol/L VITAMIN B1, PLASMA (322) VITAMIN B1, WHOLE BLOOD (5042) VITAMIN B6 (926) 2.1 21.7 ng/mL 2.1 21.7 ng/mL VITAMIN C (929) 0.20 1.90 mg/dL VITAMIN D, 25-HYDROXY (17306) VITAMIN D, 25-OH, D2 ng/ml VITAMIN D, 25-OH, D3 ng/ml VITAMIN D, 25-OH, TOTAL 30 100 ng/ml VITAMIN E (931) VITAMIN K (3578) pg/mL VLDL-CHOLESTEROL 5 50 mg/dL 5 50 mg/dL VMA mg/24 hr Page 102 Reference ranges 2013 VMA (22326) VOL % O2 15 23 ML. O2/DL VOLATILES SCREEN (72408) VOLUME ML ML ML ML ML ML GRAMS 1.5 5 ML VOLUME (PE) VOLUME (SEMEN) 2.0 5 ML VON WILLEBRAND COMP PNL 197908 VON WILLEBRAND FACTOR AG(4919) % 50 217 % VON WILLEBRAND MULTIMER (47963) VON WILLEBRAND PANEL (2106) VON WILLEBRAND SCREEN 900171 VORICONAZOLE (19574) "<0.1" mcg/mL VORICONAZOLE MIC VRE SCREEN VRE SCREEN STOOL VWD MUTATION 19837 VWF AG, MULTIMERIC VWF PROTEASE 145328 VWF PROTEASE ACTIVITY ">530" ng/mL VWF PROTEASE INHIBITOR VZV AB PANEL (23112) VZV IgG AB ">=1.10" Index VZV IgG AB (4439) VZV IgM AB 0.00 0.90 ISR VZV IgM AB (23072) VZV-PCR, EYE FLUID (QUEST/FOCUS) Valine W. EQUINE ENCEPHALITIS AB PANEL, IFA WARFARIN (5103) ug/mL 1.0 10.0 ug/mL WAXY CASTS "NONE" /LPF WBC 4 11 K/cmm #/cmm #/cmm #/cmm #/cmm WBC (NE-GA) 4.6 10.2 K/uL WBC CAST (NE-GA) /LPF WBC CLUMP "NONE" WE INTERPT. WE IgG titer WE IgM titer titer WEAK ADP 17 % WEAK RISTOCETIN 9 % WEAKLY & FREE BOUND TESTOSTERONE (2106) WEST NILE AB (IGG,IGM)36597 WEST NILE IGG "<1.30" index WEST NILE IGM "<0.90" index WEST NILE VIRUS CSF(132764) WEST NILE, SER132762 "Not detected" WEST NILE/ARBOVIRUS (CSF) (GPHL) WEST NILE/ARBOVIRUS (SERUM) (GPHL) WEST NILE/ARBOVIRUS IgG WEST NILE/ARBOVIRUS IgM WEST. BLOT Page 103 Reference ranges 2013 WESTERGREN ESR & CBC WESTERGREN* MM/HR 3.0 7.0 mm/hr 36.0 52 mm/hr 7 11 mm/hr 80 100 mm/hr WET PREP: SKIN SCRAPING (NE-GA) WET PREP: URETHRAL (NE-GA) WET PREP: VAGINAL (NE-GA) WHOLE BLOOD - LAB WHOOPING COUGH CULTURE WINTROBE ESR & CBC WINTROBE* 0 12 WINTROBE, WESTERGREN, CBC WK COLLAGEN 69 % WKLD CROSSMATCH WN VIRUS IgG titer WN VIRUS IgM titer titer WP-BACTERIA (NE-GA)
WP-CLUE CELLS (NE-GA) WP-EPITH (NE-GA)
WP-TRICHOMONAS (NE-GA)
WP-WBC (NE-GA)
WRIGHT STAIN X25 ALLELE 1 (dc'd 09/10/07) X25 ALLELE 2 (dc'd 09/10/07) XANTHURENIC ACID XYLOSE ABSORPTION (Prior to 3/25/02)
YEAST YEAST (CANDIDA SPP.) "NEGATIVE" "NEGATIVE" YEAST PHASE YERSINIA CULTURE YO AUTOANTIBODIES (2106) Yo Yo Ab Titer Yo Ab, IFA Z-SCORE (FEMALE) Z-SCORE (MALE) ZDV ZINC mg/24 hr ug/dL ZINC (945) ZINC, 24 HOUR URINE 946 ZINC, 24HR UR (DC'D 03/10/11) ZINC, 24HR URINE 100 1200 mcg/24hr ZPP ZZ24HR U.PROTEIN ZZ25 OH VITAMIN D 20 100 ng/mL 20 100 ng/mL ZZADDITONAL CD MARKER16 ZZADDITONAL CD MARKER17 ZZAFB CULTURE/AFB SMEAR ASPIRATE ZZAFB CULTURE/AFB SMEAR BRONCHIAL WASH ZZAFB CULTURE/AFB SMEAR EXUDATE ZZAFB CULTURE/AFB SMEAR PERICARDIAL ZZAFB CULTURE/AFB SMEAR PERITONEAL Page 104 Reference ranges 2013 ZZAFB CULTURE/AFB SMEAR PLEURAL ZZAFB CULTURE/AFB SMEAR SPUTUM ZZAFB CULTURE/AFB SMEAR SYNOVIAL ZZAFB CULTURE/AFB SMEAR TISSUE ZZAFB CULTURE/AFB SMEAR TRANSTRACHEAL ZZANTI IGA AB (2106) ZZANTI-DNASE B ZZBETA 2-MICROGLOB (2106) ZZC&S (ANA)/GRAM STAIN ASPIRATE ZZC&S (ANA)/GS TRANSTRACHEAL ZZC&S (ANAEROBE)/GRAM STAIN EXUDATE ZZC&S (ANAEROBES)/GRAM STAIN PERICARDIAL ZZC&S (ANAEROBES)/GRAM STAIN PERITONEAL ZZC&S (ANAEROBES)/GRAM STAIN PLEURAL ZZC&S (ANAEROBES)/GRAM STAIN SYNOVIAL ZZC&S (ANAEROBES)/GRAM STAIN TISSUE ZZC&S/GC CULTURE/GRAM STAIN CERVICAL ZZC&S/GC CULTURE/GRAM STAIN URETHRAL ZZC&S/GRAM STAIN BRONCHIAL WASH ZZC&S/GRAM STAIN EYE ZZC&S/GRAM STAIN LEFT EAR ZZC&S/GRAM STAIN NASAL ZZC&S/GRAM STAIN RIGHT EAR ZZC&S/GRAM STAIN SPUTUM ZZC&S/GRAM STAIN WOUND ZZC. DIFFICILE TOXIN A ZZCARBON MONOXIDE (2106) ZZCARDIAC ENZYMES ZZCARDIOLIPIN PANEL (2106) ZZCBC (WITH DIFF) ZZCBC (WITH DIFF) ZZCHEM 20 ZZCHLAMYDIA CULTURE (877) ZZCHLAMYDIA SP PANEL, G,M,A (6927) ZZCHLAMYDIA/GC DNA PROBE (2669*) ZZCHOLINEST. SER 37965 IU/L ZZCIPROFLOXACIN (2106) ZZCLOSTRIDIUM DIFFICILE CULTURE ZZCOAGULATION (PT & PTT) ZZCOCAINE (URINE) ZZCOMPLEMENT TOTAL (2106) ZZCORTISOL 7 25 ug/dl 7 25 uG/DL ZZCREATINE ZZDIFF COUNT (BLOOD) ZZDNA (2106) ZZDRUG SCREEN, URINE ZZETHOSUXIMIDE ZZFECAL FAT ZZFLT3 MUTATIONAL ANALYSIS ZZFUNGAL ANTIGEN (2106) ZZFUNGUS CULTURE/KOH PREP BRONCHIAL WASH ZZFUNGUS CULTURE/KOH PREP SPUTUM ZZFUNGUS CULTURE/KOH PREP TISSUE ZZFUNGUS CULTURE/KOH PREP TRANSTRACHEAL ZZGC CULTURE/GRAM STAIN CERVICAL ZZGC CULTURE/GRAM STAIN EYE SWAB ZZGC CULTURE/GRAM STAIN RECTAL SWAB ZZGC CULTURE/GRAM STAIN URETHRAL ZZGIEMSA STAIN ZZGLUCOSE (NSP) 70 110 MG/DL 75.0 89.0 MG/DL 185.0 215.0 MG/DL 269.0 319.0 MG/DL ZZGLUCOSE, 2HR P.P. (prior to 12/23/03) ZZHCG Page 105 Reference ranges 2013 ZZHEMOGLOBIN (QUEST) 12.4 17.2 g/dL ZZHEPATITIS C - PCR (QUAL) ZZHIV ANTIBODY EIA (prior to 7/28/08) ZZHIV RNA PCR (2106)(dc'd 10/04/07) ZZHLA B8 ZZHLA TYPING DR (ARC) (dc'd 8/22/07) ZZHLA-ABC & DR PHENOTYPE PANEL (3897) ZZHOMOCYSTINE (2106) ZZIMI+DES ZZIMMUNOFLUORESCENCE, DIRECT (EMORY) ZZINDIA INK PREP/FUNGUS CULTURE CSF ZZINFLUENZA TYPE A AB, TITER (GPHL) ZZIRON GROUP (NEW) ZZKETONES "NEG" "NEG" ZZKRAS MUTATION ANALYSIS (16510) "NEGATIVE" ZZLIPID PROFILE (Prior to 7/16/99) ZZMETHANOL (2106) ZZMYASTHENIA GRAV(21572)(DC'D10/5/11) ZZMYELOPEROXIDASE AB ZZNOVA PANEL ZZNTX,24HR URINE (DC'D 06/21/10) ZZOPEN HEART ADMISSION ZZOPEN HEART ROUTINE ZZOR BLOOD GAS ZZPARASITE EXAM STOOL ZZPHENYLALANINE ZZPLASMA FREE HGB ZZPLATELET AGGREGATION ZZPLATELET AGGREGATION-GRADY (2106) ZZPORPHYRINS FRACT. (DC'D 1/19/11) ZZPORPHYRINS, URINE, QUALITIATIVE (229) ZZPROINSULIN ZZPROTEINASE-3 AB ZZPT Mean of Normals of Norm ZZREQUEST FOR BLOOD BANK SAMPLE ZZROCKY MTN SPOTTED FV. TITER ZZSECOBARBITAL ZZSEROTONIN RELEASE ASSAY (SRA)(14627) "<20 % release" % ZZSTOOL CULT. (VIBRIO) ZZSTROKE-CBC (WITHOUT DIFF.) ZZT-HELPER PROFILE ZZTROPONIN I & T (2106)* ZZTROPONIN T ZZTROPONIN T (2106) ZZTROPONIN-I CENTAUR ng/mL 4.10 6.10 NG/ML 25.8 38.7 NG/ML ZZTYPHUS AB TITER ZZURINALYSIS ZZURINALYSIS (NE-GA) ZZURINE MICROSCOPIC ZZURORISK (MISSION) ZZVIT D, 1,25-DIHYDROXY ZZVITAMIN B-12 ZZVITAMIN B-2 ZZZALCOHOL PROFILE (2106) ZZZBLOOD CULTURE ZZZBLOOD GASES ZZZC&S (ANAEROBES)/GRAM STAIN CSF ZZZDIGOXIN (DO NOT USE) ZZZFOLATE PROFILE (NEW) ZZZHAVAB PANEL(TOTAL & IgM) ZZZHIV IMMUNOLOGY ZZZOCCULT BLOOD (PARASITOLOGY) Page 106 Reference ranges 2013 ZZZOCCULT BLOOD (x3) ZZZOR CARDIAC PANEL ZZZPLATELET AGGREGATION ZZZPROROTEIN C ANTIGEN (2106) ZZZRJE1 ZZZTOX SCREEN ZZZULTRA OR BLOOD GAS ZZZURINALYSIS ZZZURINE MICROSCOPY c100 & 5-1-1 (NS4) c22 (Gene Region c) c33c (Gene Region NS3) d-XYLOSE ABSORPTION, BLOOD (147) d-XYLOSE ABSORPTION, URINE (116) d-XYLOSE, 1HR. mg/dL d-XYLOSE, 2HR. mg/dL d-XYLOSE, 30MIN mg/dL d4T MUTATIONS d4T ddC MUTATIONS ddC ddI MUTATIONS ddI eGFR(AFR.AMER.) 60 60 eGFR(NON-AFR.AMER.) 60 60 hSOD junction b2a2 (EXON 2) junction b3a2 (EXON 3) junction e1a2 (EXON 1) p53 pro-BNP pg/mL proBNP (SEND OUT)11188 pg/ml t(15;17),PML,RAR ALPHA,RT-PCR (11574) t(9;22) tTG IgA AB (8821) U/mL vWF ANTIGEN % 50 217 % zzcbc (without diff)
Press RETURN to continue...
Enter or Edit File Entries Print File Entries Search File Entries Inquire to File Entries Data Dictionary Utilities ... Lab Messaging - New results received for LA7V HOST AML Enter "VA to jump to VIEW ALERTS option
Page 107